etoposide and ifosfamide
etoposide has been researched along with ifosfamide in 1528 studies
Research
Studies (1,528)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 80 (5.24) | 18.7374 |
1990's | 496 (32.46) | 18.2507 |
2000's | 501 (32.79) | 29.6817 |
2010's | 372 (24.35) | 24.3611 |
2020's | 79 (5.17) | 2.80 |
Authors
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
Alim, Z; Beydemir, Ş | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carter, SK; Slavik, M | 1 |
Bunn, PA; Chretien, PB; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston, AV; Kenady, DE; Lipson, SD; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
Bunn, PA; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston-Early, A; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE | 1 |
Crown, JP; Doherty, M; Fair, W; Gulati, SC; Herr, H; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Weisen, S | 1 |
Ansari, R; Einhorn, L; Loehrer, PJ; Pennington, K; Rynard, S; Songer, J | 1 |
Burghouts, JT; Carney, DN; Festen, J; Palmen, FM; Planting, AS; Postmus, PE; Quoix, E; Roozendaal, K; Splinter, TA; Vendrik, C | 1 |
Faustini, M; Gianni, L; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R | 1 |
Barnhill, DR; Blessing, JA; Hatch, KD; Soper, JT; Sutton, GP | 1 |
Thongprasert, S | 2 |
Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M | 2 |
Evans, WK; Goss, PE; Latreille, J; Logan, D; Maroun, J; Paul, K; Shepherd, FA; Stewart, D; Warner, E | 1 |
Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Smit, EF | 1 |
Bonfrer, JM; Jassem, E; Mooi, WJ; van Tinteren, H; van Zandwijk, N | 1 |
García Arroyo, R; García Gómez, R; González del Val, R; Martínez del Prado, P; Meana García, A; Pérez Manga, G | 1 |
Akita, H; Arimoto, T; Asakawa, M; Fujikane, T; Isobe, H; Kawakami, Y; Miyamoto, H; Nakabayashi, T; Shimizu, T; Suzuki, A | 1 |
Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S | 1 |
Dahrouge, S; Evans, WK; Goss, G; Latreille, J; Logan, D; Maroun, J; Shepherd, FA; Stewart, D; Warner, E | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ; Vlamis, V; Weisen, S | 1 |
Chariot, P; de Cremoux, H; Le Chevalier, T; Monnet, I; Quoix, E; Ruffié, P; Saltiel, JC; Voisin, S | 1 |
Kudo, R; Sagae, S | 1 |
Beyer, J; Grabbe, J; Huhn, D; Lenz, K; Siegert, W; Strohscheer, I; Weisbach, V | 1 |
Ezaki, K; Hirano, M; Ino, T; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Shimizu, K; Shinkai, K; Sobue, R | 1 |
Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A | 1 |
Bross, K; Brugger, W; Dern, P; Frisch, J; Kanz, L; Mertelsmann, R; Weber, B | 1 |
Saxman, S | 1 |
Arnold, H; Bross, K; Heidemann, E; Heim, ME; Hoffman, I; Josten, K; Manegold, C; Reinold, HM; Schalk, KP; Steinke, B | 1 |
Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M | 1 |
Ezaki, K; Hirano, M; Maruyama, F; Okamoto, M | 1 |
Cabanillas, F | 3 |
Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S | 1 |
Smith, IE | 1 |
Weiss, RB | 1 |
Bryant, G; Carter, C; Cottler-Fox, M; Cowan, KH; Goldspiel, B; Jain, V; Longo, DL; Steinberg, SM; Wilson, WH; Wittes, RE | 1 |
Fletcher, B; Kun, L; Marina, N; Meyer, WH; Parham, D; Pratt, CB; Rao, B; Roberson, P | 1 |
Gedikoğlu, G; Zülfikar, B | 1 |
Hansen, HH; Hansen, M; Hansen, OP; Lund, B | 1 |
Einhorn, LH; Langefeld, C; Loehrer, PJ; Munshi, NC; Neuman, A; Nichols, CR; Roth, BJ; Sledge, G; Walsh, WB; Williams, SD | 1 |
Higashihara, T; Hojo, K; Kajiyama, K; Kumasaka, Y; Nishiyama, S; Okada, M; Oku, Y | 1 |
Biron, P; Blay, JY; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Clavel, M; Dumontet, C; Meckenstock, R; Philip, I; Philip, T | 1 |
Baba, H; Tomita, K; Tsuchiya, H; Ueda, Y; Yasutake, H; Yokogawa, A | 1 |
Brugger, W; Frisch, J; Kanz, L; Mertelsmann, R; Pressler, K; Schulz, G | 1 |
Bokemeyer, C; Harstrick, A; Hohnloser, J; Illiger, HJ; Metzner, B; Osternamm, A; Preiss, J; Ruther, U; Schmoll, HJ; Wilke, H | 1 |
Watts, RG | 1 |
Ben-Shahar, M; Epelbaum, R; Haim, N; Robinson, E; Rosenblatt, E; Wollner, M | 1 |
Broun, ER; Einhorn, LH; Loehrer, PJ; Nichols, CR; Tricot, G; Williams, SD | 1 |
Arimoto, T; Asakawa, M; Fujikane, T; Kawakami, Y; Miyamoto, H; Nakabayashi, T; Onodera, S; Shimizu, T; Suzuki, A; Yasuda, S | 1 |
Ash, CM; Geddes, D; Goldman, J; Harper, PG; Souhami, RL; Spiro, SG; Tobias, JS; Twelves, CJ | 1 |
Becker, H; Drings, P; Flechtner, H; Hans, K; Heim, M; Hruska, D; Mende, S; Pritsch, M; Schroeder, M; Wolf, M | 1 |
Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N | 1 |
Cherryman, G; Hoskin, PJ; Parton, D; Smith, IE; Yarnold, JR | 1 |
Bokemeyer, C; Bruderek, L; Casper, J; Harstrick, A; Köhne-Wömpner, CH; Schmoll, E; Schmoll, HJ; Schöber, C; Stahl, M; Wilke, H | 1 |
Albertazzi, L; Bassetto, MA; Marangolo, M; Pizzocaro, G; Rosti, G; Salvioni, R; Valzania, F | 1 |
Broun, ER; Einhorn, LH; Nichols, CR; Tricot, GJ | 1 |
Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R | 2 |
Bremer, K; Uhlenbusch, R | 1 |
Anderson, H; Prendiville, J; Radford, JA; Swindell, R; Thatcher, N | 1 |
Berdel, W; Bokemeyer, C; Harstrick, A; Illiger, HJ; Manegold, C; Metzner, B; Ostermann, H; Räth, U; Schmoll, HJ; Siegert, W | 1 |
Izumi, S; Nagasue, N; Nishida, T; Sakihama, H; Yakushiji, M | 1 |
Bosl, GJ; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Tan, CC | 1 |
Croles, JJ; Hoekstra, JW; Splinter, TA; van der Gaast, A | 1 |
Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W | 1 |
Anders, CH; Moritz, T; Nagel-Hiemke, M; Niederle, N; Nowrousian, MR; Schmidt, CG; Seeber, S | 1 |
Bourstyn, E; Brice, P; Colin, P; D'Agay, MF; Extra, JM; Fermand, JP; Fermé, C; Frija, J; Lepage, E; Miclea, JM | 1 |
Brack, N; Brittinger, G; Dornoff, W; Engelhard, M; Enne, W; Gassmann, W; Gerhartz, H; Hallek, M; Heise, J; Meusers, P | 1 |
Andreopoulos, D; Glöckner, WM; Klose, KC | 1 |
Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
Alonso Muñoz, C; Blanco Guerrero, R; Climent Durán, MA; Germà Lluch, JR; López López, JJ; López Pousa, A; Mercedes Ramírez, A | 1 |
Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R | 1 |
Kredentser, DC | 1 |
Hausamen, TU; Loeffler, TM; Weber, FW | 1 |
Denzlinger, C; Gerl, A; Issels, RD; Mittermüller, J; Ortmaier, A; Sauer, H; Simon, W; Wilmanns, W | 1 |
Bottero, G; Bruzzone, M; Campora, E; Donadio, M; Ferrari, I; Giudici, S; Iskra, L; Merlini, L; Ragni, N | 1 |
Ash, CM; Earl, HM; Harper, PG; James, L; Miles, DW; Rudd, R; Souhami, RL; Spiro, SG; Tobias, JS; Trask, CW | 1 |
Avella, M; Bacci, G; Dallari, D; De Cristofaro, R; Ferruzzi, A; Manfrini, M; Marangolo, M; Mercuri, M; Picci, P; Pignatti, G | 1 |
Akiba, Y; Fujita, Y; Ikushima, Y; Ishida, S; Ohosaki, Y; Onodera, S; Sakai, E; Saotome, K; Shimizu, T; Tagaki, S | 1 |
Airo, I; Helve, O; Hiltunen, KM; Mattila, J | 1 |
Brincker, H; Mirza, MR | 1 |
Clemm, C | 1 |
Baker, MA; Buick, S; Farquharson, HA; Goss, PE; Scott, JG; Shepherd, FA; Sutcliffe, S; Sutton, D; Warner, E | 1 |
Calabró, F; Daniele, O; Fiore-Donati, L; Fiorentino, MV; Fornasiero, A; Ghiotto, C; Piazza, M; Rea, F | 1 |
Bickel, J; Drings, P; Kaufmann, M; Manegold, C; Schmid, H; Worst, P | 1 |
Fletcher, BD; Jenkins, JJ; Lemmi, MA; Marina, NM; Meyer, WH; Parham, DM; Slade, W | 1 |
Berger, H; Boehm, E; Denecke, H; Issels, RD; Jauch, KW; Nagele, A; Peter, K; Prenninger, SW; Sauer, H; Wilmanns, W | 1 |
Iqbal, Z; Mallick, JA; Zaidi, SH | 1 |
Dubbelman, R; Franklin, H; McVie, JG; Simonetti, G; ten Bokkel Huinink, WW; van Tinteren, H; van Zandwijk, N; Wanders, J | 1 |
Anderson, H; Carroll, KB; Lind, MJ; Swindell, R; Thatcher, N; Woodcock, A | 1 |
Ashley, SA; Ford, HT; Forgeson, GV; Perren, TJ; Smith, IE; Woodiwiss, J; Yarnold, JR | 1 |
Evans, WK; Goss, PE; Latreille, J; Logan, D; Maroun, J; Shepherd, FA; Stewart, D; Warner, E | 1 |
Loehrer, PJ | 1 |
Bernard, JP; Brune, J; Champel, F; Chauvin, F; Clavel, M; Cordier, JF; Emonot, A; Guérin, JC; Kalb, JC; Trillet, V | 1 |
Brandes, A; Cipriani, A; Favaretto, A; Festi, G; Fornasiero, A; Ghiotto, C; Paccagnella, A; Pappagallo, G; Vinante, O; Volpi, A | 1 |
Chasen, MR; Falkson, G; Falkson, HC | 1 |
Bronchud, MH; Kamthan, AG; Lind, MJ; Ranson, MR; Steward, WP; Stout, R; Thatcher, N | 1 |
Bedini, AV; Bidoli, P; Casali, P; Guzzon, A; Santoro, A; Spinazzè, S | 1 |
Arriagada, R; Daurès, JP; Douillard, JY; Dubois, JB; Godard, P; Le Chevalier, T; Mary, H; Pujol, JL; Rossi, JF; Rouanet, P | 1 |
Bajorin, DF; Cooper, K; Dmitrovsky, E; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sogani, P | 1 |
Hamaguchi, K; Harataka, J; Nagasue, N; Nishimura, H; Okura, N; Yakushiji, M | 1 |
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
Bruntsch, U; Eschenbach, I; Gropp, C; Köppler, H; Lötzke, E; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, EU; Zeller, W | 1 |
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Schneider, A; Stieber, P | 1 |
Neuhaus, KL; Zeymer, U | 1 |
Cawley, JC; Davies, JM; Hay, CR; Nash, JR; Parry, H; Phillips, JK; Spearing, RL | 1 |
Kaern, J; Tropé, C; Vergote, I; Vossli, S | 1 |
Enblad, G; Glimelius, B; Hagberg, H; Lindemalm, C | 1 |
Breatnach, F; Broadbent, V; Craft, AE; Hartmann, O; Morris-Jones, P; Pearson, AD; Pinkerton, CR; Pritchard, J; Wallendszus, KR; Zucker, JM | 1 |
Dombrowski, H; Drings, P; Hans, K; Harms, V; Havemann, K; Holle, R; Victor, N; Wolf, M | 1 |
Brittinger, G; Dörken, B; Engelhard, M; Engert, W; Enne, W; Fuchs, R; Gerhartz, HH; Hagen-Aukamp, CH; Huhn, D; Thiel, E | 1 |
Brittinger, G; Engelhard, M; Gerhartz, H; Heinz, R; Huhn, D; Meusers, P; Neubauer, A; Siegert, W; Stacher, A; Thiel, E | 1 |
Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
Boven, E; De Pauw, M; Harris, A; Jones, W; Kaye, SB; Sleijfer, D; Splinter, T; Stoter, G; Ten Bokkel Huinink, W; Van Oosterom, A | 1 |
Kelland, LR; Steel, GG; Tonkin, KS | 1 |
Alton, NK; Bronchud, M; Crowther, D; Dexter, TM; Scarffe, JH; Souza, LM; Testa, NG; Thatcher, N | 1 |
Diehl, V; Schaadt, M; von Kalle, AK | 1 |
Bross, K; Heidemann, E; Heim, ME; Hofmann, I; Josten, K; Kraft, A; Löffler, B; Reinold, HM; Richter, C; Steinke, B | 1 |
Brittinger, G; Engelhard, M; Gerhartz, HH; Heinz, R; Huhn, D; Meusers, P; Siegert, W; Stacher, A; Thiel, E; Wilmanns, W | 1 |
Bergerat, JP; Duclos, B; Dufour, P; Garcia, JJ; Herbrecht, R; Oberling, F | 1 |
Clemm, C; Hartenstein, R; Sauer, H | 1 |
Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M | 1 |
Anders, C; Höffken, K; Meier, CR; Nowrousian, MR; Osieka, R; Schmidt, CG; Schoetensack, B | 1 |
Buckner, JC; Edmonson, JH; Long, HJ; Loprinzi, CL; Schaid, DJ | 1 |
Einhorn, LH | 1 |
Drings, P | 1 |
Becker, H; Drings, P; Flechtner, H; Goerg, R; Hans, K; Havemann, K; Holle, R; Schroeder, M; Wolf, M | 1 |
Einhorn, LH; Loehrer, PJ; Williams, SD | 1 |
Cerny, T; Lind, M; Stout, R; Swindell, R; Thatcher, N | 1 |
Azab, M; Droz, JP; Ghosn, M; Guimares, J; Mahjoubi, M; Moran, A; Ostronoff, M; Pico, J; Ribrag, V; Theodore, C | 1 |
Bodrogi, I | 1 |
Campbell, C; Carroll, KB; Lind, M; Moussalli, H; Payne, C; Stout, R; Thatcher, N | 1 |
Errington, RD; Green, JA; Hardman, PD; Myint, S; Warenius, HM | 1 |
Kano, Y; Masaoka, T; Mikuni, C; Sakamoto, S; Sampi, K; Takagi, T | 1 |
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P | 1 |
Abdel-Hadi, S; Adde, M; el-Taneer, O; Gad-el-Mawla, N; Hussein, MH; Magrath, I | 1 |
Anderson, H; Barber, PV; Barnes, P; Cerny, T; Deiraniya, A; Stout, R; Thatcher, N; Wolstenholme, RJ | 1 |
Dommes, M; Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Mende, S; Schroeder, M; Wolf, M | 1 |
Ardizzoni, A; Baracco, F; Capaccio, A; Fabiano, F; Felletti, R; Fusco, V; Gulisano, M; Nosenzo, M; Pastorino, G; Pronzato, P | 1 |
Bozzino, JM; Cantwell, BM; Corris, P; Harris, AL | 1 |
Einhorn, LH; Kalasinski, LA; Lauer, R; Loehrer, PJ; Roth, BJ; Williams, SD | 1 |
Becker, H; Gropp, C; Hans, K; Havemann, K; Klasen, H; Maasberg, M; Schroeder, M; Stalleicken, D; von Bültzingslöwen, F; Wolf, M | 1 |
Becker, H; Bülzebruck, H; Djawid, N; Drings, P; Ruchalla, E; Stiefel, P; Tessen, HW | 1 |
Brust, J; Paschke, R; Queisser, W; Worst, P | 1 |
Nagasue, N; Nishida, T; Obuchi, T; Sasaki, T; Yakushiji, M | 1 |
Grieve, RJ; Harris, RI; Leyland, MJ; Patton, WN; Sangster, G | 1 |
Drings, P; Manke, HG | 1 |
Barkley, HT; Benjamin, RS; Bodey, GP; Frankmann, C; Jeffries, DG; McMurtrey, MJ; Murphy, WK; Valdivieso, M; Welch, SR | 1 |
Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Manke, HG; Schroeder, M; Victor, N; Wolf, M | 1 |
Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P | 1 |
Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS | 1 |
Forquer, R; Jarosinski, P; Kinsella, TJ; Magrath, I; Miser, JS; Triche, TJ; Tsokos, M; Wesley, R | 1 |
Hino, K; Ibaraki, T; Katou, Y; Kiyozuka, Y; Maruyama, M; Nabuchi, K; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M | 1 |
Baume, D; Droz, JP; Ghosn, M; Kramar, A; Moran, A; Ostronoff, M; Pico, JL; Salloum, E; Spielmann, M; Theodore, C | 1 |
Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ | 1 |
Berger, NA; Lazarus, HM | 1 |
Greist, A; Hoffman, R; Kubilis, PS; Loehrer, PJ; Nichols, CR | 1 |
Arnold, W; Nowak, C; Steinhoff, G; Tanneberger, S | 1 |
Chiuten, D; Dhingra, HM; Dicke, K; Farha, P; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M; Vellekoop, L; Zander, A | 1 |
Bergsagel, DE | 1 |
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Riggs, S; Salvador, P; Tannir, N; Velasquez, WS | 1 |
Cabanillas, F; Fuller, L; Hagemeister, FB; McLaughlin, P; Riggs, S; Smith, T; Velasquez, WS | 1 |
Crowther, D; Gasser, AB; Scarffe, JH; Steward, WP; Wagstaff, J | 1 |
Cavallin-Ståhl, E; Hagberg, H; Lind, J | 1 |
Drings, P; Gropp, C; Havemann, K; Konrad, RM; Liesenfeld, A; Mahnke, HG; Seifert, W; Thomas, C; Wellens, W; Westerhausen, M | 1 |
Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ | 1 |
Adolphs, HD; Hartlapp, J; Schwabe, HW | 1 |
Gahrton, G | 1 |
Barkley, HT; Bodey, GP; Burgess, MA; Hersh, EM; Mountain, CF; Rodriguez, V; Tenczynski, TF; Valdivieso, M | 1 |
Denck, H; Karrer, K; Pridun, N; Zwintz, E | 1 |
Boutin, P; Carcassone, Y; Cupissol, D; Michel, FB; Plagne, R; Serrou, B | 1 |
Havemann, K | 1 |
Nakhosteen, JA; Niederle, N | 1 |
Barkley, HT; Bodey, GP; Burgess, MA; Cabanillas, F; Chen, T; Frazier, H; Keating, M; Murphy, WK; Valdivieso, M | 1 |
Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S | 1 |
Cattaneo, MT; Piazza, E; Varini, M | 1 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B | 1 |
Bremer, K; Niederle, N; Scheulen, ME; Seeber, S | 1 |
Drings, P; Grimm, V; Kleckow, M; Manke, HG; Schmitteckert, H; Stiefel, P | 1 |
Barkley, HT; Benjamin, RS; Bodey, GP; Ertel, M; Freeman, MB; Mountain, CF; Smith, TL; Valdivieso, M | 1 |
Dicke, KA; Lanzotti, V; Litam, J; McCredie, KB; Samuels, ML; Spitzer, G; Valdivieso, M; Verma, DS; Zander, A | 1 |
Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
Scheulen, ME; Schilcher, RB; Schmidt, CG; Seeber, S | 1 |
Bremer, K; Higi, M; Krischke, W; Niederle, N; Scheulen, ME; Schmidt, CG; Seeber, S | 1 |
Akbulut, H; Arican, A; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoğuz, H | 1 |
Agranat, P; Epardeau, B; Extra, JM; Jedynak, P; Mignot, L | 1 |
Bleehen, NM; Girling, DJ; Machin, D; Stephens, RJ | 2 |
Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 2 |
Dieckmann, KP; Loy, V | 2 |
Kawamura, J; Nakano, S; Onishi, T; Sugimura, Y; Tochigi, H; Yanagawa, M | 1 |
Ezaki, K; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
Broun, ER; Einhorn, LH; Lazarus, HM; Loehrer, PJ; Nichols, CR; Roth, BJ; Turns, M; Williams, SD | 1 |
Ben-Dayan, D; Djaldetti, M; Floru, S; Mittelman, M | 1 |
Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R | 1 |
Hirano, M | 1 |
Chiang, Y; Cowan, KH; Dunbar, CE; Goldspiel, B; Kohler, D; McDonagh, KT; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, BP; Wilson, W | 1 |
Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE | 2 |
Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M | 1 |
Akakura, K; Akimoto, S; Masai, M; Ohki, T; Shimazaki, J | 1 |
Dexter, TM; Pettengell, R; Testa, NG; Thatcher, N; Woll, PJ | 1 |
Brugger, W; Frommhold, H; Kanz, L; Mertelsmann, R; Pressler, K | 1 |
Hobisch, A; Joannidis, M; Krall, M; Nevinny-Stickel, M; Pfaller, W; Schober, M; Thorwartl, U | 1 |
Bildet, F; Cour-Chabernaud, V; Hodgetts, J; Lomax, L; Thatcher, N; Woll, PJ | 1 |
Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
Brandi, M; De Lena, M; Ditonno, P; Lorusso, V; Marzullo, F; Pellecchia, A; Timurian, A; Ventrella, V | 1 |
Cabanillas, F; Cortes, JE; Kurzrock, R; Seymour, JF; Talpaz, M | 1 |
Dercksen, MW; Dirkson, MK; Gerritsen, WR; Pinedo, HM; Rodenhuis, S; Schaasberg, WP; Slaper-Cortenbach, IC; van der Schoot, CE; von dem Borne, AE | 1 |
Saeter, G; Solheim, OP; Talle, K | 1 |
Mead, GM; Simmonds, PD; Whitehouse, JM | 1 |
Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C | 1 |
Crawford, J; George, M | 1 |
Khan, AA; Rodriguez, JM | 1 |
Ben-Shahar, M; Epelbaum, R; Haim, N | 1 |
Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ | 1 |
Amill, B; Brunet, S; Domingo-Albós, A; García-López, J; Madoz, P; Martínez, C; Mateu, R; Portos, JM; Subirà, M; Sureda, A | 1 |
Cardenal, F; Garciá del Muro, X; Vicente, P | 1 |
Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
Postmus, PE; Smit, EF | 1 |
Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N | 1 |
Heinz, R; Hopfinger, G; Koller, E; Pittermann, E; Schneider, B | 1 |
Ansari, R; Einhorn, LH; Fisher, W; Gonin, R; Loehrer, PJ; Monaco, F; Sandler, A | 1 |
Aledo, A; Boland, P; Casper, ES; Gerald, WL; Healey, JH; Heller, G; Kushner, BH; La Quaglia, MP; Meyers, PA; Wollner, N | 1 |
Brewster, AE; Burt, PA; Hopwood, P; Stout, R; Thatcher, N | 1 |
Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
Bonomi, PD; Comis, RL; Ettinger, DS; Johnson, DH; Neuberg, D; Ruckdeschel, JC; Wolff, AC | 1 |
de Campos, E; Dougal, M; Milroy, R; Radford, J; Steward, W; Swindell, R; Testa, N; Thatcher, N | 1 |
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 2 |
Meisenberg, BR | 1 |
Chang, AY | 1 |
Cairo, MS | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC | 1 |
Betticher, D; Hanley, S; Hardy, C; Lee, SM; Lorigan, P; Thatcher, N; Weir, D; Woodhead, M | 1 |
Elfenbein, GJ; Fields, KK; Perkins, JB | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hsieh, S | 1 |
Hamada, M; Inoue, H; Nakagawa, Y; Ozaki, T; Sugihara, S | 1 |
Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
Desai, SJ; Dickerman, JD; Goorin, AM; Harris, MB; Inoue, S; Krischer, JP; Kung, FH; Murphy, SB; Pratt, CB; Toledano, S | 1 |
Andersen, J; Antman, K; Elias, A; Frel, E; Holden, S; Rosowsky, A; Schwartz, G; Tretyakov, O; Wheeler, C; Wright, JE | 1 |
Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N | 1 |
Bicknell, S; Cassidy, J; Hatton, MQ; Semple, P; Stack, B; Steward, WP | 1 |
Aster, JC; Inhorn, RC; Roach, SA; Slapak, CA; Soiffer, R; Stone, RM; Tantravahi, R | 1 |
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 1 |
Hagemeister, FB | 2 |
Brugger, W; Kanz, L; Mertelsmann, R | 2 |
Bertz, H; Birken, R; Brugger, W; Frisch, J; Hecht, T; Kanz, L; Mertelsmann, R; Pressler, K; Schulz, G | 1 |
Bonnel, C; Catry-Thomas, I; Eghbali, H; Hoerni, B; Soubeyran, P | 1 |
Gallup, DG; Garris, PD; Melton, K | 1 |
Ansari, R; Einhorn, LH; Faylona, EA; Gonin, R; Loehrer, PJ; Sandler, AB | 1 |
Crooks, GM; Sato, JK | 1 |
Douglass, EC; Green, DM; Grier, HE; van Hoff, J | 1 |
Göbel, U; Harms, D; Pape, H; Spaar, HJ; Wessalowski, R; Willers, R | 1 |
Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E | 1 |
Bajorin, DF; Bokemeyer, C; Bosl, GJ; Demetri, GD; Einhorn, LH; Kantoff, PW; Nichols, CR; Schmoll, HJ | 1 |
Ogawa, M; Tanaka, H; Tanaka, T; Tanizawa, M; Watanabe, Y | 1 |
Bokemeyer, C; Clemm, C; Harstrick, A; Illiger, HJ; Link, H; Metzner, B; Ostermann, H; Rüther, U; Schmoll, HJ; Siegert, W | 1 |
Boyter, AC; Cargill, RI; Lipworth, BJ | 1 |
André, T; Bonnak, H; Bouleuc, C; Donsimoni, R; Esteso, A; Firmin, C; Gerota, J; Izrael, V; Lotz, JP; Merad, Z | 1 |
Colvin, OM; Frenkel, E; Kamen, BA | 1 |
Ballester, OF; Cooper, BW; Creger, RJ; Elfenbein, GJ; Fields, KK; Hiemenz, JH; Janssen, WE; Lazarus, HM; Perkins, JB; Zorsky, PE | 1 |
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
Ekberg, L; Elisson, LO | 1 |
Berchier, MC; Bureau, G; Giner, V; Kroll, F; Küstner, U; Michel, J; Mommen, P; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
Ettinger, DS | 2 |
Einhorn, LH; Loehrer, PJ | 1 |
Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N | 1 |
Cabanillas, F; Hagemeister, FB; Hill, D; McLaughlin, P; Moore, DF; Rodriguez, MA; Romaguera, JE; Sarris, AH; Swan, F; Younes, A | 1 |
Elfenbein, GJ; Fields, KK; Hiemenz, JW; Janssen, WE; Kronish, LE; Machak, MC; Perkins, JP; Zorsky, PE | 1 |
Baurmann, H; Beyer, J; Bokemeyer, C; Huhn, D; Oettle, H; Schmoll, HJ; Siegert, W; Strohscheer, I; Zimmermann, R; Zingsem, J | 1 |
Bajetta, E; Buzzoni, R; Colleoni, M; Nelli, P; Nolè, F | 1 |
Hayot, M; Le Chevalier, T; Michel, FB; Pujol, JL; Rouanet, P | 1 |
Baker, LH; Blair, SC; Zalupski, MM | 1 |
Asbury, R; Boros, L; Chang, AY; Hsieh, RK | 1 |
Douglass, EC; Jones, DP; Marina, NM; Meyer, WH; Pratt, CB; Wilimas, JA | 1 |
Antman, KH; Ayash, LJ; Elias, AD; Frei, E; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
Gandara, DR; Gardner, SL; Perez, EA; Sowray, PC | 1 |
Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
Fanning, J; Hilgers, RD; Hutson, E | 1 |
Burt, P; Lorrigan, P; Stout, R; Thatcher, N | 1 |
Bowman, LC; Douglass, EC; Furman, WL; Hudson, M; Marina, NM; Meyer, WH; Pappo, A; Rodman, J; Santana, VM; Shema, SJ | 1 |
Ardiet, JM; Boyer, J; Chauvin, F; Fournel, P; Laennec, E; Mornex, F; Perol, M; Piperno, D; Trillet-Lenoir, V; Voloch, A | 1 |
Cabanillas, F; Rodriguez, MA | 1 |
Burghouts, JT; Haaxma-Reiche, H; Postmus, PE; van der Graaf, WT | 1 |
Elomaa, I | 1 |
Cottler-Fox, M; Cowan, K; Dunbar, CE; Goodman, S; Leitman, S; Nienhuis, AW; O'Shaughnessy, J; Quesenberry, P; Sorrentino, BP; Stewart, FM | 1 |
Berdel, W; Bokemeyer, C; Clemm, C; Harstrick, A; Hohnloser, J; Illiger, HJ; Metzner, B; Räth, U; Schmoll, HJ; Siegert, W | 1 |
Elfenbein, GJ; Fields, KK; Hiemenz, JW; Kronish, LE; Zorsky, PE | 1 |
Bowman, LC; Furman, W; Jones, DP; Marina, NM; Meyer, WH; Murry, DJ; Pratt, CB; Rodman, JH; Shema, SJ | 1 |
Birkmann, J; Eschenbach, I; Gropp, C; Holle, R; Köppler, H; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, UE; Zeller, W | 1 |
Comis, R; Haas, N; Kilpatrick, D; Krigel, RL; Langer, C; Padavic, K; Palackdharry, CS | 1 |
Dahrouge, S; Evans, WK; Goss, G; Latreille, J; Logan, D; Maroun, JA; Shepherd, FA; Stewart, DJ; Warner, E; Wierzbicki, R | 1 |
Gandara, DR; Perez, EA | 1 |
Krigel, RL; Palackdharry, CS | 1 |
Hamdan, H; Skubitz, KM; Thompson, RC | 1 |
Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P | 1 |
Beddoe, AM; Cohen, CJ; Dottino, PR | 1 |
Kamble, R; Raina, V; Sharma, S; Singh, SP; Tanwar, R | 1 |
Mai, KT; Stewart, DA; Stewart, DJ | 1 |
Craft, AW; Pearson, AD; Yule, SM | 1 |
Ihara, H; Kageyama, S; Kawabe, K; Kurita, Y; Mugiya, S; Nakano, M; Suzuki, K; Ueda, D; Ushiyama, T; Yamaguchi, Y | 1 |
Siegert, W | 1 |
Hibi, S; Imashuku, S; Kataoka, Y; Morimoto, M; Naya, M; Takaya, K; Todo, S | 1 |
Bryant, G; Cowan, KH; Dunbar, C; Goldspiel, B; Gress, R; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, B; Stewart, FM; Wilson, W | 1 |
Craft, AW; Davies, SM; Jones, PH; King, DJ; Kynaston, JA; Malcolm, AJ; Mitchell, CD; Oakhill, A; Stiller, CA | 1 |
Beyer, J; Bokemeyer, C; Illiger, HJ; Kneba, M; Kynast, B; Metzner, B; Ostermann, H; Poliwoda, H; Räth, U; Schmoll, HJ | 1 |
Bell, B; Bernstein, ML; Buchanan, GR; Devine, S; Dreyer, Z; Grier, H; Krischer, J; Kung, F; Land, V; Whitehead, VM | 1 |
Gajewski, J; Lee, M; Nimer, S; Schiller, G; Territo, M | 1 |
Ashley, S; Catovsky, D; Cunningham, D; Gore, ME; Hickish, T; Mansi, J; Nicolson, V; Roldan, A; Smith, IE | 1 |
Abdel-Rahman, S; Bosse, D; Issels, RD; Jauch, KW; Schildberg, FW; Starck, M; Wilmanns, W | 1 |
Kirkpatrick, A; Postmus, PE; Smit, EF; Splinter, TA | 1 |
Johnson, BE | 1 |
Cornelius, AS; Murry, DJ; Teresi, ME | 1 |
Denzlinger, C; Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
Droz, JP; Kramar, A; Pico, JL | 1 |
Cassidy, J; Kaye, SB | 1 |
Anderson, H; Ashcroft, L; Hopwood, P; Prendiville, J; Radford, JA; Thatcher, N | 1 |
Barnett, MJ; Coppin, CM; Klingemann, HG; Murray, N; Nantel, SH; Nevill, TJ; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
Herrmann, C; Hiddemann, W; Meyer, T; Schauer, A | 1 |
Bowman, LC; Douglass, E; Furman, W; Hudson, M; Marina, NM; Meyer, W; Rodman, J; Santana, VM; Shema, SJ; Wilimas, J | 1 |
Golembe, B; Holbrook, CT; Homans, AC; Jaffe, N; Kung, FH; Nitschke, R; Pratt, CB; Schwenn, M; Strother, D; Vega, RA | 1 |
Bell, DR; Dalley, D; Levi, J; Simes, RJ; Stuart-Harris, R; Wiltshaw, E | 1 |
Kellner, R; Schütte, J; Seeber, S | 1 |
Abdel-Rahman, S; Berger, H; Bosse, D; Issels, RD; Jauch, KW; Panzer, M; Peter, K; Sauer, H; Starck, M; Stiegler, H | 1 |
Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
Baker, TR; Hempling, RE; Piver, MS | 1 |
Bacci, G; Battistini, A; Ferrari, S; Orlandi, M; Puggioli, C; Sassoli, V; Strazzari, S | 1 |
Köpf-Maier, P; Sass, G | 1 |
Juliusson, G | 1 |
Barrantes, JC; García, I; Lobo-Sanahuja, F; Santamaría, S | 1 |
Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
Cheng, AL | 1 |
Carstens, C; Lowry, PA | 1 |
Bastion, Y; Berger, F; Brice, P; Chéron, N; Fermé, C; Gabarre, J; Lepage, E; Morel, P; Nédellec, G; Reman, O | 1 |
Baker, M; Goss, P; Scott, JG; Shepherd, F; Sutcliffe, S; Sutton, D | 1 |
Elfenbein, GJ; Fields, KK; Moscinski, LC; Perkins, JB | 1 |
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
Fukuda, M; Horibe, K; Matsumoto, K; Miyajima, Y; Mori, H; Numata, S | 1 |
Göbel, U; Harms, D; Jürgens, H; Niehues, T | 1 |
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
Adde, MA; Arndt, C; Gootenberg, J; Horak, ID; Magrath, IT; Neely, JE; Nieder, ML; Seibel, NL; Shad, AT; Venzon, DJ; Weintraub, M | 1 |
Bonilla, MA; Boulad, F; Cheung, NK; Crouch, G; Gerald, WL; Ghavimi, F; Kelleher, JF; Kushner, BH; LaQuaglia, MP; Lindsley, KL; Merchant, TE; Meyers, PA; Steinherz, PG; Wollner, N | 1 |
Biron, P; Droz, JP | 1 |
Dover, JS; Lee, PK | 1 |
Lokich, J | 1 |
Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H | 1 |
Békradda, M; Culine, S; Droz, JP; Farhat, F; Terrier-Lacombe, MJ; Théodore, C | 1 |
Anderson, PM; Skubitz, KM | 1 |
Crowther, D; Deakin, DP; Harris, M; Morgenstern, GR; Pettengell, R; Radford, JA; Ryder, D; Scarffe, JH; Wilkinson, PM; Woll, PJ | 1 |
Enblad, G; Glimelius, B; Hagberg, H | 1 |
Chen, B; Chen, S; DiGiusto, R; Gearing, D; King, J; Murray, L; Reading, C; Simonetti, D; Tong, J; Van den Berg, D; Wessman, M; Yamasaki, G | 1 |
Benvenuto, F; Carella, AM; Carlier, P; Chimirri, F; Dejana, A; Ferrara, RA; Florio, G; Frassoni, F; Gatti, AM; Incagliato, M; Lerma, E; Piaggio, G; Pitto, A; Podestà, M; Pollicardo, N; Prencipe, E; Soracco, M; Valbonesi, M; Vassallo, F; Vimercati, R | 1 |
DeAngelis, LM; O'Brien, JP; Portlock, CS; Wong, ET | 1 |
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL | 1 |
Vose, JM | 1 |
Effenbein, GJ; Fields, KK; Perkins, JB | 1 |
Nichols, CR | 2 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L | 1 |
Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P | 1 |
Harstrick, A; Klaassen, U; Schleucher, N; Schröder, J; Seeber, S; Vanhoefer, U; Wilke, H | 1 |
Amenta, P; Drachtman, RA; Ettinger, LJ; Han, P | 1 |
Avery, L; Fang, L; Furman, WL; Luo, X; Marina, N; Pratt, CB | 1 |
Avilés, A; Delgado, S; Díaz-Maqueo, JC; García, EL; Guzmán, R; Nambo, MJ | 1 |
Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Kroll, F; Küstner, U; Lecomte, J; Michel, J; Mommen, P; Paesmans, M; Sculier, JP; Sergysels, R; Van Cutsem, O | 1 |
Bucsky, P; d'Oleire, F; Eleftheriadis, S; Feyerabend, T; Freund, C; Gillis, W; Katschinski, DM; Mentzel, M; Robins, HI; Touhidi, RR; van Heek, R; Wagner, T; Weiss, C; Wiedemann, GJ | 1 |
Andersen, S; Blatter, J; Bosanquet, N; Copley-Merriman, K; Drings, P; Johnson, N; Koch, P; van Schaik, J | 1 |
Aguilar-Ponce, L; Dueñas-Gonzalez, A; Frias-Mendivil, M; Gallardo-Rincon, D; Lara-Medina, F; Miranda-Lopez, E; Reynoso-Gomez, E; Sobrevilla-Calvo, P; Zinser-Sierra, J | 1 |
Anderson, N; Bern, M; Coco, F; Dow, E; Lokich, J; Moore, C | 1 |
Izrael, V; Lotz, JP | 1 |
Akaza, H; Kawai, K | 1 |
Avila, N; Balis, FM; DeLaney, TF; Hijazi, YM; Horowitz, ME; Jacobson, J; Jarosinski, P; Steinberg, SM; Tsokos, M; Weaver-McClure, L; Wexler, LH | 1 |
Clamon, G; Crawford, J; Graziano, SL; Green, MR; Herndon, JE; Rege, VB; Richards, F; Valone, FH | 1 |
Arpin, D; Bohas, C; Cordier, JF; Court-Fortune, I; Ecochard, D; Perol, M; Riou, R; Soler, P; Trillet-Lenoir, V | 1 |
Gautier, V; Michel, FB; Pujol, JL; Zinaï, A | 1 |
Blanke, C; Einhorn, LH; Loehrer, PJ; Nichols, CR | 1 |
Bolzicco, G; Crinó, L; De Marinis, F; Emiliani, E; Figoli, F; Gentile, A; Marangolo, M; Maranzano, E; Masiero, P; Meacci, L; Morandi, MG; Ricardi, U; Rosti, G; Scagliotti, GV; Tonato, M | 1 |
Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
Fisch, P; Herbst, B; Köhler, G; Kulmburg, P; Lindemann, A; Mackensen, A; Mertelsmann, R; Rosenthal, FM; Schaefer, HE; Veelken, H | 1 |
Fountzilas, G; Karabelis, A; Kattis, K; Kosmidis, P; Mylonakis, N; Pavlidis, N; Samantas, E; Skarlos, D | 1 |
Anteby, SO; Edelman, DZ; Peretz, T | 1 |
Carella, AM; Frassoni, F | 1 |
Ahn, C; Doroshow, JH; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Tetef, M | 1 |
Beyer, J; Bokemeyer, C; Diehl, A; Droz, JP; Einhorn, LH; Greinix, A; Kramar, A; Linkesch, W; Mandanas, R; Nichols, CR; Pico, JL; Schmoll, HJ; Siegert, W | 1 |
Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
Bosquée, L; Cetto, GL; Hamdan, O; Humblet, Y; Lange, A; Leyvraz, S; Marangolo, M; Pampallona, S; Pasini, F; Perey, L; Rosti, G | 1 |
Bokemeyer, C; Schmoll, HJ | 1 |
Motzer, RJ | 2 |
André, T; Bazelly, B; Bouleuc, C; Chapiro, J; Gattegno, B; Gligorov, J; Houry, S; Izrael, V; Lotz, JP; Péne, F; Selle, F | 1 |
Beyer, J; Siegert, W | 1 |
Abu Rabia, A; el-Attar, I; el-Said, A; Gaafar, R; Gad el-Mawla, N; Hamza, MR; Khaled, HM; Magrath, I | 1 |
Brandt, A; Palmer, AJ | 1 |
Burghouts, JT; Curran, D; Giaccone, G; Gozzelino, F; Groen, HJ; Kirkpatrick, A; Postmus, PE; Sahmoud, T; Scagliotti, G; Splinter, TA | 1 |
Horn, TD; Prussick, R; Turner, MC; Wilson, WH | 1 |
Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
Amill, B; Aventin, A; Azqueta, C; Berlanga, J; Boqué, C; Cancelas, JA; de la Banda, E; Español, JI; Ferrá, C; García, J; Grañena, A; Llucià, M; Muñoz, J; Petit, J; Sarrá, J; Torrico, C | 1 |
Fanning, J; Hilgers, RD | 1 |
Bargou, R; Dörken, B; Hildebrandt, M; Körner, IJ; Krahl, D; Mapara, MY; Reichardt, P | 1 |
Finegold, MJ; Gunawardena, SW; Ogden, AK; Trautwein, LM | 1 |
Beyer, J; Huhn, D; Kingreen, D; Krause, M; Schleicher, J; Schwaner, I; Schwella, N; Siegert, W | 1 |
Boerrigter, L; Mooi, WJ; Rodenhuis, S; Slebos, RJ; Top, B; van Zandwijk, N; van't Veer, L | 1 |
Hirao, Y; Kaneko, Y; Momose, H; Okajima, E; Ozono, S; Samma, S; Tsumatani, K; Watanabe, S; Yamada, K | 1 |
Ameri, A; Delattre, JY; Monjour, A; Poisson, M; Ronchin, P; Sahmoud, T; Sanson, M | 1 |
Rodriguez, MA | 1 |
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
Crahé, R; Deeken, M; Eleftheriadis, S; Gutsche, S; Katschinski, DM; Mentzel, M; Robins, HI; Storer, B; Wagner, T; Weiss, C; Wiedemann, GJ | 1 |
Baltes-Engler, S; Dederichs, B; Diehl, V; Engelhard, M; Engert, A; Küpper, F; Lathan, B; Reiser, M; Scheulen, ME; Schnell, R; Tesch, H; Wilhelm, M; Winterhalter, B; Wörmann, B | 1 |
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 2 |
Burgut, R; Hastürk, S; Kocabas, A; Kurt, B; Orüç, O | 1 |
Aydemir, U; Bierwolf, S; Brittinger, G; Engelhard, M; Gerhartz, HH; Griesser, H; Huhn, D; Lennert, K; Meusers, P; Siegert, W; Thiel, E; Tiemann, M; Wilmanns, W | 1 |
Broun, ER; Cornetta, K; Einhorn, LH; Gize, G; Hromas, RA; Nichols, CR; Schacht, B | 1 |
Leo, E; Lindemann, A; Schlegel, PG | 1 |
Avet-Loiseau, H; Berger, C; Bernard, JL; Brunat-Mentigny, M; De Lumley, L; Demaille, MC; Gentet, JC; Kalifa, C; Pacquement, H; Pein, F; Pillon, P; Sariban, E; Schmitt, C | 1 |
Bleyer, A; Fairclough, D; Furman, WL; Garrison, L; Luo, X; Marina, N; Meyer, WH; Pratt, CB | 1 |
Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ | 1 |
Chen, YM; Chou, CM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, MF; Yang, KY | 1 |
Allan, DR; Bernstein, CN; Greenberg, H; Johnston, JB; Pimentel, M | 1 |
Oliver, RT | 1 |
Baek, SY; Choi, GB; Choi, JH; Han, WS; Shim, KN; Sung, SH | 1 |
Champlin, R; Edwards, CL; Giralt, S; Kavanagh, JJ; Kudelka, AP; Mehra, R; Piamsonboom, S; Termrungruanglert, W; van Besien, K; Verschraegen, C | 1 |
Engelhardt, M; Henschler, R; Lange, W; Mertelsmann, R; Waller, C; Winkler, J | 1 |
Barişta, I; Başçil, N; Celik, I; Güllü, IH; Kars, A; Tekuzman, G; Yalçin, S | 1 |
Bajorin, DF; Bosl, GJ; Mazumdar, M; McCaffrey, JA; Motzer, RJ; Vlamis, V | 1 |
Bergman, I; Cnaan, A; Garvin, JH; Goldwein, JW; Grass, J; Molloy, P; Needle, MN; Phillips, PC; Sutton, L; Zhao, H | 1 |
Anderson, S; Haynes, AP; McQuaker, IG; Russell, NH; Stainer, C | 1 |
Chao, HT; Wang, HM; Wang, PH; Yuan, CC | 1 |
Brennemann, W; Helmers, A; Jäger, N; Klingmüller, D; Mezger, J; Stoffel-Wagner, B | 1 |
Dodds, D; Mehta, M; Nonis, J; Rampling, R | 1 |
Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
Junker, K; Rübe, C; Semik, M; Thomas, M; von Eiff, M | 1 |
Carey, RW; Elias, AD; Grossbard, ML; Herbst, R; Jacobs, C; Kwiatkowski, DJ; Leong, T; Lynch, C; Lynch, TJ; Skarin, AT; Strauss, GM | 1 |
Hallahan, D; Mundt, AJ; Williams, SF | 1 |
Cabanillas, F; Rodriguez-Monge, EJ | 1 |
Oblon, DJ; Paul, S; Yankee, R | 1 |
Chen, YM; Liu, JM; Perng, RP; Whang-Peng, J; Wu, MF; Yang, SL | 1 |
Agaliotis, DP; Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Mattox, T; Perkins, JB; Rosen, RM; Zorsky, PE | 1 |
Ben-Shahar, M; Epelbaum, R; Faraggi, D; Haim, N; Leviov, M; Tsuri-Etzioni, A | 1 |
Bertz, H; Brugger, W; Fetscher, S; Kanz, L; Krieger, G; Lange, W; Mertelsmann, R | 1 |
Albera, C; Bèguelin, R; Cacchione, R; Campestri, R; Dragosky, M; Dupont, J; Fernández, J; Garay, G; Nicastro, M; Noviello, V; Nucifora, E; Riveros, D; Schnidrig, P; Triguboff, E | 1 |
Alvegård, TA; Erlanson, M; Hannisdal, E; Klepp, R; Monge, OR; Raabe, N; Saeter, G; Söderberg, M; Solheim, OP; Strander, H; Turesson, I; Wist, E | 1 |
Fosså, SD; Herlofson, BB; Norman-Pedersen, K; Redfors, M | 1 |
Eishi, Y; Fukuda, H; Kanno, J; Kawakami, S; Kihara, K; Morita, T; Nagahama, K; Ohtsuka, Y; Okada, Y; Oshima, H; Saito, K | 1 |
Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M | 1 |
Beyer, J; Kingreen, D; Lenz, K; Rick, O; Siegert, W; Weinknecht, S | 1 |
Akan, H; Aydogdu, I; Beksac, M; Gurman, G; Ilhan, O; Koc, H; Konuk, N; Ozerol, E; Uysal, A | 1 |
Abe, H; Fujieda, K; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
Huhn, D; Kingreen, D; Kirsch, A; Kleiner, S; Schwaner, I; Schwella, N; Siegert, W | 1 |
Malik, S; Oblon, DJ; Oblon, MB; Paul, SR | 1 |
Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E | 1 |
Champlin, R; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Lifshitz, S; Mante, RP; Piamsomboon, S; Schomer, DF; Termrungruanglert, W; Van Besien, K; Verschraegen, CF | 1 |
Arnold, B; Furman, WL; Garrison, L; Hanna, R; Luo, X; Marina, N; Meyer, WH; Pratt, CB; Rodman, JH; Tonda, ME | 1 |
Goessl, C; Heicappell, R; Miller, K; Müller, M; Steiner, U | 1 |
Fossella, F; Glisson, B; Hong, WK; Lee, JS; Murphy, WK; Palmer, J; Perez-Soler, R; Shin, DM | 1 |
Fossella, F; Glisson, B; Komaki, R; Kurie, J; Lee, JS; Murphy, WK; Perez-Soler, R; Schea, R; Shin, DM; Vadhan-Raj, S | 1 |
Fink, FM; Heitger, A; Maurer, K; Niederweiser, D; Schwaighofer, H | 1 |
Clancy, L; de Wit, R; Fennelly, J; Frisch, J; Gatzemeier, U; Koschel, G; Pfeifer, W; Steward, WP; Thatcher, N; Verweij, J; von Eiff, M; von Pawel, J; Woll, P | 1 |
Bodrogi, I; Collette, L; Cullen, M; De Prijck, L; deMulder, P; deWit, R; Fossa, S; Kaye, SB; Lallemand, E; Mead, GM; Stenning, S; Sylvester, R; van Groeningen, C | 1 |
Beyer, J; Höltl, W; Pont, J; Siegert, W; Weissbach, L | 1 |
Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M | 1 |
Akiyama, Y; Fujino, M; Kawakami, Y; Kirisawa, T; Naya, Y; Ohe, M | 1 |
Ben Arush, MW; Drumea, K; Haim, N; Kuten, A; Meller, I; Moses, M; Stein, ME | 1 |
Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG | 2 |
Burger, KJ; Heinzinger, M; Lange, W; Rosenstiel, A; Scheid, S; Waller, CF | 1 |
Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M | 1 |
Eisenhauer, E; Shepherd, FA | 1 |
Sandler, AB | 1 |
Masumori, N; Miyao, N; Niitsu, Y; Sakamaki, S; Sasamura, H; Shigyo, M; Takahashi, A; Takeda, K; Tsukamoto, T | 1 |
Hess, CF; Jürgens, H; Klingebiel, T; Koscielniak, E; Pertl, U; Pötter, R; Rossi, R; Schött, C; Spaar, HJ; Treuner, J; van Heek-Romanowski, R; Willnow, U | 1 |
Okamoto, M | 1 |
Enblad, G; Glimelius, B; Gustavsson, A; Hagberg, H | 1 |
Catalano, PJ; Crawford, ED; Einhorn, LH; Loehrer, PJ; Nichols, CR; Vogelzang, NJ | 1 |
Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Heimenz, JW; Kronish, LA; Partyka, JS; Perkins, JB; Saez, RA; Sullivan, DM | 1 |
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Magrath, I; Neely, J; Nieder, M; Owen, W; Seibel, N; Shad, A; Venzon, D; Wilson, W | 1 |
Buckner, JC; Lewis, JE; McElroy, EA | 1 |
De Leyn, PR; Demedts, MG; Deneffe, GJ; Lerut, TE; Lievens, YN; Nackaerts, KL; van der Schueren, E; Van Raemdonck, DE; Vansteenkiste, JF | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Pharo, A; Smeland, EB | 1 |
Dermitzakis, G; Fahantidou, E; Gioulekas, D; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
Antman, KH; Ayash, LJ; Coleman, N; Elias, AD; Frei, E; Ibrahim, J; McCauley, M; Mills, L; Schnipper, L; Schwartz, G; Teicher, BA; Warren, D; Wheeler, C | 1 |
Barişta, I; Celik, I; Güllü, I; Kars, A; Ozişik, Y; Tekuzman, G; Yalçin, S | 1 |
Bosq, J; Bouhris, JH; Brault, P; Carde, P; Corti, C; Cosset, JM; Decaudin, D; Girinsky, T; Hayat, M; Munck, JN; Nasr, F; Pico, JL; Ribrag, V | 1 |
Cabanillas, F; Dong, K; Hagemeister, FB; McLaughlin, P; Moon, T; Rodriguez, MA; Rodriguez-Diaz Pavón, J; Romaguera, JE | 1 |
Arisawa, C; Fujii, Y; Ishizaka, K; Kageyama, Y; Kamata, S; Kihara, K; Komatsu, F; Masuda, H; Oshima, H; Tsujii, T | 1 |
Alcalá, A; Alvarez-Carmona, AM; Besses, C; Carbonell, F; Contreras, E; Fontanillas, M; García-Conde, J; Hernando, A; León, P; López-Guillermo, A; Maldonado, J; Montserrat, E; Sancho-Tello, R; Zubizarreta, A | 1 |
Arimoto, T; Hashimoto, S; Inaba, T; Iwasaki, Y; Kubota, Y; Nakagawa, M; Shimazaki, C; Toda, S; Ueda, M; Yokomura, I | 1 |
Boqué, C; Grañena, A | 1 |
Gulati, SC; Jhanwar-Uniyal, M | 1 |
Blumenstengel, K; Fricke, HJ; Höffken, K; Kath, R; Kunert, C; Sayer, HG; Vogel, W | 1 |
Biesma, B; Cox, A; Festen, J; Postmus, PE; Splinter, TA; Tjan-Heijnen, VC; Wagener, DJ | 1 |
Barişta, I; Celik, I; Firat, D; Güler, N; Hayran, M; Kars, A; Ozyilkan, O; Tekuzman, G | 1 |
Bajorin, D; Cheung, NK; Heller, G; Kramer, K; Kushner, BH; Meyers, PA; Polyak, T; Wollner, N | 1 |
Bartsch, HH; Mumm, A; Willenbacher, W | 1 |
Collette, L; de Prijck, L; de Wit, R; Neijt, JP; Sleijfer, DT; Stoter, G; Sylvester, R; ten Bokkel Huinink, WW | 1 |
Akasaka, Y; Igarashi, H; Kondou, N; Kuroda, A; Madarame, J; Nakata, J; Ohishi, Y; Tomita, M; Yanada, S | 1 |
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
Bergeron, S; Blazar, BR; Cairo, MS; Garrison, L; Krailo, MD; Reaman, GH; Secola, R; van de Ven, C; Weinthal, JA | 1 |
Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
Adam, Z; Hájek, R; Hejlová, N; Klabusay, M; Korístek, Z; Krahulcová, E; Král, Z; Mayer, J; Müllerová, I; Navrátil, M; Penka, M; Tomíska, M; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Brown, JM; Hosker, HS; Muers, MF; Peake, MD; Poulter, KM; Shevlin, PM; Stead, ML | 2 |
Enneking, WF; Lindner, NJ; Scarborough, MT; Spanier, SS | 1 |
Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S | 1 |
Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M | 1 |
Arndt, CA; Miser, JS; Moertel, CL; Nascimento, AG; Neglia, JP; Schomberg, PJ; Schroeder, G; Sencer, SF; Silberman, TL; Tillisch, JK | 1 |
Haga, N; Honda, K; Itoh, M; Muraki, O; Ohto, H; Tsuruya, Y; Yamaguchi, O | 1 |
Kondo, E; Miura, A; Mizuno, H; Yamao, H; Yuge, M | 1 |
Ali, MA; Du, W; Herskovic, AM; Kalemkerian, GP; Kraut, MJ; Valdivieso, M | 1 |
Borchmann, P; Diehl, V; Engert, A; Münch, R; Reiser, M; Schnell, R; Straub, G; Ubelacker, R; Wilhelm, M; Wörmann, B | 1 |
Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
Cuomo, AM; Pavesi, L; Poggi, G; Preti, P; Robustelli della Cuna, FS; Zambelli, A | 1 |
Fujii, H; Igarashi, T; Itoh, K; Minami, H; Ohtsu, T; Sasaki, Y; Wakita, H; Watanabe, Y | 1 |
Beyer, J; Rick, O; Siegert, W | 2 |
Cupissol, D; Khial, F; Lafontaine, T; Michel, FB; Pujol, JL; Quantin, X; Reme-Saumon, M | 1 |
Albiani, R; Bacci, G; Brach del Prever, A; Busca, A; Fagioli, F; Madon, E; Miniero, R; Nesi, F; Picci, P; Vassallo, E | 1 |
Fukui, I; Hiratsuka, H; Izutani, T; Kin, T; Maeda, Y; Nakagawa, K; Okumura, S; Oyama, H; Shishido, T; Yonese, J | 1 |
Beyer, J; Huhn, D; Kingreen, D; Kirsch, A; Krusch, A; Rick, O; Schleicher, J; Schwella, N; Siegert, W | 1 |
Fountzilas, G; Kalofonos, C; Klouvas, G; Panoussaki, E; Pavlidis, N; Pectasides, D; Poulakis, N; Samantas, E; Skarlos, DV; Tsiakopoulos, E | 1 |
Bachier, C; Cabanillas, F; Hagemeister, FB; McLaughlin, P; Preti, H; Rodriguez, MA; Romaguera, JE; Sarris, AH; Weber, D; Younes, A | 1 |
Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H | 1 |
Gysler, J; Jaehde, U; Schunack, W | 1 |
Harris, MB; Krischer, JP; Kung, FH | 1 |
Yalçin, S | 2 |
Cabanillas, F; Fayad, L; Hagemeister, FB; Hess, M; McLaughlin, P; Rodriguez, J; Rodriguez, MA; Romaguera, J; Santiago, M | 1 |
Ahmad, R; Davis, M; Mayol, BR; Rougraff, BT | 1 |
Leyvraz, S; Perey, L; Rollier, P; Wasserfallen, JB | 1 |
Ikeda, J; Kitamura, K; Miyasaka, K; Sawamura, Y; Shirato, H; Suzuki, K | 1 |
Bailey, CC; Gattamaneni, HR; Lashford, LS; Lewis, IJ; Michelagnoli, MP | 1 |
Korístek, Z; Mayer, J; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Bertino, JR; Elkin, N; Glassman, JR; Moskowitz, CH; Nimer, SD; O'Brien, JP; Portlock, CS; Straus, DJ; Yahalom, J; Zelenetz, AD | 1 |
Fukui, I; Izutani, T; Kin, T; Kitsukawa, S; Maeda, Y; Shishido, T; Yonese, J | 1 |
Biron, P; Blay, JY; Droz, JP; Fléchon, A; Philip, I | 1 |
Alba, E; Aparicio, J; Barnadas, A; Garcia del Muro, X; Germà-Lluch, JR; Sánchez, M; Tabernero, JM | 1 |
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R | 2 |
Alvegård, TA; Fernberg, JO; Hall, KS; Monge, O; Saeter, G; Strander, H; Wiklund, T | 1 |
Daskalakis, A; Lange, W; Musahl, V; von Lintig, F; Waller, CF | 1 |
Benboubker, L; Bout, M; Cartron, G; Colombat, P; Delain, M; Lamagnere, JP; Linassier, C | 1 |
Cain, AM; Greenwald, C; Marina, NM; Meyer, WH; Pappo, AS; Parham, DM; Poquette, CA; Pratt, CB; Rao, BN | 1 |
Caramatti, C; Cesana, C; Garau, D; Mangoni, L; Regazzi, E; Rizzoli, V | 1 |
Felgenhauer, J; Hawkins, D; Radich, J; Thomson, B | 1 |
Bauman, NM; Callaghan, EJ; McCulloch, TM; Victoria, L | 1 |
Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
Behnisch, W; Göbel, U; Hilgenfeld, E; Schneider, DT; Schwabe, D; Wessalowski, R; Zoubek, A | 1 |
Byrne, J; Haynes, A; McQuaker, I; Russell, N; Stainer, C | 1 |
Beyer, J; Bokemeyer, C; Einhorn, L; Harstrick, A; Hartmann, JT; Kanz, L; Kollmannsberger, C; Meisner, C; Metzner, B; Nichols, C; Schmoll, HJ | 1 |
Bosquée, L; Humblet, Y; Lange, A; Leyvraz, S; Marangolo, M; Pampallona, S; Pasini, F; Perey, L; Peters, R; Rosti, G | 1 |
Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F | 1 |
Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
Arakawa, S; Gohji, K; Gotoh, A; Hara, I; Hara, S; Kamidono, S; Miyake, H; Nakamura, I; Nomi, M; Oka, Y; Takechi, Y; Yamada, Y; Yamanaka, K | 1 |
Campioni, N; Cognetti, F; Del Vecchio, MR; Ferraresi, V; Milella, M; Nardi, M; Pasquali-Lasagni, R; Santomaggio, C; Scinto, AF; Tucci, E | 1 |
Agus, DB; Bertino, JR; Childs, B; Coady-Lyons, N; Filippa, D; Frank, R; Glassman, JR; Goy, A; Hedrick, EE; Hunte, S; Jurcic, J; Louie, D; Moskowitz, CH; Nimer, SD; Noy, A; O'Brien, J; Portlock, CS; Straus, DS; Yahalom, J; Zelenetz, AD | 1 |
Balaña, C; Martin, C; Rosell, R | 1 |
Langer, CJ; Socinski, MA | 1 |
Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
Asbury, R; Boros, L; Chang, AY; Garrow, G; Hui, L; Rubins, J | 1 |
Foss, HD; Keilholz, U; Knauf, W; Siehl, J; Szelényi, H; Thiel, E | 1 |
Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
Amill, B; Aventín, A; Blanco, A; Boqué, C; Brunet, S; González, JR; Grañena, A; Larriba, I; Martín-Henao, GA; Martino, R; Petit, J; Sierra, J; Sureda, A | 1 |
Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Miki, T; Saiki, S; Usami, M | 1 |
Kawakita, M; Matsuda, T; Terachi, T; Yoshida, O | 1 |
Akaza, H; Hara, I; Hoshi, S; Miki, T; Naito, K; Naito, S; Nakagawa, S; Nishiyama, T; Nonomura, N; Okano, T; Ozono, S; Sonoda, Y; Terachi, T; Tsukamoto, T; Yoshida, O | 1 |
Kawakami, K; Kayama, T; Saino, M; Sakurada, K; Sato, S | 1 |
Arakawa, M; Chou, D; Gejyo, F; Ito, K; Kagamu, H; Sakai, K; Shimbo, T; Suzuki, E; Takahashi, M; Tanaka, H; Tanaka, J; Wakabayashi, M; Yoshizawa, H | 1 |
Chihara, K; Inoue, R; Iwata, N; Kajimoto, Y; Matsui, T; Matsuoka, H; Natazuka, T; Shimoyama, M; Tamekane, A | 1 |
Altés, A; Brunet, S; Martino, R; Salar, A; Sierra, J; Sureda, A | 1 |
Menéndez, B; Salar, A; Sierra, J; Sureda, A | 1 |
Anderlini, P; Andersson, B; Blamble, DA; Cabanillas, F; Champlin, RE; Donato, ML; Durett, A; Gajewski, JG; Gee, A; Giralt, S; Hagemeister, F; Hester, J; Ippoliti, C; Khouri, I; Korbling, M; Lauppe, J; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Sarris, A; Van Besien, KW; Younes, A | 1 |
Cavenagh, JD; Eden, AG; Hughes, A; Kelsey, SM; Lamont, A; McBride, NC; Mills, MJ; Newland, AC; Ward, MC | 1 |
Bains, M; Bajorin, DF; Bosl, GJ; Flombaum, C; Macapinlac, HA; Mariani, T; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J; Tong, WP | 1 |
Fukui, I; Kin, T; Kitsukawa, S; Maeda, Y; Tsukamoto, T; Yonese, J; Yoshida, T | 1 |
Daller, RT; Fenton, JG; Miser, JS; Womer, RB | 1 |
Filejski, W; Gerke, P; Robins, HI; Steinhoff, J; Wiedemann, GJ | 1 |
Anselmo, AP; Cavalieri, E; Enrici, RM; Funaro, D; Mandelli, F; Meloni, G; Pescarmona, E; Proia, A | 1 |
Billio, A; Coser, P; Fabris, P; Pescosta, N; Rosanelli, C | 1 |
Bakhshandeh, A; Bruns, I; Eberhardt, K; Wiedemann, GJ | 1 |
Halme, M; Isokangas, OP; Joensuu, H; Mäntylä, M; Mattson, K; Pekonen, M; Pyrhönen, S; Ruotsalainen, T; Sarna, S | 1 |
De Laroche, G; Garnier, JF; Jacquin, JP; Pichon, A; Roques, B | 1 |
Arvelo, F; Bourgeois, Y; De Cremoux, P; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF | 1 |
Aleman, A; Anderlini, P; Bast, RC; Bevers, M; Bodurka-Bevers, D; Boyer, J; Burke, T; Champlin, RE; Donato, ML; Freedman, R; Gajewski, JG; Gershenson, D; Giralt, S; Ippoliti, C; Korbling, M; Lauppe, J; Levenback, C; Molldrem, J; Ueno, N; Wharton, JT; Wolf, J | 1 |
Ayala-Sánchez, M; Esparza, MA; García-León, LD; González-Llaven, J; Guevara-Moreno, ME; Montiel-Cervantes, L; Rosas-Cabral, A; Sánchez-Cortés, E; Tripp-Villanueva, F; Vela-Ojeda, J | 1 |
Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES | 1 |
Heinz, R; Karlic, H; Mühlberger, H; Pavlova, B; Pfeilstöcker, M; Pittermann, E; Salamon, J; Strobl, H | 1 |
Fernandez, MC; Gerbing, RR; Krailo, MD; Matthay, KK | 1 |
Bodoky, G; Eckhardt, S; Láng, I; Pápai, Z; Poller, I; Rahóty, P; Szántó, J; Szendroi, M | 1 |
Bamberg, M; Beyer, J; Böhlke, I; Bokemeyer, C; Derigs, G; Hartmann, JT; Kanz, L; Kollmannsberger, C; Nichols, C; Rüther, U; Schleucher, N; Schmoll, HJ; Schöfski, P | 1 |
Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kiamouris, C; Kosmidis, P; Papadimitriou, C; Papakostas, P; Pavlidis, N; Sikiotis, K; Skarlos, DV | 1 |
Glisson, B; Komaki, R; Movsas, B; Scott, C; Wagner, H | 1 |
Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
Bodurka-Bevers, D; Champlin, RE; Donato, ML; Gershenson, D; Wharton, JT | 1 |
Kisic, J; Tropé, CG; Vergote, I | 1 |
Anthony, LB; Drouant, G; Espanan, GD; Maloney, TJ; McCarthy, KE; Meyers, MO; Woltering, EA | 1 |
Jacky, E; Jost, LM; Stahel, RA; Tscherry, G | 1 |
Giebel, S; Hołowiecki, J; Kachel, L; Kata, D; Krawczyk-Kuliś, M; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
Donnelly, GB; Hedrick, EE; Hunte, S; Kewalramani, T; Lyons, NC; Moskowitz, CH; Nimer, SD; Priovolos, AC; Qin, J; Yahalom, J; Zelenetz, AD | 1 |
Ardiet, C; Boissel, JP; Court-Fortune, I; Freyer, G; Girard, P; Ligneau, B; Rebattu, P; Riou, R; Souquet, PJ; Tranchand, B; Trillet-Lenoir, V | 1 |
Hatano, H; Hatano, N; Kajita, Y; Kinoshita, T; Takasu, S; Usui, T; Wakabayashi, T; Yoshida, J | 1 |
Andrieu, JM; Coscas, Y; Dabouis, G; Jaillon-Abraham, C; Tourani, JM | 1 |
Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Jackson, GH; Lennard, AL; Leonard, RC; McQuaker, IG; Proctor, SJ; Russell, N; Taylor, PR; Windebank, K | 1 |
Baláz, M; Drahokoupilová, M; Fuchsberger, P; Koza, I; Lakota, J; Mardiak, J; Sálek, T; Sycová-Milá, Z | 1 |
Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M | 1 |
Biron, P; Blay, JY; Bouhour, D; Dumontet, C; Philip, T; Ray-Coquard, I | 1 |
Aktoğu, S; Büyükşirin, M; Capa, G; Durak, H; Erkmen, G; Ertay, T; Ozbilek, E; Sayit, E | 1 |
Deichmann, M; Goldschmidt, H; Hartschuh, W; Hegenbart, U; Ho, A; Jäckel, A; Näher, H; Waldmann, V | 1 |
Fraser, G; Nicoll, J; Rampling, R; Smith, C; Stephen, M | 1 |
Cesaro, S; Chinello, P; Rossi, L; Zanesco, L | 1 |
Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
Brown, JM; Gurney, EM; Hepburn, PM; Johnson, PW; Muers, MF; Napp, VV; Peake, MD; Poulter, KM | 1 |
Gallagher, CJ; Gupta, RK; Kelsey, S; Lister, TA; Newland, AC; O'Doherty, CA; Oliver, RT; Shamash, J | 1 |
Edan, C; Guegan, Y; Hanna, A; Heresbach, N | 1 |
Burt, PA; Davies, R; Hodgetts, J; Lee, SM; Lomax, L; Pettengell, R; Simms, T; Stout, R; Thatcher, N; Woll, PJ | 1 |
Kushner, BH; Meyers, PA | 1 |
Bertino, JR; Coady-Lyons, N; Filippa, DA; Frank, R; Gonzales, M; Goy, A; Hedrick, EE; Louie, D; Moskowitz, CH; Nimer, SD; Noy, A; O'Brien, JP; Portlock, CS; Qin, J; Straus, D; Trippett, T; Walits, J; Yahalom, J; Zelenetz, AD | 1 |
Ambros, PF; Blohm, ME; Bolkenius, M; Calaminus, G; Gnekow, AK; Göbel, U; Harms, D; Heidemann, PH; Schneider, DT; von Schweinitz, D; Weinel, P | 1 |
Fenstad, GU; Skovlund, E | 1 |
Böhm, P; Einsele, H; Horny, HP; Kunz, W | 1 |
Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G | 1 |
Bauer, M; Blatt, J; Blazar, BR; Cairo, MS; Frierdich, S; Krailo, MD; Liu-Mares, W; Miser, JS; Reaman, GH; Sato, JK; Shen, V | 1 |
Ames, MM; Bergeron, S; Blazar, BR; Bracho, F; Cairo, MS; Davenport, V; Krailo, MD; Liu-Mares, W; Panoskaltsis-Mortari, A; Reaman, GH; Reid, JM; Secola, R; Shen, V; van de Ven, C | 1 |
Ahn, YC; Bae, HS; Hyun, IG; Jung, KS; Kim, HJ; Kim, WS; Kwon, SH; Lee, JA; Oh, DH; Park, CH; Park, K; Park, MJ; Park, YL; Park, YS; Woo, IS | 1 |
Hashiguchi, Y; Inoue, T; Kobayashi, Y; Maed, K; Tsuda, H; Umesaki, N; Yamamoto, K | 1 |
Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
Czownicki, Z; Koźlik, H; Michałek, A; Pasz, P; Zientek, A; Zientek, J | 1 |
Dingemans, AC; Giaccone, G; Postmus, PE; Scagliotti, GV; Span, S; van Ark-Otte, J; van der Valk, P | 1 |
Ali, MA; Kalemkerian, GP; Kraut, MJ; Luthra, K; Valdivieso, M; Wozniak, AJ | 1 |
Mazeron, JJ; Noël, G | 1 |
Beyer, J; Bokemeyer, C; Rick, O; Siegert, W | 1 |
Aisner, J; Aisner, S; Green, M; Jiroutek, M; Johnson, DH; Livingston, R; Loehrer, PJ; Thomas, CR | 1 |
Cabanillas, FF; Cox, JD; Ha, CS; Hess, MA; Rodriguez, MA; Tucker, SL; Wilder, RB | 1 |
Belhadj, K; Maubec, E; Oberlin, O; Roujeau, JC | 1 |
Aggarwal, AN; Behera, D; Gupta, D; Jindal, SK; Sharma, SC | 1 |
Borel, C; Ducreux, M; Fizazi, K; Le Chevalier, T; Ruffié, P; Saghatchian, M; Théodore, C | 1 |
Dieckmann, K; Schuller, E; Seidl, R; Slavc, I; Wandl, C | 1 |
Carella, AM | 1 |
de Wit, R; Stoter, G | 1 |
Brugarolas, A; García-Rayo, S; Inogés, S; Martín-Algarra, S; Martínez-Aguillo, M; Ordóñez, JM; Pérez-Calvo, J; Ramón y Cajal, T; Santisteban, M; Subirá, ML | 1 |
Berthold, F; Fichtner, I; Fulda, S; Hero, B | 1 |
Fukuda, M; Horibe, K; Inaba, J; Kondo, M; Matsumoto, K; Miyajima, Y; Miyashita, Y | 1 |
Berthold, F; Gahr, M; Hero, B; Hunneman, DH | 1 |
Ponarska, A; Rogala, E; Rogińska, E; Rowińska-Zakrzewska, E; Szopiński, J | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Rusten, LS | 1 |
Cernilová, I; Doubek, M; Klabusay, M; Korístek, Z; Mayer, J; Navrátil, M; Petráková, K; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
Browne, PV; Daly, PA; Duggan, C; Enright, H; Gardiner, N; Kennedy, MJ; McCann, SR; O'Connell, N | 1 |
Coleman, M; Kaufman, TP; Leonard, J; Shuster, MW | 1 |
Beyer, J; Huhn, D; Kingreen, D; Kleiner, S; Reif, S; Siegert, W | 1 |
Avigan, D; Giallombardo, N; Hurley, D; Joyce, RM; Kraser, CN; Levine, J; McDermott, D; Regan, M; Tetrealt, JC; Uhl, L; Umiel, T | 1 |
Fukui, I; Ishiwata, D; Kim, T; Tohma, T; Tsukamoto, T; Yonese, J; Yoshida, T | 1 |
Lassmann, J; Loening, SA; Taupitz, M; Wiechen, K; Wille, A | 1 |
Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
Abdel-Rahman, S; Aydemir, U; Falk, MH; Hiddemann, W; Issels, RD; Kurze, V; Sauer, H; Wendtner, C | 1 |
Abdel-Rahman, S; Baumert, J; Falk, MH; Hiddemann, W; Issels, RD; Krych, M; Santl, M; Wendtner, C | 1 |
Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ | 1 |
Azinovic, I; Brugarolas, A; Fernández-Hidalgo, O; García-Rayo, S; Martín-Algarra, S; Martínez-Aguillo, M; Martínez-Monge, R; Pérez-Calvo, J; Rebollo, J; Subirá, L | 1 |
Baruchel, S; Fouladi, M; Gammon, J; Grant, R; Greenberg, ML; Klein, J; Koren, G; Stempak, D | 1 |
Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
Grimm, J; Jaehde, U; Kingreen, D; Kloft, C; Reif, S; Schunack, W; Siegert, W | 1 |
Baiardi, P; Cuomo, AM; Preti, P; Robustelli della Cuna, FS; Robustelli della Cuna, G; Torazzo, R | 1 |
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
Droz, JP; Fléchon, A | 2 |
Benike, CJ; Caspar, CB; Czerwinsk, DK; Davis, TA; Engleman, EG; Hsu, FJ; Levy, R; Liles, TM; Taidi, B; van Beckhoven, A | 1 |
Hosomi, Y; Shibuya, M | 1 |
Hanafusa, T; Hosokawa, Y; Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M | 1 |
Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
Berchier, MC; Berghmans, T; Florin, MC; Giner, V; Klastersky, J; Koumakis, G; Lafitte, JJ; Lecomte, J; Michel, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
Boccieri, MG; Bruschi, G; Lo Re, G; Saracchini, S; Toffoli, G; Tumolo, S | 1 |
Li, X; Liu, L; Wu, L | 1 |
Bernstein, M; Devidas, M; Ferguson, W; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Link, M; Schwartz, CL; Siegal, GP | 1 |
Berger, F; Brice, P; Colin, P; Diviné, M; Fermé, C; Jaubert, J; Lederlin, P; Mounier, N; Reman, O; Salles, G; Stamatoullas, A; Voillat, L | 1 |
Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J | 1 |
De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
Aoyama, H; Fujieda, K; Ikeda, J; Miyasaka, K; Sawamura, Y; Shirato, H | 1 |
Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
Ansari, R; Fisher, W; Hanna, N; Jung, SH; Sandler, A; Shen, J | 1 |
Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M | 1 |
Arush, MW; Beck, D; Ben-Izhak, O; Postovsky, S | 1 |
Ansari, R; Einhorn, LH; Hanna, NH; Jung, SH; Lane, K; Loehrer, PJ; Sandier, AB | 1 |
Christodoulou, C; Efstathiou, E; Klouvas, G; Papazachariou, E; Plyta, M; Skarlos, DV; Zervakis, D | 1 |
Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H | 1 |
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
Fukuyama, T; Hishizawa, M; Ichinohe, T; Ito, N; Kakehi, Y; Kamato, T; Kobayashi, T; Nakamura, E; Ogawa, O; Yamamoto, S | 1 |
Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H | 1 |
Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N | 1 |
Abu-Ghosh, AM; Cairo, MS; Davenport, V; Goldman, SC; Krailo, MD; Laver, JH; Morris, E; Reaman, GH; Slack, RS | 1 |
Advani, SH; Banavali, SD; Bhatia, KG; Magrath, I; Naresh, KN; Soman, CS | 1 |
Aebi, S; Betticher, DC; Calderoni, A; Solenthaler, M; von Briel, C | 1 |
Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R | 1 |
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K | 1 |
Behr, W; Brockmeyer, C; Ehnle, S; Hempel, P; Müller, P; Oruzio, D; Riethmüller, R; Schlimok, G; Wochner, M | 1 |
Moskowitz, C | 1 |
Hensley, ML | 1 |
Badve, S; Khan, SA | 1 |
Casanova, M; Cefalo, GS; Collini, P; Ferrari, A; Fossati-Bellani, F; Gasparini, M; Luksch, R; Massimino, M; Polastri, D; Spreafico, F; Terenziani, M | 1 |
Beyer, J; Jaehde, U; Kloft, C; Siegert, W | 1 |
Abdel-Rahman, S; Baumert, J; Baur, A; Hiddemann, W; Issels, RD; Krych, M; Lindner, LH; Wendtner, CM | 1 |
Alinari, L; Baccarani, M; Bonifazi, F; Gabriele, A; Molinari, AL; Salvucci, M; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zuffa, E | 1 |
Antoniolli, SZ; Bassetto, MA; Beltrami, P; Curti, P; Maffei, N; Porcaro, AB | 1 |
Grigg, A; Guarnaccia, C; Hatton, CS; Lewis, MS; McKendrick, J; Mead, GM; Norbert, P; Pescosta, N; Stenning, SP; Sydes, MR; Walewski, J; Wright, D | 1 |
Iwamoto, Y; Matsuda, S; Matsunobu, T; Sakamoto, A; Tanaka, K | 1 |
Chen, H; Chen, J; Fu, RY; Gu, LJ; Pan, C; Tang, JY; Wang, YP; Wu, Y; Xue, H; Zhao, H | 1 |
Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N | 1 |
Douglas, J; Felgenhauer, J; Gooley, T; Hawkins, DS; Kreissman, S; Park, J; Pendergrass, TW; Rowley, SD; Sanders, JE; Thomson, B | 1 |
Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
Altés, A; Escoda, L; Guardia, R; López-Guillermo, A; Martino, R; Montserrat, E; Perea, G; Ribera, JM; Salar, A; Sierra, J | 1 |
Berdel, WE; Dölken, G; Kienast, J; Klinke, F; Macha, H; Mohr, M; Oelmann, E; Schmidt, EW; Serve, H; Thomas, M; Zühlsdorf, M | 1 |
Arpaci, F; Caglar, K; Kinalp, C; Komurcu, S; Ozet, A; Ozturk, B; Saglam, K; Turan, M; Vural, A; Yavuz, I; Yenicesu, M | 1 |
Aurer, I; Bogdanić, V; Duraković, N; Kovacević-Metelko, J; Labar, B; Mikulić, M; Mrsić, M; Nemet, D; Radman, I; Sertić, D; Zupancić-Salek, S | 1 |
Bessho, A; Fujii, N; Harada, M; Hiramatsu, Y; Ikeda, K; Imai, T; Ishimaru, F; Koide, N; Kojima, K; Kozuka, T; Maeda, Y; Matsuo, K; Niiya, K; Noguchi, T; Shinagawa, K; Sunami, K; Takenaka, K; Tanimoto, M; Teshima, T; Yamamoto, K | 1 |
Connolly, DL; Davis, RC; Hamaad, A | 1 |
Emmanouilides, C; Grody, W; Lill, M; Rosen, P; Rosenfelt, F; Telatar, M; Territo, M | 1 |
Chen, XB; Li, DX | 1 |
Harada, H; Iwasaki, Y; Nagata, K; Nakagawa, M; Ohsugi, S; Takemura, Y | 1 |
Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
Hagiwara, S; Iyama, S; Kato, J; Kobayashi, D; Kogawa, K; Kuribayashi, K; Matsunaga, T; Niitsu, Y; Oku, T; Sato, T; Sato, Y; Takada, K; Takahashi, M; Takahashi, S; Terui, T | 1 |
Fukui, I; Ishii, N; Maezawa, T; Tsukamoto, T; Yonese, J | 1 |
Fuhr, U; Jaehde, U; Jetter, A; Kingreen, D; McLeod, H; Reif, S; Siegert, W | 1 |
Blütters-Sawatzki, R; Gossen, R; Neugebauer, M; Reiter, A; Woessmann, W | 1 |
Levine, AM | 1 |
Barnette, DJ; Feldman, BD; Graham, BS; Hardaway, CA | 1 |
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
Baker, J; Hand, S; Macbeth, FR; Smith, AP | 1 |
Catalano, GP; Curigliano, G; De Braud, F; De Pas, T; Leo, F; Pastorino, U; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
Bakhshandeh, A; Bruns, I; Dalhoff, K; Demedts, A; Eberhardt, K; Ehlers, EM; Gatzemeier, U; Gruber, Y; Hegewisch-Becker, S; Kaukel, E; Kohlmann, T; Koschel, G; Peters, SO; Robins, HI; Traynor, A; Wiedemann, GJ; Zumschlinge, R | 1 |
Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
Starkhammar, H; Wall, N | 1 |
Catalano, PJ; David Crawford, E; Einhorn, LH; Hinton, S; Loehrer, PJ; Nichols, CR; Trump, D; Vogelzang, N | 1 |
Hamlin, PA; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; Portlock, CS; Qin, J; Satagopan, JM; Straus, DJ; Verbel, D; Yahalom, J; Zelenetz, AD | 1 |
Debelenko, L; Granowetter, L; Hensle, TW; Lam, JS; Tennenbaum, SY | 1 |
Bacci, G; Longhi, A; Macchiagodena, M; Vitali, G | 1 |
Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G | 1 |
Hamlin, P; Kewalramani, T; Moskowitz, CH; Nimer, S; Yahalom, J; Zelenetz, AD | 1 |
Benson, W; Bradstock, KF; Crombie, C; Gottlieb, D; Hertzberg, MS; Taper, J | 2 |
Sneller, V; Vose, J | 1 |
Avigan, D; Giallombardo, N; Hurley, D; Joyce, RM; Lamontagne, D; Levine, J; McDermott, D; Ottaway, J; Regan, M; Smith, T; Tetreault, JC; Uhl, L; Umiel, T | 1 |
Zinzani, PL | 1 |
Angus, B; Jackson, GH; Lennard, A; Lucraft, HL; Proctor, SJ; Taylor, PR; White, J; Windebank, K; Wood, K | 1 |
Bailey, H; Bakhshandeh, A; Finet, J; Gillis, W; Jager, D; Jager, E; Katschinski, DM; Knuth, A; Longo, W; Neumann, A; Peters, SO; Robins, HI; Tiggelaar, CL; Van Dijk, JD; Vörde Sive Vörding, PZ; Westermann, AM; Wiedemann, GJ | 1 |
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R | 1 |
Snee, MP | 1 |
Hitchcock, RJ; Mitchell, CD; Patel, Y | 1 |
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Metzner, B; Rick, O; Schleucher, N; Schmoll, HJ; Thomas, M | 1 |
Erturk, D; Unsal, M | 1 |
Ahn, HS; Choi, HS; Khwarg, SI; Kim, JH; Shin, HY; Yu, YS | 1 |
Briggs, T; Cannon, S; Cassoni, AM; Cobb, J; Driver, D; Hall-Craggs, M; Kilby, A; McTiernan, A; Michelagnoli, M; Pringle, J; Sandison, A; Strauss, SJ; Whelan, JS; Witt, J | 1 |
Aass, N; Alfsen, GC; Fossa, SD; Lien, HH; Oldenburg, J; Waehre, H | 1 |
Mead, G; Woodcock, J; Young, C | 1 |
Gorlick, R; Healey, JH; Huvos, AG; Kolb, EA; Kushner, BH; LaQuaglia, MP; Laverdiere, C; Meyers, PA; Qin, J; Vu, HT; Wexler, L; Wolden, S | 1 |
Goy, A; Hedrick, E; Moskowitz, C; Noy, A; Portlock, C; Qin, J; Straus, DJ; Teruya-Feldstein, J; Wang, ES; Zelenetz, AD | 1 |
Antoneli, CB; Arias, V; Chojniak, MM; de Camargo, B; de Cássia Braga Ribeiro, K; Novaes, PE; Steinhorst, F | 1 |
Grassin, F; Guigay, J; L'her, P; Le Moulec, S; Margery, J; Vaylet, F | 1 |
Boehm, R; Joppich, I; Landes, J; Schmid, I; Till, H | 1 |
Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B | 1 |
Motzer, RJ; Sheinfeld, S | 1 |
Andreesen, R; Berdel, WE; Beyer, J; Bokemeyer, C; Hartmann, JT; Hossfeld, D; Kanz, L; Kollmannsberger, C; Metzner, B; Rick, O; Schleicher, J; Schleucher, N; Schmoll, HJ; Schöffski, P | 1 |
La Mura, N; Lombardi, D; Sorio, R; Spazzapan, S; Tabaro, G; Veronesi, A | 1 |
Cerecedo-Díaz, F; Delgado-Huerta, S; Hernández-Contreras, I; López-Aguilar, E; Ramón-García, G; Rivera-Márquez, H; Rodríguez-Jiménez, H; Romo-Rubio, HA; Santacruz-Castillo, E; Sepúlveda-Vildósola, AC; Valdés-Sánchez, M; Wanzke-del Angel, V | 1 |
Christodoulou, J; Haferlach, T; Schnittger, S; Schoch, C | 1 |
Bilsland, D; Dawn, G; Jackson, R; Morrison, A; Morton, R | 1 |
Hashimoto, H; Inada, F; Ishida, H; Kaneko, S; Kita, M; Okuyama, M; Saga, Y; Sasaki, Y; Tokumitsu, M; Yachiku, S | 1 |
Davidson, KL; Devaney, MB; Dunlop, DJ; Johnson, PR; Mackie, MJ; Rogers, SY; Thomas, RV; Tighe, JE | 1 |
Bahrs, H; Gruber, Y; Kempgens, B; Kisro, J; Wagner, T | 1 |
Hanioka, K; Maeda, A; Matsushita, A; Nagai, K; Sugimoto, N; Takahashi, T; Watanabe, N | 1 |
Aoyagi, N; Boshi, H; Kounami, S; Nakayama, K; Sakiyama, M; Takeuchi, T; Yoshikawa, N; Yoshiyama, M | 1 |
Filippa, DA; Gencarelli, A; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, O; Portlock, C; Qin, J; Straus, D; Teruya-Feldstein, J; Waxman, A; Yahalom, J; Zelenetz, AD | 1 |
Bogdahn, U; Dietrich, J; Marienhagen, J; Schalke, B; Schlachetzki, F | 1 |
Fujisawa, M; Ishikawa, T; Kamidono, S | 1 |
Brunetto, AL; Leone, LD; Loss, JF; Santos, PP | 1 |
Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P | 1 |
Kunishio, K; Matsumoto, Y; Miyake, K; Nagao, S; Nishiyama, Y; Ohkawa, M; Okada, M | 1 |
Kitawaki, T; Nishikori, M; Ohno, H; Uchiyama, T; Ueda, C | 1 |
Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M | 1 |
Ishizuka, O; Mizuno, H; Mizusawa, H; Nishizawa, O; Satoh, T; Seki, S | 1 |
Aboulafia, DM; Waddington, TW | 1 |
Gisselbrecht, C; Mounier, N | 1 |
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M | 1 |
Cheong, K; Chrystal, K; Harper, P | 1 |
Elinder, G; Kimby, E; Sverrisdottir, A | 1 |
Bakhshandeh, A; Bruns, I; Kohlmann, T; Wiedemann, GJ | 1 |
Fujioka, T; Ishida, Y; Konda, R; Matsushita, Y; Murai, K; Obara, W; Ohmori, S; Sugimura, J; Tanji, S; Tokunaga, H | 1 |
Aoki, N; Fukui, I; Ishikawa, Y; Maezawa, T; Nakagawa, K; Nakaishi, M; Ohkubo, Y; Okumura, S; Sakura, M; Takimoto, K; Tsukamoto, T; Yonese, J | 1 |
Abker, S; Bosse, U; Junker, K; Klinke, F; Müller, KM; Thomas, M | 1 |
Champlin, R; Devine, S; Gajewski, J; Giralt, S; Khouri, I; Mehra, R; Peace, D; Sosman, J; Stock, W; Van Besien, K; Wadehra, N; Wickrema, A | 1 |
Fisher, D; Howard, O; Lacasce, A; Lib, S; Neuberg, D; Shipp, M; Weng, A | 1 |
Einhorn, LH; Look, KY; McClean, JW; Shaheen, M; Stender, MJ | 1 |
Castellano, A; Cozza, R; De Laurentis, C; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
Fisher, C; Hemmings, C | 1 |
Fukase, M; Hotta, T; Ishikawa, S; Kawashima, H; Ogose, A | 1 |
Bokemeyer, C; Clemm, C; Gerl, A; Hartmann, JT; Horwich, A; Kanz, L; Kollmannsberger, C; Meisner, C; Oliver, T; Rückerl, CP; Schmoll, HJ; Stenning, S | 1 |
Duman, RS | 1 |
Holte, H; Jerkeman, M; Kvaløy, S; Leppä, S | 1 |
Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M | 1 |
Kobayashi, M; Suzuki, K; Tokue, A | 1 |
Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L | 1 |
Annunziata, M; Copia, C; D'Amico, MR; De Simone, M; Ferrara, F; Mele, G; Palmieri, S; Pocali, B; Schiavone, EM; Viola, A | 1 |
Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM | 1 |
Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B | 1 |
Guo, W; Li, DS; Tang, S; Tang, XD; Yang, RL; Yang, Y | 1 |
Chuman, H | 1 |
Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
Bang, YJ; Heo, DS; Jo, YH; Kim, DW; Kim, JH; Kim, NK; Kim, TY; Lee, CH; Rhee, CS; Wu, HG | 1 |
Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
de Cremoux, P; Decaudin, D; Fréneaux, P; Judde, JG; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF; Sastre, X; Tran-Perennou, C | 1 |
Anderson, B; Angiolillo, A; Cairo, MS; Cheung, YK; Davenport, V; Krailo, M; Reaman, G; Van Winkle, P | 1 |
Batchelor, AG; Liddington, MI; Rawlins, JM; Towns, G | 1 |
Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J | 1 |
Sugiura, H; Suzuki, Y; Takahashi, M; Yamada, K | 1 |
Lamerz, R; Stieber, P | 1 |
Allam, A; Bazarbashi, S; El Foudeh, M; El Hassan, I; El Weshi, A; Ezzat, A; Memon, M; Pai, C; Rahal, M; Raja, M | 1 |
Berg, SL; Bessmertny, O; Cairo, MS; Davenport, V; Goldman, SC; Kreissman, SG; Laver, J; Reaman, GH; Secola, R; Shen, V; van de Ven, C | 1 |
Argon, A; Basaran, M; Bavbek, SE; Camlica, H; Darendeliler, E; Dizdar, Y; Onat, H; Ozger, H; Sakar, B; Yaman, F | 1 |
Abdi, E; Biagi, JJ; Dale, B; Falkson, C; Herbert, KE; Januszewicz, H; Leahy, M; Matthews, JP; Prince, HM; Richards, K; Seymour, JF; Smith, C; Wolf, M | 1 |
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
Berta, M; Bertoni, F; del Prever, AB; Fagioli, F; Ferrari, S; Mercuri, M | 1 |
Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
Mikami, K; Miki, T; Mizutani, Y | 1 |
Bex, A; Horenblas, S; Kerst, M; Meinhardt, W; Nieuwenhuijzen, JA; Pos, F; van Boven, H | 1 |
Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
Antonescu, CR; Athanasian, E; Gorlick, R; Meyers, P; Oppenheimer, O | 1 |
Achiwa, H; Bessho, Y; Hattori, N; Kato, D; Maeda, H; Niimi, T; Oguri, T; Sato, S; Shimizu, S; Ueda, R | 1 |
Angiolillo, AL; Ayello, J; Bonilla, MA; Cairo, MS; Davenport, V; Krailo, M; Militano, O; Miller, LL; Reaman, G; van de Ven, C | 1 |
Dong, M; Feng, FY; He, XH; Huang, DZ; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhang, P; Zhou, SY | 1 |
Chen, KT | 1 |
Hakamada, A; Isoda, K; Mizutani, H; Nomura, E; Yamaguchi, M; Yamanaka, K | 1 |
Ashcroft, LF; Lorigan, P; O'Brien, ME; Sampson, MR; Thatcher, N; Woll, PJ | 1 |
Abali, H; Barista, I; Demirkazik, F; Kansu, E; Kars, A; Koc, Y; Oyan, B; Tekin, F; Tekuzman, G; Turker, A; Uner, A | 1 |
Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA | 1 |
Alapetite, C; Anract, P; Babinet, A; Barthier, S; de Pinieux, G; Laurence, V; Palangié, T; Pierga, JY; Pouillart, P | 1 |
Biron, P; Bouzy, J; Droz, JP; Horwich, A; Koza, V; Kramar, A; Lelli, G; Linkesch, W; Marangolo, M; Pico, JL; Pizzocaro, G; Rosti, G; Salvioni, R; Schmoll, HJ; Siegert, W; Theodore, C; Wandt, H | 1 |
Alcutt, D; Grogan, L; Morris, P; Nasser, Q; Razak, AR | 1 |
Billups, CA; Davidoff, AM; Fuller, CE; Krasin, MJ; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
Farmakis, D; Pectasides, D; Pectasides, M | 1 |
Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
Bazari, H; Forman, JP; Humphreys, BD; Magee, CC; Seifter, J; Zandi-Nejad, K | 1 |
Hayashi, T; Ishii, N; Ohno, R; Watanabe, T; Yamada, T; Yoshinaga, A | 1 |
Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
Abella, E; Brunet, S; del Potro, E; Esteve, J; Oriol, A; Ribera, JM | 1 |
Cook, PA; Cullen, MH; Harper, P; Huddart, R; Mason, M; Mead, GM; Rustin, GJ; Stenning, SP | 1 |
Nath, SV; Seymour, JF | 1 |
Hobson, R; Morland, B; Ng, A; Williams, D | 1 |
Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
Kansu, E; Kars, A; Koc, Y; Oyan, B; Ozdemir, E; Tekuzman, G; Turker, A | 1 |
Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R | 1 |
Enschede, SH; Gregory, SA; Larson, ML | 1 |
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D | 1 |
Alektiar, KM; Boland, PJ; Healey, JH; La, TH; Laquaglia, MP; Meyers, PA; Wexler, LH; Wolden, SL | 1 |
Lapeyre-Mestre, M; Montastruc, JL; Pathak, A; Rigal-Huguet, F; Tournamille, JF | 1 |
Lewis, I; McTiernan, A; Meyer, T; Michelagnoli, MP; Whelan, JS | 1 |
Jordan, K; Kegel, T; Maher, G; Müller, L; Schmoll, HJ; Voigt, W | 1 |
Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
Arimoto, T; Hara, H; Iwasaki, Y; Kubota, Y; Nagata, K; Nakanishi, M; Natuhara, A; Ueda, M | 1 |
Cho, JH; Kim, HS; Ko, YH; Park, CS | 1 |
Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS | 1 |
Alvarnas, J; Chow, W; Doroshow, JH; Frankel, P; Kogut, N; Leong, LA; Lim, D; Margolin, KA; McNamara, M; Morgan, RJ; Schriber, J; Shibata, S; Somlo, G; Stalter, S; Twardowski, P; Yen, Y | 1 |
Handa, M; Hirai, S; Ihaya, A; Imamura, Y; Kawabe, M; Morioka, K; Sasaki, K; Shinoda, T; Tanabe, S; Tanaka, K; Uesaka, T; Yamada, N | 1 |
Beitler, B; Bellesso, M; Chamone, D; de Almeida Macedo, MC; Dias, LC; Dorlhiac-Llacer, PE; Dulley, FL; Neto, AE; Pereira, J; Pracchia, LF | 1 |
Clark, PI; Girling, DJ; Hopwood, P; Owens, R; Qian, W; Sambrook, RJ; Stephens, RJ; Thatcher, N | 1 |
Bagatell, R; Bowman, LC; Brodeur, GM; Castleberry, R; Cohn, SL; Frantz, C; Joshi, V; London, WB; Look, AT; Rao, PV; Rumcheva, P; Thorner, P | 1 |
Berger, J; Christiansen, H; Hermann, RM; Nitsche, M; Pradier, O | 1 |
Fan, Y; Huang, ZY; Luo, LH; Yu, HF | 1 |
Abali, H; Dizdar, O; Erdem, I; Eren, OO; Erman, M; Karadağ, O; Türker, A; Uluç, K; Yilmaz, A | 1 |
Fujinami, K; Maruta, I; Miura, T; Osada, Y; Takizawa, A; Tanaka, M | 1 |
Choi, JH; Chun, M; Hwang, SC; Kang, S; Kim, HC; Lee, HW; Lim, HY; Oh, YJ; Oh, YT; Park, JS; Park, KJ; Sheen, SS | 1 |
De Giorgi, U; Rosti, G | 1 |
Kitamura, Y; Komatsubara, S; Saito, T | 1 |
Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S | 1 |
Boldrini, R; Cozza, R; De Ioris, M; De Sio, L; Dominici, C; Donfrancesco, A; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
Akioka, T; Hanafusa, T; Hara, S; Kobayashi, K; Oka, S; Tsuji, M; Yokote, T | 1 |
Billups, CA; Cain, AM; Furman, WL; Hale, GA; Merchant, TE; Navid, F; Pappo, AS; Rao, BN; Santana, VM; Spunt, SL | 1 |
Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH | 1 |
Craft, A; Juergens, C; Juergens, H; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Weston, C; Whelan, J; Zoubek, A | 1 |
Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ | 1 |
Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
Bo, J; DA, WM; Li, HH; Wang, QS; Wang, SH; Wu, XX; Yu, L; Zhao, Y | 1 |
Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C | 1 |
Gatt, MK; Glover, DM | 1 |
Kageyama, Y; Kihara, K; Kobayashi, T; Kubo, Y; Yokoyama, M | 1 |
Fukumori, T; Harada, A; Izaki, H; Kanayama, HO; Katto, K; Kishimoto, T; Nakatuji, Y; Nishitani, M; Oka, N; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
Gisselbrecht, C; Hagberg, H | 1 |
Bedano, PM; Bonnin, J; Einhorn, LH | 1 |
Depierre, A | 1 |
Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC | 1 |
Dome, JS; Hareyama, M; Hatakeyama, N; Hirama, T; Hori, T; Kudoh, T; Kuroiwa, Y; Matsuno, T; Mizue, N; Nui, A; Oda, T; Suzuki, N; Tsutsumi, H; Yamamoto, M; Yokoyama, S | 1 |
Dabbas, B; Ford, CD; Gabor, F; Morgan, R | 1 |
Date, I; Kobayashi, N; Masuko, T; Miyoshi, Y; Omori, M; Watanabe, E | 1 |
Antoneli, CB; Arias, V; Castilho, MS; Chojniak, MM; de Aguirre Neto, JC; Novaes, PE; Ribeiro, KB | 1 |
Anderson, JR; Breitfeld, PP; Lager, JJ; Lyden, ER; Meyer, WH; Pappo, AS | 1 |
Brunetto, AL; Castro, CG; Cruz, LB; Rech, A; Ribeiro, AS; Rosa, LG | 1 |
Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M | 1 |
Budach, V; Felix, R; Ganter, H; Gellermann, J; Hildebrandt, B; Issels, R; Reichardt, P; Tunn, PU; Wlodarczyk, W; Wust, P | 1 |
Arakawa, S; Fujisawa, M; Hara, I; Muramaki, M; Shigemura, K; Tanaka, K | 1 |
Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
Anderson, J; Meyer, WH; Meza, JL; Pappo, AS | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, DW; Kim, NK; Kim, TY; Lee, KW; Park, S; Yoon, SS; Yun, T | 1 |
Acholonu, S; Anderlini, P; Champlin, R; Couriel, DR; De Lima, M; Donato, ML; Giralt, S; Hosing, C; Khouri, IF; Körbling, M; McMannis, J; Okoroji, GJ; Saliba, RM | 1 |
Atil, H; Aysan, T; Cok, G; Göksel, T; Güzelant, A; Soyer, S | 1 |
Akaza, H; Kawai, K; Minami, M; Mori, K; Naoi, M; Shimazui, T; Takaoka, E | 1 |
de Castro Brito, GA; Ferreira, FV; Lima, MV; Macedo, FY; Ribeiro, RA | 1 |
Argnani, M; Cariello, A; Dazzi, C; De Giorgi, U; Frassineti, L; Kopf, B; Leoni, M; Marangolo, M; Molinari, A; Monti, G; Rosti, G; Scarpi, E; Tienghi, A; Turci, D; Vertogen, B | 1 |
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P | 1 |
Fukumori, T; Harada, A; Hayashi, H; Izaki, H; Kanayama, HO; Kishimoto, T; Nishitani, MA; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
Fujisawa, M; Furukawa, J; Hara, I; Kumano, M; Miyake, H; Takenaka, A; Yamada, Y; Yamanaka, K | 1 |
Balzarotti, M; Bramanti, S; Castagna, L; Magagnoli, M; Mazza, R; Nozza, A; Russo, F; Santoro, A; Sarina, B; Siracusano, L; Timofeeva, I; Todisco, E | 1 |
Lam, MS | 1 |
Classen, CF; Papke, K; Trotter, A; Wagner, S; Warmuth-Metz, M; Wolff, JE | 1 |
Alloisio, M; Banna, GL; Castagna, L; De Giorgi, U; Ferrari, B; Marangolo, M; Rosti, G; Santoro, A | 1 |
Anderson, JR; Arndt, CA; Hawkins, DS; Meyer, WH; Neglia, JP; Sencer, SF | 1 |
Bishton, MJ; Haynes, AP | 1 |
Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C | 1 |
Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F | 1 |
Su, Y | 1 |
Kudriavtsev, DV; Mardynskiĭ, IuS; Zolotkov, AG | 1 |
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Budnick, A; Deluca, J; Ishill, N; Kondagunta, GV; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J | 1 |
Akaza, H; Hara, I; Miki, T; Mizutani, Y; Naito, K; Nonomura, N; Ozono, S; Terachi, T; Tsukamoto, T; Yoshida, O | 1 |
Naru, T; Nawaz, FH; Rizvi, J | 1 |
Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K | 1 |
Ichioka, M; Ishiga, T; Saito, K; Tanigawa, M | 1 |
Abe, S; Ishii, T; Kawai, A; Matsumine, A; Obata, H; Ozaki, T; Tanaka, K; Tsuchiya, H; Ueda, T; Yabe, H | 1 |
Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
Brugières, L; Dupoüy, N; Entz-Werlé, N; Gentet, JC; Guinebretière, JM; Kalifa, C; Le Deley, MC; Marec-Bérard, P; Pacquement, H; Pichon, F; Schmitt, C; Tabone, MD; Vanel, D | 1 |
Bishton, MJ; Byrne, JL; Haynes, AP; Lush, RJ; Russell, NH; Shaw, BE | 1 |
Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A | 1 |
Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM | 1 |
Abdel-Rahman, S; Baumert, J; Falk, M; Hentrich, M; Hiddemann, W; Issels, RD; Licht, T; Salat, C; Schlemmer, M; Straka, C; Wendtner, CM | 1 |
Buchholz, E; Drings, P; Manegold, C; Pilz, L; Thatcher, N | 1 |
Catalano, G; De Braud, F; De Pas, T; Gandini, S; Leo, F; Pelosi, G; Scanagatta, P; Spaggiari, L; Veronesi, G | 1 |
Burke, MJ; Duerst, RE; Jacobsohn, DA; Kletzel, M; Walterhouse, DO | 1 |
Bakshi, A; Gujral, S; Gupta, S; Nair, R; Parikh, P; Prabhash, K; Sengar, M | 1 |
Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
Breslow, NE; Feusner, JH; Green, DM; Norkool, PA; Ritchey, ML; Takashima, JR | 1 |
Andreesen, R; Blank, C; Hart, C; Hennemann, B; Krause, SW | 1 |
Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP | 1 |
Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T | 1 |
Goldstein, JD; Hered, RW; Sandler, E; Smithwick, W | 1 |
Koizumi, K; Kondo, M; Minauchi, K; Mukai, M; Odani, T; Takada, A | 1 |
Berdel, WE; Beyer, J; Bokemeyer, C; Egerer, G; Haas, A; Hartmann, JT; Kollmannsberger, C; Lorch, A; Metzner, B; Rick, O; Schirren, R; Schleicher, J; Schmidt-Wolf, IG; Weissinger, F | 1 |
Ansell, SM; Colgan, JP; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, KM; Simpson, L; Witzig, TE | 1 |
Blancard, PS; Guigay, J; Jounieaux, V; Lher, P; Magois, E; Margery, J; Milleron, B | 1 |
Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
Aoyama, T; Hagiwara, S; Imataki, O; Inoue, N; Kataoka, T; Katsumata, M; Katsuta, T; Kawakami, K; Mochizuki, T; Motokawa, S; Tamai, Y; Yoshida, T | 1 |
Krege, S; Rübben, H; vom Dorp, F | 1 |
Antoneli, CB; Arias, VA; Chojniak, MM; Malogolowkin, M; Novaes, PE; Ribeiro, KB; Rodriguez-Galindo, C; Soares, FA | 1 |
Hosoi, H; Iehara, T; Iwai, N; Koizumi, M; Misawa, A; Miyaji, M; Nishimura, T; Sugimoto, T; Tokiwa, K; Tsuchiya, K; Yagyu, S; Yanagisawa, A | 1 |
Bauditz, J; Lochs, H; Ventz, M | 1 |
Aoyama, T; Imataki, O; Kawakami, K; Tamai, Y | 1 |
Abla, O; Dror, Y; Shago, M | 1 |
Bordier, V; de Cremoux, P; Decaudin, D; Ekue, R; Garcia, M; Grandjean, I; Lokiec, F; Poupon, MF; Rezaï, K; Weill, S | 1 |
Galsky, MD; Kondagunta, V; Sonpavde, G | 1 |
Fibbe, WE; Huijgens, PC; Lugtenburg, PJ; van 't Veer, MB; van Imhoff, GW; van Oers, MH; van Putten, WL; Vellenga, E; Verdonck, LF; Wijermans, PW; Zijlstra, JM | 1 |
Billups, CA; Krasin, MJ; Liu, T; Navid, F; Rao, BN; Rodríguez-Galindo, C | 1 |
Bai, CM; Chen, SC; Yang, D; Zhou, JF | 1 |
Jain, S; Mandal, S; Varma, K | 1 |
Albo, C; Alonso, N; Arranz, R; Caballero, D; Conde, E; Fernández-Rañada, JM; Gandarillas, M; García Vela, JA; Garzón, S; Grande, C; Hernández, MT; Lahuerta, JJ; Mateos, MV; Rodríguez, J | 1 |
Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gauler, T; Gerl, A; Hartmann, JT; Horger, M; Kuczyk, MA; Mayer-Steinacker, R; Metzner, B; Rick, O; Schleicher, J | 1 |
Allen, PK; Davenport, SD; Grosshans, DR; Komaki, R; Meyers, CA | 1 |
Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY | 1 |
Baker, N; Barker, P; Boogaerts, M; Canizo, CD; Johnsen, HE; Mesters, R; Russell, N; Schmitz, N; Schubert, J; Skacel, T | 1 |
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
Hasegawa, Y; Izutsu, K; Kawa, K; Kim, WS; Kwong, YL; Nakamura, S; Okamura, T; Oshimi, K; Suzuki, R; Suzumiya, J; Yamaguchi, M | 1 |
Barada, WM; Bazarbachi, A; Beydoun, A; Hourani, R; Masroujeh, R; Otrock, ZK | 1 |
Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
Grifols, JR; Juncà, J; Morgades, M; Ribera, JM; Sancho, JM; Vives, S | 1 |
Al-Saleem, T; Jambusaria, A; Perlis, C; Shafer, D; Wu, H | 1 |
McMillan, A; O'Connor, S; Wills, AJ | 1 |
Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
Bishton, MJ; Fox, CP; Haynes, AP; McMillan, AK; Russell, NH | 1 |
Aversa, S; Brunsvig, P; Lange, A; Leyvraz, S; Martinelli, G; Montes, A; Pampallona, S; Perey, L; Peters, S; Ploner, F; Rosti, G; Yilmaz, U | 1 |
Bunn, PA | 1 |
Bosl, GJ; Feldman, DR; Ishill, N; Jathavedam, A; Motzer, RJ; Patil, S; Turkula, S; Weinstock, DM | 1 |
Bacon, C; Egerer, G; Freier, K; Hofele, CM; Thiele, OC | 1 |
Alexandrova, EN; Istomin, YP; Petrovich, SV; Sergeyeva, OP; Zhavrid, EA | 1 |
Chabaud, S; Court-Fortune, I; Falandry, C; Fournel, C; Freyer, G; Girard, P; Ribba, B; Souquet, PJ; Tod, M; Tranchand, B; Trillet-Lenoir, V; You, B | 1 |
Abali, H; Budakoğlu, B; Güler, T; Oksüzoğlu, B; Ozet, G; Urün, Y; Yildirim, N; Zengin, N | 1 |
Becker, H; Lübbert, M; Schäfer, HS; Schmitt-Gräff, A | 1 |
Chatzimichael, A; Kalmanti, M; Katzilakis, N; Mantadakis, E; Raissaki, M; Tzardi, M | 1 |
Csomor, J; Egyed, M; Egyházi, Z; Fekete, S; Kaszás, I; Kollár, B; Pajor, L; Timár, B | 1 |
Arpaci, F; Ataergin, S; Beyzadeoglu, M; Caglar, K; Kaya, A; Oysul, K; Ozyigit, G; Surenkok, S; Yenicesu, M | 1 |
Anhalt, GJ; Hosler, GA; Liégeois, N; Moresi, JM | 1 |
Aoyama, H; Fujieda, K; Ikeda, J; Ishii, N; Iwasaki, Y; Kashiwamura, M; Sawamura, Y; Shirato, H; Taguchi, H; Yasuda, K | 1 |
de Wilde, PC; Groot-Loonen, J; Hulsbergen-van der Kaa, C; Merkx, MA; Neven, J | 1 |
Keller, U; Licht, T; Menzel, H; Müller, A; Peschel, C; Von Schilling, C | 1 |
Barrans, SL; Clawson, SM; Jack, AS; Mead, GM; Qian, W; Radford, JA; Stenning, SP; Walewski, J; Wolf, M; Yule, CL | 1 |
Baba, S; Hosokawa, S; Mineta, H; Suzuki, K; Takebayashi, S | 1 |
Gilman, AL; Oesterheld, J | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, BS; Kim, CW; Kim, DW; Kim, NK; Kim, TY; Park, S; Yoon, SS | 1 |
Castleberry, R; Kletzel, M; Kretschmar, C; London, WB; Marcus, R; Murray, K; Zage, PE; Zhang, Y | 1 |
Fujii, Y; Fukui, I; Kawakami, S; Komai, Y; Okubo, Y; Yamamoto, S; Yonese, J | 1 |
Fujii, Y; Fukui, I; Ishikawa, Y; Kawakami, S; Komai, Y; Okubo, Y; Takeshita, H; Tatokoro, M; Yamamoto, S; Yonese, J | 1 |
Bourgeois, JM; Hodson, I; Macdonald, P; Midia, M; Mullah-Ali, A; Portwine, C; Ramsay, JA | 1 |
Yamaguchi, M | 3 |
Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A | 1 |
Andreesen, R; Grassinger, J; Hart, C; Hennemann, B | 1 |
Barnich, M; Cairo, M; Chang, M; Griffin, TC; Gross, TG; Hutchison, R; Shiramizu, B; Weinstein, H; Weitzman, S; Wiley, J; Woods, D | 1 |
Alinari, L; Baccarani, M; Derenzini, E; Fanti, S; Gandolfi, L; Musuraca, G; Stefoni, V; Tani, M; Venturini, F; Zinzani, PL | 1 |
Kanz, L; Kopp, HG; Vogel, W; Weisel, KC; Yildirim, S | 1 |
Chamberlain, MC; Glantz, MJ | 1 |
Arpaci, F; Ataergin, S; Beyzadeoglu, M; Komurcu, S; Oysul, K; Ozet, A; Ozturk, M; Solchaga, L; Surenkok, S; Turan, M | 1 |
Daw, NC; Gregornik, D; Jenkins, JJ; Jones, DP; Kun, LE; Marina, N; McPherson, V; Rodman, J; Wilimas, J; Wu, J | 1 |
Jarkowski, A | 1 |
Cordier, JF; Cottin, V; Girard, N; Lapalus, MG; Tronc, F | 1 |
Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
Boldrini, R; Cozza, R; De Ioris, MA; De Sio, L; Donfrancesco, A; Fidani, P; Garrè, ML; Ilari, I; Milano, GM; Serra, A | 1 |
Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
Kim, KJ; Kim, YD; Lee, YH | 1 |
Bregni, M; Pedrazzoli, P | 1 |
Cui, XZ; Hao, XS; Li, LF; Li, W; Liu, PF; Liu, XM; Qiu, LH; Wang, HQ; Zhang, HL | 1 |
Arpaci, F; Ataergin, S; Kilic, S; Komurcu, S; Kuzhan, O; Ozet, A; Ozturk, B; Ozturk, M | 1 |
Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J | 1 |
Druck, P; Gupta, P; Iwamoto, C; Mesa, H; Niehans, GA; Rawal, A; Rezcallah, A | 1 |
Hara, T; Hatano, M; Kinoshita, Y; Koga, Y; Kohashi, K; Matsuzaki, A; Oda, Y; Saito, Y; Suminoe, A; Taguchi, T; Tajiri, T; Tsuneyoshi, M | 1 |
Riese, MJ; Vaughn, DJ | 1 |
Fujime, M; Hojo, M; Kato, J; Kodani, T; Nagahara, A; Nagao, K; Ogihara, T; Osada, T; Otaka, M; Saito, H; Shibuya, T; Ueyama, H; Watanabe, S | 1 |
Osanai, T; Sugawara, M; Tsuchiya, T | 1 |
Bairey, O; Lazar, AD; Shaklai, M; Shpilberg, O | 1 |
Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R | 1 |
Beaven, AW; Chao, N; Gabriel, DA; Garcia, RA; Gockerman, JP; Moore, DT; Rizzieri, DA; Serody, JS; Shea, TC | 1 |
DuBois, SG; Grier, HE | 1 |
Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Qiao, W; Siefker-Radtke, AO; Thall, PF; Williams, DL | 1 |
Chang, JH; Cheong, JW; Hong, SJ; Kim, JS; Kim, KM; Kim, SJ; Lee, HW; Lee, ST; Min, YH | 1 |
Bernard, C; Grushka, JR; Laberge, JM; Mueller, C; Nguyen, VH; Puligandla, PS; Roessingh, Ade B; Ryckman, J; St Vil, D; Walton, JM | 1 |
Al Balushi, Z; Bulduc, S; Lallier, M; Mulleur, C | 1 |
Fujii, N; Harada, M; Ikeda, K; Maeda, Y; Matsuo, K; Matsuoka, K; Nishimori, H; Shinagawa, K; Takenaka, K; Tanimoto, M | 1 |
Alousi, A; Anderlini, P; Andersson, B; Champlin, R; de Lima, M; Giralt, S; Hosing, C; Jones, R; Kebriaei, P; Khouri, I; Körbling, M; McMannis, J; Nieto, Y; Popat, U; Qazilbash, M; Saliba, R; Shpall, E; Thandi, R; Thomas, S; Wang, M; Weber, D | 1 |
Romanick, M; Shiu, JR; Stobart, K | 1 |
Gouliamos, A; Koukourakis, GV; Kouloulias, V; Maravelis, G; Papadimitriou, C; Platoni, K; Zacharias, G | 1 |
Aoki, T; Matsutani, M; Miyatake, S; Mizutani, T; Nojima, K; Nozaki, K; Okumura, R; Takagi, T; Takahashi, JA; Taki, W; Ueba, T; Yuba, Y | 1 |
Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
Hongo, H; Inui, K; Kishi, Y; Kodawara, T; Takahashi, J; Yano, I; Yano, Y | 1 |
Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC | 1 |
Kanemoto, M; Karahashi, T; Kato, T; Kobayashi, C; Morita, S; Tanabe, J | 1 |
Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
Abdel-Rahman, S; Issels, RD; Lindner, LH; Reiser, MF; Santl, M; Stahl, R; Wang, T | 1 |
Conrad, AL; Go, RS | 1 |
Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M | 1 |
Cui, H; Filatov, A; Moskowitz, CH; Persky, DO; Saxena, R; Teruya-Feldstein, J | 1 |
Pappo, A; Paulino, AC | 1 |
Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
Domm, J; Eckrich, MJ; Frangoul, H; Ho, R; Whitlock, JA | 1 |
Akbulut, H; Buyukcelik, A; Demirkazik, A; Dincol, D; Dogan, M; Icli, F; Onur, H; Samur, M; Senler, FC | 1 |
Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, TJ; Lee, JH; Lee, JW | 1 |
Hotta, T; Ishikura, S; Ishizawa, K; Ishizuka, N; Isobe, Y; Itoh, K; Kagami, Y; Kinoshita, T; Kobayashi, Y; Maseki, N; Matsuno, Y; Nawano, S; Oguchi, M; Ohshima, K; Oshimi, K; Terauchi, T; Tobinai, K; Usui, N; Wasada, I; Yamaguchi, M | 1 |
Abe, K; Furuhashi, S; Maebayashi, T; Sakaguchi, M; Shizukuishi, T; Sugitani, M; Takahashi, M; Tanaka, Y; Uematsu, A | 1 |
Arvelo, F; Assayag, F; Bourgeois, Y; Daniel, C; Decaudin, D; Froget, B; Legrier, ME; Livartowski, A; Némati, F; Poupon, MF | 1 |
de Wit, R; Sternberg, CN; Troost, MM | 1 |
Beyer, J; Bokemeyer, C; Kollmannsberger, C | 1 |
Ahn, YC; Cho, J; Eom, HS; Huh, J; Kang, KM; Kim, BS; Kim, CY; Kim, JS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Lee, GW; Lee, SW; Pyo, HR; Suh, C | 1 |
Bosch, F; Carreras, E; Esteve, J; Fernández de Larrea, C; Fernández-Avilés, F; Gaya, A; López-Guillermo, A; Lozano, M; Martínez, C; Montserrat, E; Nomdedeu, B; Rovira, M | 1 |
Kinoshita, T | 1 |
Biamonte, R; Ceniti, S; Conforti, S; De Simone, R; Filice, A; Liguori, V; Manfredi, C; Mastroianni, C; Palazzo, S; Patitucci, G; Rovito, A; Turano, S; Viscomi, C | 1 |
Cen, XN; Chen, H; Han, MZ; Han, XH; He, XH; Huang, H; Huang, HQ; Jiang, WQ; Liu, P; Ma, J; Ren, HY; Shen, XM; Shi, YK; Wang, C; Wang, JM; Yang, S; Zhou, SY; Zhu, J | 1 |
Antolín, I; Casado-Zapico, S; García-Santos, G; Martín, V; Rodriguez, C; Rodriguez-Blanco, J; Sánchez-Sánchez, AM | 1 |
Byrne, GE; Coleman, F; Escalón, MP; Hosein, PJ; Lossos, IS; Morgensztern, D; Rosenblatt, JD; Walker, GR | 1 |
Atkinson, HD; Macmull, S; O'Donnell, P; Saso, S; Skinner, JA; Tirabosco, R | 1 |
Filippa, D; Hamlin, P; Horowitz, S; Kewalramani, T; Maragulia, J; Moskowitz, AJ; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, OA; Portlock, C; Rice, RD; Straus, D; Teruya-Feldstein, J; Trippett, T; Vanak, J; Yahalom, J; Zelenetz, AD; Zhang, Z | 1 |
Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M | 1 |
Bains, M; Bajorin, DF; Bosl, GJ; Feldman, DR; Fischer, P; Ishill, N; Motzer, RJ; Patil, S; Reich, LM; Sheinfeld, J; Turkula, S | 1 |
Angamuthu, N; Boyd, K; Chasty, R; Davies, J; Forsyth, P; Jack, F; Lennard, AL; Lyons, S; Mounter, P; Proctor, SJ; Revell, P; Sieniawski, M | 1 |
Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S | 1 |
Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y | 1 |
Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
Arnold, D; Behlendorf, T; Jordan, K; Kegel, T; Mueller, LP; Schmoll, HJ; Sippel, C; Voigt, W; Wolf, HH | 1 |
Andreoiu, M; Beck, SDW; Brames, MJ; Cheng, L; Ehrlich, Y; Einhorn, LH; Foster, RS; Ulbright, TM | 1 |
Arima, H; Imai, Y; Inoue, D; Kimura, T; Maruoka, H; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Nagano, S; Shimoji, S; Suzuki, R; Tabata, S; Takahashi, T; Takiuchi, Y; Togami, K; Yanagita, S | 1 |
Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Lehner, B; Mechtersheimer, G; Schmitt, T; Strauss, LG; Stroebel, P; Vasamiliette, J | 1 |
Fukuda, H; Fukui, N; Higashi, Y; Hyochi, N; Ichiyanagi, N; Inoue, M; Ishioka, J; Kageyama, Y; Numao, N; Saito, K; Tanak, M | 1 |
Ishii, N; Matsuda, T; Morozumi, M; Takagi, D; Terao, T; Yamada, T; Yamashita, T; Yoshinaga, A | 1 |
Feng, FY; Liu, P; Qin, Y; Shi, YK; Xing, PY | 1 |
Abdel-Rahman, S; Baur-Melnyk, A; Blay, JY; Daugaard, S; Dürr, HR; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Lindner, LH; Mansmann, U; Ploner, F; Reichardt, P; Salat, C; Schem, BC; Verweij, J; Vujaskovic, Z; Wendtner, CM; Wessalowski, R; Wust, P | 1 |
Bartels, U; Bouffet, E; Greenberg, M; Halliday, W; Kamaly-Asl, ID; Kulkarni, AV; Lafay-Cousin, L; Mabbott, DJ; Tabori, U; Taylor, MD | 1 |
André, M; Bretel, JJ; Caliandro, R; Grassin, F; Le Chevalier, T; Margery, J; Paleiron, N; Ruffié, P; Terrier, P | 1 |
Craft, A; Dirksen, U; Hjorth, L; Jürgens, H; Ladenstein, R; Le Deley, MC; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Pötschger, U; van den Berg, H; Whelan, J | 1 |
Aliev, MD; Chernov, IS; Machak, GN; Meluzova, OM; Polotskiĭ, BE | 1 |
Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G | 1 |
Behm, FG; Graham, K; Hale, GA; Howard, SC; Hudson, MM; Kaste, S; Krasin, MJ; Kun, LE; Lowe, E; Mahmoud, H; Metzger, ML; Onciu, M; Pui, CH; Razzouk, BI; Rencher, R; Ribeiro, RC; Sandlund, JT; Zhou, Y | 1 |
Estlin, EJ; Moulin, CJ; Pauly-Takacs, K | 1 |
Bosly, A; Brière, J; Gisselbrecht, C; Glass, B; Hagberg, H; Ketterer, N; Linch, DC; Ma, D; Moskowitz, CH; Mounier, N; Schmitz, N; Shpilberg, O; Singh Gill, D; Trneny, M | 1 |
El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
Alapetite, C; Baranzelli, MC; Ben-Hassel, M; Bernier, V; Bouffet, E; Brisse, H; Carrie, C; Cuilliere, JC; Frappaz, D; Gaboriaud, G; Habrand, JL; Patte, C; Raquin, MA; Thiesse, P | 1 |
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
Gibbs, CP; Indelicato, DJ; Islam, S; Keole, SR; Lagmay, JP; Marcus, RB; Morris, CG; Scarborough, MT | 1 |
Kewalramani, T; Maragulia, JC; Moskowitz, AJ; Moskowitz, CH; Vanak, JM; Yahalom, J; Zelenetz, AD | 1 |
Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Eghbali, H; Foussard, C; Gressin, R; Jaubert, J; Lamy, T; le Gouill, S; Lucas, V; Maloisel, F; Milpied, N; Peoch, M; Rossi, JF; Simon, A; Thyss, A; Tournilhac, O; Vilque, JP | 1 |
Bosly, A; Brière, J; Coiffier, B; Gisselbrecht, C; Molina, T; Morel, P; Mounier, N; Munck, JN; Quesnel, B; Ranta, D; Reyes, F; Thyss, A; Tilly, H | 1 |
Fukuhara, N; Harigae, H; Ichikawa, S; Ishizawa, K; Kameoka, J; Kohata, K; Nakajima, S; Okitsu, Y; Onishi, Y; Suzuki, M; Yamamoto, J | 1 |
Behlendorf, T; Jahn, F; Jahn, P; Jordan, K; Kegel, T; Ruessel, J; Schmoll, HJ; Stein, A | 1 |
Agarwala, S; Bhatnagar, V; Garg, R | 1 |
Hishiki, T; Hiyama, E; Horie, H; Ida, K; Kamimatsuse, A; Kondo, S; Matsunaga, T; Ohnuma, N; Oue, T; Sasaki, F; Tajiri, T; Watanabe, K; Yano, M | 1 |
Hayashi, K; Kitamura, S; Miwa, S; Nishida, H; Nojima, T; Shirai, T; Takeuchi, A; Tsuchiya, H | 1 |
Aass, N; Bokemeyer, C; Collette, L; Daugaard, G; De Santis, M; De Wit, R; Dumez, H; Lluch, JRG; Marreaud, S; Schmoll, HJ; Skoneczna, I | 1 |
Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
Ambroszkiewicz, J; Chełchowska, M; Gajewska, J; Klepacka, T; Laskowska-Klita, T; Woźniak, W | 1 |
Ardeshna, KM; Goldstone, AH; Kayani, I; Linch, DC; Lowry, L; Marafioti, T; Mohamedbhai, SG; Sibson, K | 1 |
Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L | 1 |
Narita, Y; Ohno, M | 1 |
Suzuki, R | 1 |
Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T | 1 |
Guo, L; Han, X; Lang, J; Leng, J; Xiang, Y | 1 |
Athanasopoulos, A; Daladimos, T; Karabelis, A; Kosmas, C; Mylonakis, N; Theotikos, E; Tsakonas, G | 1 |
El-Modir, A; Pettit, L | 1 |
Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
Balcerska, A; Iżycka-Świeszewska, E; Kobierska-Gulida, G; Stachowicz-Stencel, T; Synakiewicz, A | 1 |
Ferreti Bonan, PR; Martelli-Júnior, H; Miranda Soares, PB; Pereira DE Souza, W; Quirino Filho, S | 1 |
Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S | 1 |
Chang, PM; Chang, SY; Chen, MH; Chu, PY; Huang, YC; Tzeng, CH; Yang, MH | 1 |
Abramson, JS; Barnes, JA; Feng, Y; Hochberg, EP; Lacasce, AS; Michaelson, JS; Neuberg, D; Toomey, CE | 1 |
Chin, C; Midulla, P; Shapiro, M; Wistinghausen, B | 1 |
Cardesa, T; Cruz, O; de Torres, C; Galván, P; Huguet, R; Mora, J; Parareda, A; Rodríguez, E; Salvador, H; Suñol, M; Torner, F | 1 |
Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C | 1 |
Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
Bascoul-Mollevi, C; Beyer, J; De Giorgi, U; Einhorn, L; Fléchon, A; Germà-Lluch, JR; Kollmannsberger, C; Kramar, A; Lorch, A; Lotz, JP; Margolin, K; Massard, C; Necchi, A; Powles, T | 1 |
Fujii, S; Kaneko, H; Matsui, Y; Miura, Y; Nakamura, C; Sugino, N; Tsudo, M; Wakasa, T; Watanabe, M | 1 |
Camus, M; Guillet, G; Hainaut-Wierzbicka, E; Levillain, P; Lopez, L; Saulnier, JP | 1 |
Anderlini, P; Fanale, M; Fayad, L; Horowitz, S; Ji, Y; Kwak, LW; Liboon, MJ; Nunez, C; Popat, U; Pro, B; Samaniego, F; Younes, A | 1 |
Dunning, D; Löckenhoff, CE; O'Donoghue, T | 1 |
Delaplace, M; Goré, C; Machet, L; Mélard, P; Perrinaud, A; Vergier, B | 1 |
Balzer, RJ; Champlin, R; de Lima, M; Giralt, S; Hosing, C; Khouri, I; McMannis, J; Popat, U; Qazilbash, M; Rhodes, B; Smith, V; Thompson, R; Walters, K | 1 |
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M; Yamashita, Y | 1 |
Bridge, JA; Hori, T; Huang, D; Kanamori, M; Kimura, T; Suzuki, K; Yasuda, T | 1 |
Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A | 1 |
Iwaba, A; Kato, T; Nagaoka, A; Naito, S; Sakurai, T; Tomita, Y; Tsukigi, M; Yamagishi, A; Yamakawa, M | 1 |
Homma, C; Miwa, A; Sekiguchi, N; Shikai, T; Takezako, N; Takezako, Y; Tanimura, A; Yamagata, N | 1 |
Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A | 1 |
Huang, DS; Liu, XC; Wu, YP; Yang, YP; Zhang, WL; Zhang, Y | 1 |
Avansino, J; Gow, KW; Hawkins, DS; Meehan, J; Stephenson, J | 1 |
Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Miura, K; Sawada, U; Takei, K; Takeuchi, J; Tanaka, T; Yagi, M; Yamazaki, T | 1 |
Bonnabry, P; Fleury-Souverain, S; Geiser, L; Hochstrasser, D; Nussbaumer, S; Sadeghipour, F; Veuthey, JL | 1 |
Aksu, C; Başaran, M; Bavbek, S; Ekenel, M; Keskin, S; Kiliçaslan, I; Tunç, M | 1 |
Kawase, T; Takahashi, S; Yoshida, K | 1 |
Braquet, P; Chapelle, A; Jorgensen, C; Pers, YM | 1 |
Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T | 1 |
Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J | 1 |
Bulanov, A; Burova, A; Fainshtein, I; Fedyanin, M; Figurin, K; Garin, A; Kanagavel, D; Sergeev, U; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Cathomas, R; Frick, H; Furrer, M; Potocnik, P; Schwitter, M; von Moos, R | 1 |
Bahlis, NJ; Carlson, L; Duan, Q; Duggan, P; Hasegawa, W; Russell, JA; Stewart, DA; Voralia, M | 1 |
Al-Rahawan, MM; Mitchell, CS; Siebert, JD; Smith, SD | 1 |
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T | 1 |
Boudova, L; Briere, J; Bron, D; Chevalier, C; Cogliatti, S; Cuccuini, W; Gaulard, P; Gisselbrecht, C; Hirchaud, E; Houlgatte, R; Jack, A; Mounier, N; Rosenwald, A; Schmitz, N; Soulier, J; Sundstrom, C; Thieblemont, C; Trougouboff, P; Voelker, HU; Ysebaert, L | 1 |
Maruyama, D | 2 |
Benson, W; George, B; Hertzberg, MS | 1 |
Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B | 1 |
Dawson, JL; Field, TL; Fields, KK; Goldstein, SC; Kim, J; Lush, RM; Maddox, BL; Neuger, AM; Partyka, JS; Perkins, JB; Simonelli, CE; Sullivan, DM | 1 |
Furuya, T; Ikeda, T; Inoue, M; Kaneda, H; Koshinaga, T; Maebayashi, T; Masuko, T; Mugishima, H; Ohashi, K; Sugito, K; Yagasaki, H | 1 |
Abdel Rahman, H; El Debawy, E; Ezzat, S; Mostafa, NE; Moussa, EA; Rayan, Ael R; Yones, A; Zekri, WZ | 1 |
Bischof, M; Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Strauss, LG; Wuchter, P | 1 |
Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
Bremnes, RM; Cavallin-Ståhl, E; Cohn-Cedermark, G; Dahl, O; Haugnes, HS; Laurell, A; Stierner, U | 1 |
Avci, Z; Gursel, O; Kurekci, E; Malbora, B; Olgac, A; Ozbek, N | 1 |
Andemariam, B; Coleman, M; Elstrom, RL; Furman, RR; Leonard, JP; Martin, P; Ruan, J; Shore, TB | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Kleinhans, A; Kollmannsberger, CK; Kramar, A; Lorch, A; Rick, O | 1 |
Briere, J; Bron, D; Cogliatti, S; Cuccuini, W; Gaulard, P; Gisselbrecht, C; Hirchaud, E; Houlgatte, R; Mounier, N; Rosenwald, A; Soulier, J; Sundstrom, C; Thieblemont, C; Voelker, HU; Ysebaert, L | 1 |
Guo, N; Lou, J; Peng, Z; Yang, K | 1 |
Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H | 1 |
Botteri, E; Calabrese, L; Cocorocchio, E; Martinelli, G; Peccatori, F; Piperno, G; Preda, L; Travaini, L; Vanazzi, A | 1 |
Patel, S; Rao, P; Richey, SL; Tannir, NM; Wood, CG | 1 |
Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L | 1 |
Lim, L; Powles, T; Rashid, S | 1 |
Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
Gandhi, V; Nagral, A; Nagral, S; Sable, S | 1 |
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M | 1 |
Abate, ME; Barbieri, E; Bisogno, G; Daolio, P; Eriksson, M; Fagioli, F; Ferrari, S; Gandola, L; Grignani, G; Hall, KS; Lindholm, P; Luksch, R; Picci, P; Podda, M; Prete, A; Ruggieri, P; Smeland, S; Tamburini, A; Tienghi, A | 1 |
Gafton, GI; Gudz', IuV; Ivanova, TV; Krzhivitskiĭ, PI; Kupatadze, DD; Lazareva, IuR; Levchenko, EV; Nabokov, VV; Novik, VI; Petrov, VG; Punanov, IuA; Safonova, SA | 1 |
D'Souza, R; Khan, F; McKimm, E; Vessal, S | 1 |
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
Bisogno, G; Carli, M; Casanova, M; Dall'Igna, P; De Ioris, MA; De Leonardis, F; De Salvo, GL; Ferrari, A; Manzitti, C; Meazza, C | 1 |
Adde, M; Adeodou, O; Aken'Ova, Y; Brown, BJ; Durosinmi, M; Githang'a, J; Hurwitz, N; Kaijage, J; Leoncini, L; Magrath, I; Naresh, K; Ngoma, T; Rajab, J; Raphael, M; Rohatiner, A; Scanlan, P; Venzon, D | 1 |
Afonso, M; Amaro, T; Begonha, R; Maurício, J; Sousa, N; Teixeira, A; Vieira, C | 1 |
Abeler, VM; Brennhovd, B; Frøen, H; Lehne, G; Madsbu, UE | 1 |
Ishii, Y; Kumita, S; Kuribayashi, S; Matsuno, A; Yamada, S; Yamada, SM | 1 |
Chim, CS; Kim, SJ; Kim, WS; Kwong, YL; Leung, AY; Lim, ST; Tang, T; Tse, E | 1 |
Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 1 |
Kim, HO; Kim, HS; Kim, NK; Lyu, CJ; Suh, CO | 1 |
Krege, S | 1 |
Ahmed, AB; Bruserud, O; Hatfield, KJ; Kittang, AO; Reikvam, H; Sjo, M; Tvedt, TH | 1 |
Carmichael, C; Ferrell, B; Frankel, P; Hsu, J; Margolin, K; Pal, SK; Saikia, J; Stein, CA; Sun, V; Twardowski, P; Yamzon, J | 1 |
Baruchel, S; Bernstein, ML; Brown, K; Chuba, PJ; Felgenhauer, JL; Henry, DW; Krailo, MD; Malkin, D; Marina, N; Nieder, ML; Ranganathan, S; Sailer, SL | 1 |
Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M | 1 |
Barsaoui, S; Bel Hadj Ali, Z; Belaid, I; Ben Romdhane, N; Fdhila, F; Kochbati, L; Maalej, M; Mezlini, A; Oubich, F; Rifi, H | 1 |
Dickman, PS; Dormans, JP; Grier, HE; Healey, JH; Krailo, MD; Marcus, K; Pawel, BR; Sailer, S; Weiss, AR; West, DC; Womer, RB | 1 |
Beyer, J; Droz, JP; Fizazi, K; Hartmann, JT; Kramar, A; Lorch, A; Massard, C; Pico, JL; Rosti, G | 1 |
Backes, M; Bode-Erdmann, S; Greulich, S; Hebart, H; Kaufmann, M; Mahrholdt, H; Ong, P; Ott, G; Schumm, J | 1 |
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F | 1 |
Li, AW; Liu, JM; Luo, J; Wu, FY; Zheng, D | 1 |
Hangaishi, A; Imai, Y; Kobayashi, T; Kurokawa, M; Morikawa, T; Nakamura, F; Ota, S; Shinohara, A; Takazawa, Y; Yamamoto, G | 1 |
De Luca, M; Hadjistilianou, T; Lembo, A; Nucci, P; Pichi, F | 1 |
Fujii, M; Goto, H; Ideguchi, M; Nomura, S; Sadahiro, H; Sugimoto, K; Suzuki, M; Yoshikawa, K | 1 |
Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R | 1 |
Boyd, TE; Budde, LE; Chen, TL; Frayo, SL; Gooley, TA; Gopal, AK; Kammerer, BE; Knudsen, NL; Oliveira, GR; Pagel, JM; Press, OW; Roden, JE; Shustov, AR; Warr, TA; Zhang, MM | 1 |
Arai, E; Futamura, N; Hirata, A; Ishiguro, N; Kozawa, E; Miyahara, R; Nishida, Y; Tsukushi, S; Tsurudome, I; Urakawa, H | 1 |
Brown, PN; D'Amore, F; Hagberg, H; Hagberg, O; Jerkeman, M; Pedersen, LM; Wästerlid, T | 1 |
Alapetite, C; Calaminus, G; Frappaz, D; Garrè, ML; Kortmann, R; Nicholson, JC; Patte, C; Ricardi, U; Saran, F; Worch, J | 1 |
Berdel, WE; Demant, A; Evers, G; Kessler, T; Köhler, G; Krug, U; Kuhlmann, M; Mesters, R; Mikesch, JH; Mohr, M; Müller-Tidow, C; Pohlen, M; Schliemann, C; Schmidt, E; Thoennissen, GB; Thoennissen, NH; Wessling, J | 1 |
Bachour, M; Hussein, T; Kenj, M; Salamoon, M | 1 |
Kuwano, H; Murakawa, T; Murayama, T; Nagayama, K; Nakajima, J; Sano, A; Tsuchiya, T; Yoshida, Y | 1 |
Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG | 1 |
Akiyama, M; Fukushima, T; Ida, H; Kato, T; Sakurai, H; Terao, Y; Yamaoka, M; Yokoi, K; Yokokawa, Y | 1 |
Czuczman, MS; Edvardsen, K; Fayad, L; Fecteau, D; Fennessy, M; Henkel, K; Jewell, RC; Joyce, R; Kharfan-Dabaja, MA; Liao, Q; Lisby, S; Lossos, IS; Matasar, MJ; Moskowitz, CH; Rodriguez, MA; Shea, TC; Singh, RP; Spitzer, G | 1 |
Clement, J; Drabick, JJ; Frauenhoffer, E; Rybka, W; Varlotto, J | 1 |
Al-Hader, AA; Al-Nasrallah, N; Einhorn, LH; Jain, A | 1 |
Calaminus, G; Friemann, V; Göbel, U; Kyrillopoulou, O; Leuschner, I; Matuschek, C; Mils, O; Rothe, K; Schaper, J; Schneider, DT; Schönberger, S; Wessalowski, R; Willers, R | 1 |
Chim, CS; Kwong, YL; Leung, AY; Pang, AW; Tse, E | 1 |
Biasoni, D; Catanzaro, M; Farè, E; Giannatempo, P; Gianni, AM; Mariani, L; Milani, A; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Raggi, D; Salvioni, R; Stagni, S; Torelli, T | 1 |
Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
Gisselbrecht, C | 1 |
Baranzelli, MC; Corradini, N; Cropet, C; Fasola, S; Faure-Conter, C; Frappaz, D; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Rocourt, N; Rome, A; Thebaud, E; Vérité, C | 1 |
Collins, G; Eyre, T; Hildyard, C; Sheikh, S | 1 |
Chung, JS; Kim, SK; Shin, HJ; Song, MK | 1 |
Abate, ME; Balladelli, A; Cesari, M; Fagioli, F; Ferrari, S; Luksch, R; Marchesi, E; Paioli, A; Palmerini, E; Pratelli, L; Tamburini, A | 1 |
Bokemeyer, C; Budach, W; de Zwart, P; Eckert, F; Hartmann, JT; Horger, M; Kluba, T; Königsrainer, A; von Weyhern, CH | 1 |
Aubelle, MS; Beuzeboc, P; Caty, A; Chevreau, C; Culine, S; Delva, R; Fizazi, K; Geoffrois, L; Kerbrat, P; Laplanche, A; Malhaire, JP; Priou, F; Rixe, O; Rolland, F | 1 |
Endo, T; Fukuhara, Y; Inai, H; Joraku, A; Kawai, K; Kojima, T; Miyagawa, T; Miyazaki, J; Nishiyama, H; Shimazui, T; Uchida, K; Yamauchi, A | 1 |
Alaggio, R; Bisogno, G; Cecchetto, G; Ferrari, A; Scarzello, G; Schiavetti, A; Tagarelli, A | 1 |
Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC | 1 |
Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C | 1 |
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
Angelici, A; Brunotti, G; Manfredelli, S; Marcantonio, M; Pontone, S; Zitelli, A | 1 |
Imai, H; Izumi, H; Komatsu, N; Noguchi, M; Ota, Y; Sekiguchi, Y; Shimada, A; Sugimoto, KJ; Wakabayashi, M; Yamaguchi, N | 1 |
Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC | 1 |
Chang, WJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
Elsner, P; Grimm, MO; Schummer, C; Tittelbach, J; Winkler, Y | 1 |
Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC | 1 |
Costello, BA; Dronca, RS; French, CA; Hilton, J; Marks, RS; Molina, JR; Nerby, CL; Parikh, SA; Peddareddigari, VG; Roden, AC; Shapiro, GI | 1 |
Itani, K; Miyazaki, Y; Nagamatsu, K; Otsuka, E; Saburi, M; Saburi, Y; Urabe, S | 1 |
Agresti, B; Buccoliero, AM; Cardellicchio, S; de Martino, M; Fangusaro, J; Farina, S; Genitori, L; Sardi, I | 1 |
Ajisawa, A; Hagiwara, S; Kitanaka, A; Kojima, Y; Nagai, H; Okada, S; Tanuma, J; Uehira, T | 1 |
Beaven, AW; Bejot, C; Bhattacharyya, P; Carini, C; Chow, KF; Donato, ML; Feldman, T; Gadaleta, G; Goy, A; Kdiry, S; Mato, AR; Pecora, AL; Protomastro, EA; Rowley, SD; Smith, J; Stives, S; Timberg, M; Valentinetti, M; Yang, X; Yannotti, KM | 1 |
Bastos, DA; Feldman, DR | 1 |
Chang, H; Chen, X; Dai, Y; Dong, T; He, C; Ji, J; Li, J; Liu, T; Liu, W; Xiang, B | 1 |
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
Miri-Aliabad, G | 1 |
Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
Cormenzana, M; García-Esparza, E; Hernández-Marqués, C; Lassaletta, A; Madero-López, L | 1 |
Ascani, S; Capodanno, I; Ragazzi, M; Valli, R; Zanelli, M | 1 |
Bischof, M; Debus, J; Egerer, G; Grüllich, C; Hensley, FW; Huber, PE; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Sedlaczek, O; Wuchter, P | 1 |
Bay, JO; Biron, P; Brindel, I; Bui, BN; Caty, A; de Revel, T; Delva, R; Dubot, C; Fizazi, K; Fléchon, A; Gaulet, M; Geoffrois, L; Gligorov, J; Gravis, G; Horn, E; Lotz, JP; Micléa, JM; Provent, S; Roubaud, G; Selle, F; Soares, DG; Temby, I; Wittnebel, S | 1 |
Furman, WL; Ivy, P; Lam, CG; McGregor, LM; Santana, VM; Spunt, SL; Wang, C; Wu, J | 1 |
Bai, L; Greenwood, M; Kerridge, I; Ma, CK; Reid, C; Ward, C; Wong, K; Xia, W | 1 |
Ellis, D; Necessary, CA; Roffwarg, D | 1 |
Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J | 1 |
Fujii, Y; Fukui, I; Masuda, H; Sakura, M; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E | 1 |
Burbury, K; Carney, DA; Cheah, CY; Dickinson, M; Fedele, PL; George, A; Gilbertson, M; Harrison, SJ; Herbert, KE; Januszewicz, EH; Kennedy, GA; O'Rourke, K; Opat, SS; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Tan, SY; Westerman, DA; Wolf, M | 1 |
Choi, JY; Kang, ES; Kim, SJ; Kim, WS; Ko, YH; Lim, DH; Park, S | 1 |
Hirasawa, A; Kamiya, M; Kawanami, K; Sato, K; Takahashi, E; Takeuchi, M; Wakao, N | 1 |
Kwong, YL | 1 |
Li, T; Mao, GJ; Sun, H; Sun, LL; Zhang, Y | 1 |
Jacobson, C; LaCasce, A | 1 |
Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ | 1 |
Heo, DS; Jeon, YK; Keam, B; Kim, CW; Kim, DW; Kim, KH; Kim, M; Kim, TM; Lee, JS; Lee, SH | 1 |
Beck, J; Burmeister, T; Dengler, J; Döhner, H; Domanska-Czyz, K; Dührsen, U; Fietkau, R; Gökbuget, N; Hertenstein, B; Hiddemann, W; Hoelzer, D; Horst, HA; Hüttmann, A; Kneba, M; Reichle, A; Rieder, H; Schaich, M; Schmidt-Wolf, IG; Schwartz, S; Serve, H; Spiekermann, K; Thiel, E; Viardot, A; Walewski, J | 1 |
Adiguzel, R; Andreana, PR; Arslan, Z; Ates, M; Bemis, T; Bercovitch, LG; Bögli, S; Boucherez, J; Boudouf, S; Briat, JF; Brown, BM; Busemann, A; Buters, J; Byers, JS; Cairo, MS; Carrier, F; Chalmers, JJ; Chang, E; Chen, J; Chen, Y; Christenson, MK; Cielecka-Piontek, J; Cole, PA; Cooper, BS; Davis, PH; De Silva, RA; Decato, S; DeFries, RS; Demir, V; Denic, A; Deserno, M; Dickey, AM; Diss, E; Eberlein, B; Eyerich, S; Faluvegi, G; Farlow, MR; Fletcher, JW; Francetic, T; Furlan, L; Garbacki, P; Gartung, A; Garvin, JH; Gates, L; Gaymard, F; Ghetti, B; Gibson, MP; Griffin, RG; Hamed, M; Hammad, LA; Hammond, GB; Han, J; Hann, R; Hao, N; Harrison, LA; Heidecke, CD; Hutchins, GD; Inlow, M; Irmer, H; Jani, P; Jara-Cavieres, A; Jawadi, H; Jiang, Q; Jiang, Y; Kameda, T; Keeler, EG; Kim, H; Kim, R; Kim, S; Kinney, PL; Krause, A; Kumar, V; Kwok, Y; Lam, T; Lanni, F; Le May, M; Lee, A; Lee, JF; Lee, MJ; Leontyev, IV; Li, Q; Li, X; Liu, J; Liu, NK; Lominadze, D; Lösche, M; Lu, QB; Lu, Y; Lu, Z; Mach, H; Madsen, E; Marletta, M; Marlier, ME; McDonald, BC; McKay, IS; Mckenzie, CL; Mecozzi, S; Menges, P; Meyers, D; Michaelis, VK; Montooth, KL; Moore, LR; Morgan, JK; Morris, E; Movahed, M; Nalabothula, N; Narayanan, S; Nguyen, D; Nho, K; Oken, B; Ong, TC; Osborne, LS; Paczkowska, M; Park, EK; Pennino, D; Peters, S; Potluri, LP; Qin, C; Radhakrishnan, K; Randerson, JT; Rantanen, J; Reyt, G; Ring, J; Risacher, SL; Rodriguez, M; Saykin, AJ; Schmidt-Weber, CB; Sengelaub, DR; Shatters, RG; Shen, L; Shen, V; Shindell, DT; Stuchebrukhov, AA; Swaminathan, S; Takahashi, K; Talaczyńska, A; Tallman, EF; Tan, C; Terry, SF; Trabbic, KR; Trease, AJ; Tretter, C; Uitto, J; Váradi, A; von Bernstorff, W; Voulgarakis, A; Wagenhofer, M; Wahbeh, H; Wang, EN; Wang, X; Wells, RJ; West, JD; Williams, PS; Wolff, JE; Wootla, B; Xu, B; Xu, XM; Yoder, KK; Zalewski, P; Zan, GH; Zborowski, M; Zhang, HH; Zhang, W; Zhao, J; Zoecklein, L | 1 |
Cheon, J; Cho, YM; Hong, JH; Jeong, Y; Kim, TO; Lee, JL; Lee, S; Lim, DH | 1 |
Wang, W; Wang, Z; Xiao, X | 1 |
Anninga, J; Bernstein, M; Bielack, SS; Böhling, T; Butterfass-Bahloul, T; Calaminus, G; Capra, M; Deffenbaugh, C; Dhooge, C; Eriksson, M; Flanagan, AM; Gelderblom, H; Goorin, A; Gorlick, R; Gosheger, G; Grimer, RJ; Hall, KS; Helmke, K; Hogendoorn, PC; Hook, JM; Jovic, G; Jundt, G; Kager, L; Krailo, M; Kuehne, T; Lau, CC; Letson, GD; Marina, N; Meyer, J; Meyers, PA; Morris, C; Mottl, H; Nadel, H; Nagarajan, R; Randall, RL; Schomberg, P; Schwarz, R; Smeland, S; Sydes, MR; Teot, LA; Whelan, JS | 1 |
Chen, S; Guan, M; Jia, N; Shao, Y; Wang, Y | 1 |
Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C | 1 |
de Lima, PF; de Moraes, CN; Dias, MC; Junior, JB; Maia, L; Oba, E; Raposo-Ferreira, TM; Sudano, MJ | 1 |
Abonour, R; Einhorn, LH; Matei, D; Reddy Ammakkanavar, N | 1 |
Chai, AP; Mao, RR; Xu, L; Yang, YX; Yu, CL; Zhou, H | 1 |
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C | 1 |
Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D | 1 |
Jaśkowski, P; Krzanowska, K; Krzanowski, M; Miarka, P; Sułowicz, W | 1 |
Chan, WH; Ibrahim, ZA; Narihan, MZ; Ong, EJ; Wong, SL | 1 |
Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M | 1 |
Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S | 1 |
Chow, CL; Gubbels, SP; Guo, W; Trivedi, P; Zhao, X | 1 |
Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
Abou Mourad, Y; Barnett, MJ; Broady, RC; Connors, JM; Forrest, DL; Gascoyne, RD; Gerrie, AS; Hogge, DE; Karsan, A; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Savage, KJ; Sehn, LH; Shepherd, JD; Slack, GW; Song, KW; Sun, H; Sutherland, HJ; Toze, CL; Villa, D | 1 |
Fox, SY; Gerecitano, J; Grewal, R; Hamlin, PA; Horwitz, S; Kobos, R; Kumar, A; Matasar, M; McCall, SJ; Moskowitz, AJ; Moskowitz, CH; Noy, A; Palomba, ML; Perales, MA; Portlock, CS; Sauter, C; Schöder, H; Shukla, N; Steinherz, P; Straus, D; Trippett, T; Yahalom, J; Younes, A; Zelenetz, A | 1 |
Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
Baldi, L; Boni, C; Braglia, L; Gnoni, R; Pagano, M; Savoldi, L; Zanelli, F | 1 |
Abujamra, AL; Almeida, MT; Benites, E; Boldrini, E; Brunetto, AL; Castillo, LA; Costa, C; Gadelha, A; Gregianin, LJ; Kirst, D; Macedo, CD; Morais, V; Nakasato, A; Pereira, WV; Petrilli, AS; Pizza, M; Rodriguez-Galindo, C; Watanabe, FM | 1 |
Bouffet, E; Coluccia, D; Hawkins, C; Kamaly-Asl, I; Kulkarni, AV; Lafay-Cousin, L; Ramaswamy, V; Remke, M; Rutka, JT; Schneider, C; Tabori, U; Taylor, MD | 1 |
Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N | 1 |
Dufour, C; Gaspar, N; Goma, G; Loschi, S; Oberlin, O; Valteau-Couanet, D | 1 |
McKinnon, E; Xiao, P | 1 |
Allen, JC; Bouffet, E; Buxton, AB; Chuba, PJ; Donahue, B; Fisher, PG; Goldman, S; Kretschmar, CS; Pollack, IF; Robertson, PL; Zhou, T | 1 |
Fujisawa, M; Miyake, H; Nishikawa, M | 1 |
Fukuoka, K; Kuji, I; Matsutani, M; Nishikawa, R; Suzuki, T; Watanabe, Y; Yanagisawa, T | 1 |
Brisse, H; Fasola, S; Mosseri, V; Orbach, D; Winter, S | 1 |
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ | 1 |
Bassett, R; Champlin, R; Gulbis, AM; Holmberg, L; Jones, RB; Kingham, A; Ledesma, C; Margolin, K; Nieto, Y; Pagliaro, L; Tannir, N; Tu, SM | 1 |
Castex, MP; Faure-Conter, C; Fresneau, B; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Verité, C | 1 |
Agerbaek, M; Bandak, M; Daugaard, G; Gupta, R; Holm, NV; Kier, MG; Lauritsen, J; Mortensen, MS | 1 |
Eucker, J; Habbel, P; Kaul, D; Kurreck, A; Neumann, C; Possinger, K; Regierer, AC; Scholz, CW; Schulz, CO | 1 |
DuBois, SG; Felgenhauer, J; Granowetter, L; Grier, HE; Karski, EE; Krailo, M; Marina, N; McIlvaine, E; Meyers, PA; Segal, MR; Womer, RB | 1 |
Ash, S; Cohen, IJ; Issakov, J; Kollender, Y; Shkalim-Zemer, V; Toledano, H; Yaniv, I | 1 |
Gui, L; Han, XH; He, XH; Liu, P; Qin, Y; Shi, YK; Sun, Y; Yang, S; Yao, JR; Zhang, CG; Zhang, SX; Zhao, LY; Zhou, P; Zhou, SY | 1 |
Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU | 1 |
Hansen, PB; Thomsen, RH; Zakarian, K | 1 |
Altuntaş, F; Civriz Bozdağ, S; Durgun, G; Esbah, O; Kaya, A; Kayıkçı, Ö; Kocubaba, Ş; Şirinoğlu Demiriz, I; Tekgündüz, E; Tetik, A | 1 |
Bakhshi, S; Batra, A; Khan, SA; Nataraj, V; Rastogi, S; Sharma, MC; Vishnubhatla, S | 1 |
Bernstein, ML; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Healey, JH; Krailo, MD; Lipshultz, SE; Meyers, PA; Sato, JK; Schwartz, CL; Steinherz, LJ; Teot, LA; Wexler, LH | 1 |
Engert, F; Fulda, S; Probst, M; Schneider, C; Weiβ, LM | 1 |
Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
Ahn, YC; Kim, SJ; Kim, WS; Ko, YH; Oh, D | 1 |
DiPersio, JF; Fletcher, TR; Hsu, YM; Link, DC; Schmidt, AP; Stock, W; Trinkaus, KM; Uy, GL; Westervelt, P | 1 |
Kawamoto, H; Kobayashi, E; Nakatani, F; Yasui, N; Yoshida, A | 1 |
Dong, L; Du, J; Gao, X; Li, G; Li, Y; Song, Y; Sun, X; Wei, X; Xu, B | 1 |
Anderson, JR; Arndt, CA; Hawkins, DS; Lyden, E; Meyer, WH; Michalski, JM; Parham, DM; Rodeberg, DA; Weigel, BJ | 1 |
Benson, C; Jones, RL; Judson, I; Kasper, B; Khabra, K; Kollàr, A; Langer, R; Miah, A; Noujaim, J; Thway, K | 1 |
Brickman, A; Gallo, K; Gattuso, P; Seder, CW; Warren, WH | 1 |
Ferrari, S; Serra, M | 1 |
Ahn, JY; Cho, EK; Cho, EY; Hong, J; Hwang, I; Lee, JH; Park, J; Park, S; Shin, DB | 1 |
Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
Bond, MC; Felgenhauer, JL; Femino, JD; Gorlick, R; Krailo, MD; Laack, NN; Marina, N; Mascarenhas, L; Meyer, J; Ranganathan, S; Villaluna, D; Womer, RB | 1 |
Ishizawa, K; Kagami, S; Okada, N; Watanabe, H | 1 |
Bartels, U; Bouffet, E; Hader, W; Hawkins, C; Lafay-Cousin, L; Laperriere, N; Laughlin, S; Lindzon, G; Nordal, R; Taylor, MD | 1 |
Bratta, M; Candeloro, G; D'Orazi, V; Fumagalli, LA; Pasta, V; Rea, S; Recchia, F; Rosselli, M | 1 |
Avivi, I; Gibstein, L; Herishanu, Y; Joffe, E; Perry, C; Polliack, A; Sarid, N | 1 |
Ben-Ami, T; Fried, I; Marc, W; Revel-Vilk, S; Waldman, E; Weintraub, M | 1 |
Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R | 1 |
Dong, LH; Du, JW; Gao, X; Lei, W; Li, GP; Li, YF; Sun, X; Wang, WJ; Zhang, LJ | 1 |
Carpten, JD; Cortes, D; Craig, D; Kirov, I; McEachron, TA; Sassoon, A; Sender, LS; Wungwattana, M; Zabokrtsky, KB | 1 |
Aguiar, Sdos S; Almeida, MT; Barreto, JH; Bruniera, P; D'Andrea, ML; de Oliveira, CZ; Lima, ER; Lopes, LF; Lopes, PM; Macedo, CR; Martins, GE; Melaragno, R; Milone, M; Moreira, ME; Pianovski, MA; Sonaglio, V; Vianna, SM; Watanabe, FM | 1 |
Amorim, S; Brice, P; Fleury, I; Harel, S; Mounier, N; Thieblemont, C | 1 |
Bacon, CL; Bracken-Clarke, D; Browne, PV; Conneally, E; Daly, PA; Flynn, C; Gardiner, N; Hayden, PJ; Kennedy, MJ; Lee, G; McCaffrey, J; Ni Chonghaile, M; O'Donnell, DM; O'Kane, G; Power, D; Vandenberghe, E | 1 |
Hoda, ST; Miccio, JA; Oladeru, OT; Parker, RI; Ryu, S; Stessin, AM; Xue, Y; Yang, J | 1 |
Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
Lee, AC | 1 |
Cho, SH; Jung, KS; Kang, ES; Kim, SJ; Kim, WS; Ko, YH | 1 |
Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E | 1 |
Fujiwara, Y; Kodaira, M; Sasada, S; Shimizu, C; Shimoi, T; Shimomura, A; Tamura, K; Yonemori, K; Yunokawa, M | 1 |
Liu, YF | 1 |
Ando, M; Ando, Y; Emi, N; Hayashi, T; Inaguma, Y; Ito, K; Okamoto, A; Okamoto, M; Tomono, A; Tsuge, M; Yamada, S | 1 |
Arima, N; Fukunaga, A; Hyuga, M; Iwasaki, M; Kishimoto, W; Maesako, Y; Nakae, Y | 1 |
Huang, Y; Li, MJ; Shu, Q; Tang, DX; Wang, JH; Wu, DH; Xu, S | 1 |
Craig, MD; Cumpston, A; D'Souza, A; Dhakal, B; Eastwood, D; Esselman, J; Fenske, TS; Hamadani, M; Hari, P; Kanate, AS; Pasquini, MC; Shillingburg, A; Veltri, LW; Watkins, K | 1 |
Brons, P; Flucke, U; Salet, MC; Schreuder, B; Vogels, R | 1 |
Bae, SH; Eom, HS; Hong, J; Jeong, SH; Kang, HJ; Kim, SJ; Kim, WS; Kwak, JY; Lee, H; Lee, JH; Lee, MH; Park, SK; Shin, DY; Suh, C; Yang, DH; Yhim, HY; Yoon, DH | 1 |
Einhorn, LH; Kesler, KA; Ranganath, P | 1 |
Beyer, J; Lorch, A | 1 |
Hishiki, T; Hiyama, E; Hoshino, K; Ida, K; Iehara, T; Koh, K; Kurihara, S; Onitake, Y; Oue, T; Tanaka, Y; Ueda, Y; Watanabe, K; Yano, M | 1 |
Hattori, Y; Hino, M; Kobayashi, Y; Kurahasi, T; Nakagawa, H; Wada, M | 1 |
Adachi, S; Arakawa, Y; Funaki, T; Heike, T; Hiramatsu, H; Mizowaki, T; Nodomi, S; Saida, S; Ueno, H; Umeda, K | 1 |
Azuma, E; Hirayama, M; Imai, H; Iwamoto, S; Komada, Y; Matsumine, A; Miura, Y; Nakatani, K; Toyoda, H; Yodoya, N | 1 |
Al Sa'ey, H; Al Shawabkeh, MA; Al Sulaiti, M; Ganesan, S | 1 |
Pagliaro, LC | 1 |
Akiba, T; Amaki, J; Ando, T; Asano, N; Ejima, Y; Hasegawa, M; Hyo, R; Ii, N; Itami, J; Itasaka, S; Katayama, N; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Murayama, T; Oguchi, M; Saito, B; Saito, Y; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Ueda, K; Wada, H; Yamaguchi, M | 1 |
Celentano, A; Cirillo, N; De Rosa, G; Mascolo, M; Mignogna, MD | 1 |
Kaneko, T; Koike, K; Kurata, T; Motobayashi, M; Nakazawa, Y; Sano, K; Shigemura, T; Sumi, T; Suzuki, S; Watanabe, T | 1 |
Baek, SW; Choi, YS; Jo, DY; Kim, S; Lee, HJ; Moon, JY; Ryu, H; Song, IC; Yun, HJ | 1 |
Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
Grüllich, C; Grüner, M; Hadaschik, B; Hofheinz, RD; Jäger, D; Jentsch-Ullrich, K; Lasitschka, F; Zschäbitz, S | 1 |
Deng, Z; Li, S; Qiu, B; Wang, L; Yang, F; Zhang, S; Zhang, T; Zhu, S | 1 |
Akamatsu, N; Fujioka, Y; Fukuyama, M; Hasegawa, K; Hayashi, A; Ibaraki, T; Kokudo, N; Koya, J; Kurokawa, M; Mizuno, H; Nakamura, F; Shinozaki-Ushiku, A | 1 |
Chinea-Rodríguez, A; Gallego-Rivera, JI; Gorospe, L; Rioja-Martín, ME | 1 |
Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W | 1 |
Amengual, JE; Barta, SK; Bast, MA; Behdad, A; Blum, KA; Calzada, O; Cassaday, RD; Chavez, JC; Cohen, JB; Costa, C; Falkiewicz, MK; Feldman, T; Fenske, TS; Gerson, JN; Hernandez-Ilizaliturri, F; Hill, BT; Howlett, C; Kaplan, JB; Landsburg, DJ; Lansigan, F; Li, S; Lue, JK; Maly, J; Mato, AR; Medeiros, LJ; Nathan, S; Olszewski, AJ; Peace, DJ; Persky, DO; Petrich, AM; Reddy, NM; Rivera, X; Singavi, A; Torka, P; Vose, JM | 1 |
Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY | 1 |
Akagi, T; Bun, S; Fujiwara, Y; Hayashi, Y; Makino, Y; Noguchi, E; Shimizu, C; Shimoi, T; Shimomura, A; Tamura, K; Yonemori, K; Yunokawa, M | 1 |
Cheng, YM; Chiang, CT; Chou, CY; Huang, YF; New, GH; Tsai, HW; Wu, PY | 1 |
Claret, L; Copeland, AR; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Hagemeister, FB; Hu, B; Nastoupil, LJ; Neelapu, S; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, J; Samaniego, F; Turturro, F; Westin, JR; Younes, A | 1 |
Cadzin, BR; Fleisher, M; Fox, SY; Gavane, S; Gerecitano, J; Grewal, R; Hamlin, PA; Horwitz, SM; Kumar, A; Matasar, M; McCall, SJ; Moskowitz, AJ; Moskowitz, CH; Ni, A; Noy, A; Palomba, ML; Perales, MA; Portlock, CS; Sauter, C; Schöder, H; Straus, D; Thoren, KL; Yahalom, J; Younes, A; Zelenetz, AD | 1 |
Ailawadhi, S; Dholaria, B; Patel, RJ; Roy, V; Sluzevich, JC | 1 |
Bruckner, T; Cremer, M; Egerer, G; Heilig, C; Kriegsmann, K; Kriegsmann, M; Müller-Tidow, C; Novotny, P; Wuchter, P | 1 |
Hou, AJ; Jia, RF; Jiang, L; Yang, XY | 1 |
Ahmed, SK; DuBois, SG; Geller, DS; Gorlick, RG; Granowetter, L; Grier, HE; Harmsen, WS; Janeway, KA; Krailo, M; Laack, NNI; Marcus, KJ; Randall, RL; Sorger, JI; Womer, RB | 1 |
Bison, B; Bojko, S; Gielen, GH; Hoffmann, M; Kortmann, RD; Kramm, CM; Pietsch, T; Seidel, C; von Bueren, AO; Warmuth-Metz, M | 1 |
Alapetite, C; Calaminus, G; Frappaz, D; Garre, ML; Göbel, U; Kortmann, RD; Krefeld, B; Mann, JR; Murray, MJ; Nicholson, JC; Pietsch, T; Ricardi, U; Saran, F; Vasiljevic, A | 1 |
Bompas, E; Bouvier, C; Brisse, HJ; Brugieres, L; Castex, MP; Cheurfa, N; Corradini, N; Delaye, J; Entz-Werlé, N; Gaspar, N; Gentet, JC; Italiano, A; Le Deley, MC; Lervat, C; Marec-Berard, P; Mascard, E; Occean, BV; Pacquement, H; Piperno-Neumann, S; Redini, F; Saumet, L; Schmitt, C; Tabone, MD; Verite-Goulard, C | 1 |
Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H | 1 |
Beckmann, MW; Dörje, F; Fromm, MF; Grafe, C; Hein, A; Mackensen, A; Semrau, S | 1 |
Richie, JP | 1 |
Courtien, AI; Devlin, SM; Drullinsky, P; Gerecitano, J; Kumar, A; Matasar, MJ; McCall, SJ; Miller, ST; Moskowitz, CH; Noy, A; Palomba, ML; Portlock, CS; Sauter, CS; Schoder, H; Straus, DJ; Younes, A; Zelenetz, AD | 1 |
Dong, Y; Jiang, S; Wang, G | 1 |
Culine, S; Gosset, C; Mongiat-Artus, P; Razafimahefa, J; Verine, J | 1 |
Aoyama, T; Arai, H; Ikeda, T; Imataki, O; Ishide, K; Katsumata, N; Kume, T; Mori, M; Shiozaki, H | 1 |
Abdel-Rahman, S; Angele, M; Belka, C; Daugaard, S; Dürr, HR; Ghadjar, P; Gronchi, A; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Knösel, T; Lindner, LH; Mansmann, U; Mella, O; Reichardt, P; Salat, C; Schmidt, M; Verweij, J; Vujaskovic, Z; Wessalowski, R; Wust, P | 1 |
Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M | 1 |
Chihara, D; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Garg, N; Horowitz, SB; Hosing, C; Kamble, RT; Khouri, IF; Nastoupil, L; Nieto, Y; Oki, Y; Romaguera, JE; Ruben, CE; Samaniego, F; Stafford, MD; Strati, P; Wesson, ET | 1 |
Fukuhara, S; Hatta, S; Ito, Y; Izutsu, K; Kim, SW; Maeshima, AM; Makita, S; Maruyama, D; Munakata, W; Suzuki, T; Watanabe, J; Yuda, S | 1 |
Abou Mourad, Y; Barnett, MJ; Broady, R; Connors, JM; Forrest, DL; Gerrie, AS; Hogge, DE; Leitch, H; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Ramadan, K; Sanford, DS; Sehn, LH; Slack, GW; Song, KW; Sutherland, HJ; Toze, CL; Tucker, T; Zhu, KY | 1 |
Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T | 1 |
Carden, MA; Greenberg, J; McCarty, JM; Perdahl-Wallace, E | 1 |
Albany, C | 1 |
Dührsen, U; Lamm, W; Liebregts, T; Turki, AT | 1 |
Bagherifard, A; Jamshidi, K; Mirzaei, A; Ramezan Shirazi, M | 1 |
Es'haghi, Z; Hatamluyi, B; Lorestani, F | 1 |
Gharaibeh, EZ; Powers, BC; Salacz, ME; Telfah, M | 1 |
Kasami, T; Kawamoto, K; Kiryu, M; Miyoshi, H; Ohshima, K; Sone, H; Suzuki, T; Takizawa, J | 1 |
Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S | 1 |
Bonnet, E; Jaouen, A; Lazareth, A; Maillet, D; Tamarelle, B; Tartas, S; You, B | 1 |
Alnassan, A; Elshahoubi, A; Sultan, I | 1 |
Sato, S; Tamai, Y; Tanaka, E | 1 |
Hashizume, A; Hiruma, T; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Tatenuma, T; Umemoto, S; Yasui, M | 1 |
Berbegall, AP; Blanquer-Maceíras, MT; Ferrández, A; Machado, I; Martinez-Ciarpaglini, C; Navarro, S; Nieto, G; Noguera, R; Yoshida, A | 1 |
Amaki, J; Ando, T; Asano, N; Kameoka, Y; Katayama, N; Kinoshita, S; Kobayashi, Y; Kubota, N; Maeda, T; Masaki, Y; Matsuoka, H; Miyazaki, K; Niitsu, N; Oguchi, M; Saito, B; Sakai, R; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Wada, H; Yamaguchi, M | 1 |
Bergamaschi, L; Bertulli, R; Casanova, M; Chiaravalli, S; Collini, P; Diletto, B; Ferrari, A; Fiore, M; Gandola, L; Gasparini, P; Massimino, M; Morosi, C; Provenzano, S; Sangalli, C | 1 |
Hirakawa, Y; Iwai, T; Kawaji, Y; Kobayashi, T; Kuriyama, K; Kuroda, J; Muramatsu, A; Nagata, H; Ohshiro, M; Uchiyama, H; Urata, Y | 1 |
Bush, R; Cho, SY; Cole, PD; Hodgson, DC; Kelly, KM; McCarten, KM; Pei, Q; Roberts, KB; Schwartz, C | 1 |
Bajpai, J; Banavali, S; Chandrasekharan, A; Ghosh, J; Gupta, S; Hingmare, S; Mandal, T; Rangarajan, B; Rekhi, B; Shah, K; Shetty, N; Simha, V; Vora, T | 1 |
Aladjidi, N; Auperin, A; Couec, ML; Gandemer, V; Haouy, S; Jourdain, A; Lambliotte, A; Landman-Parker, J; Leblanc, T; Michon, J; Minard-Colin, V; Patte, C; Plat, G; Rigaud, C | 1 |
Anract, P; Bertucci, F; Blay, JY; Bompas, E; Brugieres, L; Collard, O; Cupissol, D; de Pinieux, G; Delaye, J; Duffaud, F; Italiano, A; Laurence, V; Le Cesne, A; Le Deley, MC; Occean, BV; Penel, N; Perrin, C; Piperno-Neumann, S; Ray-Coquard, I; Rios, M | 1 |
Auerbach, C; Cheron, R; Natarajan, E; Pashankar, F | 1 |
Ayarza, M; Clark, SM; Hairston, A; Lentz, KL; Liu, B; Morgan, KP; Wind, LS | 1 |
Abdelal, S; Abu-Hijlih, R; Abuhijla, F; Almousa, A; Halalsheh, H; Ismail, T; Jaber, O; Salah, S; Shehadeh, A; Sultan, I; Yaser, S | 1 |
Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
Chinen, Y; Horiike, S; Inaba, T; Kobayashi, T; Kuroda, J; Nagata, K; Shimura, Y; Sotozono, C; Takimoto-Shimomura, T; Tsukamoto, T | 1 |
Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV | 1 |
Aleshawi, AJ; Alhowary, A; Altal, OF; Tashtush, NA | 1 |
Carlos, R; Díaz Molina, JP; Paes de Almeida, O; Sánchez-Romero, C | 1 |
He, A; Hu, H; Huang, Y; Shen, Z; Sun, Y; Yao, Y; Zhang, J; Zhou, Y | 1 |
Biasoni, D; Bisogno, G; Boldrini, R; Conte, M; Crocoli, A; D'Angelo, P; Dall'Igna, P; De Pasquale, MD; Inserra, A; Miele, E; Siracusa, F; Spreafico, F; Terenziani, M | 1 |
Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
Bisogno, G; Hawkins, DS | 1 |
Bassale, S; Davis, LE; Lim, JY; Lu, E; Ryan, CW | 1 |
Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J | 1 |
Czauderna, C; Galle, PR; Heil, E; Heinrich, B; Heinrich, S; Kloeckner, R; Koch, S; Marquardt, JU; Philippe P Diggs, L; Schmidtmann, I; Sprinzl, M; Weinmann, A; Wörns, MA | 1 |
Bagot, M; Battistella, M; Bouaziz, JD; Brice, P; Dangien, A; de Masson, A; Lebbé, C; Moins-Teisserenc, H; Mourah, S; Peffault de Latour, R; Ram-Wolff, C; Roelens, M | 1 |
Kajita, N; Makimoto, A; Miyahara, S; Saito, Y; Yuza, Y | 1 |
Hirai, M; Ito, M; Kaneda, H; Morioka, I; Oba, D; Yagasaki, H | 1 |
Bansal, D; Jain, R; Kapoor, R; Rao, KLN; Samujh, R; Saxena, AK; Totadri, S; Trehan, A | 1 |
Fujiwara, M; Fukui, I; Hayashi, T; Komai, Y; Kouno, T; Numao, N; Takeda, H; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Bay, JO; Chatelut, E; Chevreau, C; Delmas, C; Delva, R; Filleron, T; Fléchon, A; Gravis, G; Gross-Goupil, M; Lafont, T; Lotz, JP; Marsili, S; Massart, C; Moeung, S; Thomas, F | 1 |
Cong, J; Li, X; Wang, J; Wang, L; Wei, L; Yang, J; Yang, L; Yao, N; Ye, J | 1 |
Gloude, N; Lauhan, CR; Schiff, D | 1 |
Gruner, SE; Hernandez, JA; Rainusso, N | 1 |
Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
Imai, Y; Shiseki, M; Tanaka, J; Tanaka, N; Yoshinaga, K | 1 |
Ahmad, N; Gordon, K | 1 |
Colton, BS; Glaspy, J; Hornstein, N; Larson, S; Timmerman, J | 1 |
Chen, M; Gou, Y; Jin, D; Wang, B | 1 |
Chan, JY; Farid, M; Lim, C; Lim, ST; Martin, P; Poon, E; Somasundaram, N; Tang, T; Tao, M; Toh, SQ; Yan, SX; Yunon, MJ | 1 |
Li, J; Liu, Z; Mi, M; Wang, Y; Zhang, C; Zhang, L | 1 |
Aoudjhane, M; Cervera, P; Coppo, P; Corre, E; Duléry, R; Fabiani, B; Lemonnier, MP; Marjanovic, Z; Mohty, M; Van de Wyngaert, Z | 1 |
Angelini, P; Cecil, T; Chisholm, JC; Dayal, S; Okoye, B; Sjoberg Bexelius, T | 1 |
Chumbalkar, V; Howe, AS; Kogan, BA; Lian, F; Nazeer, T; Pearce, J; Ribbons, L | 1 |
Chang, JS; Pan, M | 1 |
Bay, JO; Chatelut, E; Chevreau, C; Ciccolini, J; Culine, S; Delva, R; Filleron, T; Fizazi, K; Flechon, A; Gallois, Y; Gravis, G; Gross-Goupil, M; Guitton, J; Lelièvre, B; Lotz, JP; Massard, C; Moeung, S; Mourey, L; Olivier, P; Paci, A; Thomas, F | 1 |
Alderuccio, JP; Alencar, AJ; Iyer, SG; Lossos, IS; Reis, IM; Rosenblatt, JD; Saul, EE | 1 |
Audino, AN; Saraf, A; Wedekind, MF; Willen, F | 1 |
Bajpai, J; Banavali, SD; Bhargava, P; Chandrasekharan, A; Dandekar, S; Gupta, S; Joshi, A; Khanna, N; Laskar, S; Menon, N; Mokal, S; Noronha, V; Panda, GS; Patil, V; Prabhash, K; Rekhi, B; Srinivas, S | 1 |
Fujii, Y; Fujiwara, M; Fujiwara, R; Fukui, I; Komai, Y; Numao, N; Oguchi, T; Tanaka, H; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Bielack, SS; Fuchs, J; Hallmen, E; Kazanowska, B; Klingebiel, T; Koscielniak, E; Ladenstein, R; Ljungman, G; Niggli, F; Paulussen, M; Scheer, M; Seitz, G; Sparber-Sauer, M; Vokuhl, C | 1 |
Acharfi, N; Amaadour, L; Arifi, S; Benbrahim, Z; Darif, K; Khacha, A; Maaroufi, M; Mellas, N; Oualla, K | 1 |
Collins, GP; Cwynarski, K; Phillips, EH | 1 |
Bautista, F; Campbell-Hewson, Q; Gaspar, N; Huang, J; Okpara, CE | 1 |
Arredondo, A; Babiker, H; Banh, C; Boiles, AR; Elquza, E; Kraft, A; McBride, A; Notbohm, K; Ortega, A; Persky, D; Valsvik, K | 1 |
Bae, YJ; Cha, W; Choi, BS; Kim, H | 1 |
Acar, R; Aykan, MB; Erturk, I; Karadurmus, N; Yildiran, GS; Yildiz, B | 1 |
Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
Saeed, H; Sarfraz, S | 1 |
Gentille, C; Joshi, J; Pingali, SR; Randhawa, J; Sarfraz, H; Shah, S | 1 |
Asher, R; Connolly, EA; Forgeson, G; Goh, J; Grimison, P; Hamad, N; Heller, GZ; Hill, S; Joshi, A; Kuchel, A; Lewin, J; Liow, E; McKenzie, J; Tan, A; Tan, H; Toner, G; Tran, B; Tung, ILY; Walpole, E; Wang, Y; Weickhardt, A; Wickham, A; Winstanley, MA; Wong, V | 1 |
Borawska, A; Chełstowska, M; Dąbrowska-Iwanicka, A; Domańska-Czyż, K; Druzd-Sitek, A; Giebel, S; Knopińska-Posłuszny, W; Konecki, R; Kumiega, B; Lange, A; Malenda, A; Michalski, W; Mordak-Domagała, M; Najda, J; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Pluta, A; Popławska, L; Romejko-Jarosińska, J; Rymkiewicz, G; Świerkowska, M; Szpila, T; Szymański, M; Targoński, Ł; Taszner, M; Walewski, J; Zaucha, JM | 1 |
Chan, EHL; Chan, JYS; Chang, EWY; Chee, YL; de Mel, S; Diong, C; Farid, M; Goh, AZK; Goh, YT; Grigoropoulos, NF; Jeyasekharan, A; Khoo, LP; Lee, J; Lee, YS; Lim, C; Lim, ST; Liu, X; Nagarajan, C; Poon, E; Poon, M; Quek, R; Somasundaram, N; Tan, D; Tang, T; Tao, M; Tay, T; Yang, VSW | 1 |
Agreda-Vásquez, GP; Avendano, O; Barreyro, P; Cubero, D; Enrico, A; Fogliatto, L; Machnicki, G; Mela-Osorio, MJ; Ovilla, R; Pavlovsky, M; San Sebastián, JA; Trufelli, D; Villanova, P | 1 |
Castillo, JJ; Dittus, C; Miller, JA; Wehbie, R | 1 |
Ghandour, K; Halalsheh, H; Ibrahimi, AKH; Ismael, T; Sarhan, N; Shehadeh, A; Sultan, I; Zandaki, D | 1 |
Bajpai, J; Chatterjee, A; Chinnaswamy, G; Desai, S; Gulia, A; Jambhekar, N; Janu, A; Juvekar, S; Khanna, N; Kurkure, P; Laskar, S; Manjali, JJ; Muckaden, MA; Nayak, P; Prasad, M; Purandare, N; Puri, A; Rangarajan, V; Rekhi, B; Shah, S; Sinha, S; Vora, T | 1 |
Bach, E; Brückner, M; Franke, GN; Heyn, S; Jentzsch, M; Leiblein, S; Niederwieser, D; Pfannes, R; Platzbecker, U; Pönisch, W; Remane, Y; Rieprecht, S; Schwind, S; Vucinic, V | 1 |
André, M; Berriolo-Riedinger, A; Borel, C; Brice, P; Edeline, V; Feugier, P; Gac, AC; Gastinne, T; Ghesquières, H; Guidez, S; Le Bras, F; Morschhauser, F; Nicolas-Virelizier, E; Quittet, P; Ribrag, V; Stamatoullas, A; Vander Borght, T | 1 |
Hu, H; Huang, D; Li, F; Li, J; Li, R; Liu, Z; Zhang, W | 1 |
Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
Lucari, B; Porea, T; Sutton, VR; Tallis, E | 1 |
Ben-Ami, T; Bisogno, G; Bolle, S; Brecht, IB; DuBois, SG; Ferrari, A; Fichera, G; Flaadt, T; Fox, E; Fresneau, B; Lauer, UM; Lemelle, L; Moya-Plana, A; Orbach, D; Rodriguez-Galindo, C; Roganovic, J; Schneider, DT; Surun, A; Timmermann, B; Vokuhl, C | 1 |
Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
Anampa-Guzmán, A; Block, A; Darrall, A; DeMarco, J; Ghione, P; Groman, A; Hernandez-Ilizaliturri, FJ; Hutson, A; Johnson, M; Kader, A; Kostrewa, J; Lund, I; Mavis, C; McWhite, K; Mohr, A; Nichols, J; Przespolewski, E; Sait, SJ; Sundaram, S; Thomas, R; Torka, P; Wong, J | 1 |
Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY | 1 |
Bus, L; Hissink, E; Kuijer-Siebelink, W; Nieuwenhuis, L; Pelgrim, E; van der Schaaf, M; van Tartwijk, J | 1 |
Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
Beishuizen, A; Bhojwani, D; Burke, GAA; Burkhardt, B; Cairo, M; Curtis, M; Deshpande, S; Howes, A; Kabickova, E; Kang, HJ; Luisi, F; Minard-Colin, V; Norris, R; Nottage, K; Srinivasan, S; Sun, S; Tacyildiz, N; Tamegnon, M; Uyttebroeck, A; Vinti, L | 1 |
Badira, CP; Banavali, S; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Muckaden, MA; Prasad, M; Qureshi, S; Ramadwar, M; Ramanathan, S; Vora, T | 1 |
Alva, E; Bukowinski, A; Cramer, SL; Daley, J; Escoto, H; Fair, D; Hartt, D; Kim, H; LeBlanc, Z; Merjaneh, N; Metts, J; Pressey, JG; Ray, A; Szabo, S; Todd, K; Watanbe, M | 1 |
Bailey, KM; Daley, J; Friehling, E; Halligan, K; Howrie, D; Salgado, CM; Superdock, A | 1 |
Allen, PB; Bazzi, LA; Bryan, LJ; Casulo, C; Chmiel, JS; Dillehay, GL; Gordon, LI; Kane, KL; Karmali, R; Mehta, J; Palmer, BA; Pro, B; Savas, H; Smith, SE; Winter, JN | 1 |
Fukushima, H; Hosaka, S; Inaba, M; Masumoto, K; Mizumoto, M; Muroi, A; Okunushi, T; Sakurai, H; Suzuki, R; Tagawa, M; Takada, H; Watanabe, A; Yamaki, Y | 1 |
Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
Aiba, H; Arakawa, A; Imai, T; Iwata, S; Kawai, A; Kimura, H; Kobayashi, E; Kojima, Y; Ogawa, C; Shimoi, T; Sudo, K; Yazaki, S; Yonemori, K; Yoshida, A | 1 |
Benedetti, DJ; Kao, PC; Ma, C; Marcus, KJ; Mullen, EA; Wong, CI | 1 |
Bai, B; Gao, Y; He, Y; Huang, C; Huang, H; Ping, L; Shi, L; Wang, X | 1 |
Gan, X; Li, J; Peng, T; Wang, Y; Zhang, L | 1 |
Burke, SM; Ghasemi, M; Goey, AKL; Hernandez-Ilizaliturri, FJ; Lin, LH; Mager, DE; Mavis, CK; Nichols, JR; Torka, P | 1 |
Binitie, O; Buxton, AB; Cash, T; DuBois, SG; Gorlick, R; Grier, HE; Grohar, PJ; Healey, JH; Janeway, KA; Krailo, MD; Marcus, KJ; Pawel, BR; Reed, DR; Weiss, AR; Womer, RB | 1 |
Gao, Y; Gu, H; Hu, H; Huang, D; Li, F; Li, J; Liao, R; Wu, R; Zhang, W; Zhang, Y; Zhi, T | 1 |
Reviews
152 review(s) available for etoposide and ifosfamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Investigational drugs under study by the United States National Cancer Institute.
Topics: Acrylates; Alkylating Agents; Ancitabine; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Chromomycins; Cisplatin; DNA, Neoplasm; Drug Evaluation, Preclinical; Etoposide; Humans; Ifosfamide; Leukemia L1210; Mice; Mitosis; National Institutes of Health (U.S.); Neoplasms; Neoplasms, Experimental; Razoxane; Tegafur; Teniposide; United States | 1976 |
Salvage therapy in recurrent testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1992 |
Hypersensitivity reactions.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide | 1992 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
Ifosfamide in testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1990 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Prospective Studies; Spinal Cord Neoplasms | 1990 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone | 1989 |
Ifosfamide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms | 1989 |
Experience with ifosfamide combinations in malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone | 1989 |
Chemotherapy of malignant disease: an update.
Topics: Amsacrine; Antineoplastic Agents; Cisplatin; Coformycin; Etoposide; Female; Humans; Ifosfamide; Male; Mitoxantrone; Neoplasms; Pentostatin; Pregnancy | 1988 |
[New antineoplastic agents, their value and use].
Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids | 1982 |
Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aminoacridines; Amsacrine; Anthraquinones; Antibodies, Monoclonal; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Infant; Interferons; Leukemia; Leukemia, Lymphoid; Liposomes; Middle Aged; Mitoxantrone; Naphthacenes; Prognosis; Teniposide; Transplantation, Homologous; Transplantation, Isogeneic; Vinblastine; Vindesine | 1983 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Response of metastasized sex cord gonadal stromal tumor of the testis to cisplatin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sex Cord-Gonadal Stromal Tumors; Testicular Neoplasms | 1994 |
Transverse nail ridgings (Beau's lines) induced by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nails; Prednisone; Vincristine | 1994 |
[Malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine | 1994 |
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interleukin-6; Lung Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1995 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine | 1995 |
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor | 1995 |
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1995 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Eosinophilia; Etoposide; Fatal Outcome; Female; Humans; Hydroxyurea; Hyperplasia; Ifosfamide; Leukemia, Myeloid; Lymph Nodes; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Syndrome; Translocation, Genetic; Vincristine | 1995 |
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Separation; Cisplatin; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide | 1993 |
[A case of small cell lung cancer associated with fulminant hepatitis B].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hepatitis B; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1994 |
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Recombinant Proteins; Testicular Neoplasms | 1994 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
Intensive combined-modality therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1994 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms | 1994 |
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion, Autologous; Cisplatin; Drug Administration Schedule; Etoposide; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Humans; Ifosfamide; Neoplasms | 1993 |
Ifosfamide-induced hyperpigmentation.
Topics: Child, Preschool; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Mesna; Pigmentation Disorders; Wilms Tumor | 1993 |
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Paclitaxel; Taxoids; Thiotepa | 1995 |
Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Ifosfamide; In Situ Hybridization; Male; Radiotherapy Dosage; Remission Induction; RNA, Viral; Thymectomy; Thymoma; Thymus Neoplasms; Treatment Outcome; Tumor Virus Infections | 1996 |
Ifosfamide in the treatment of small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate | 1996 |
Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Salvage Therapy; Transplantation, Autologous | 1996 |
Ifosfamide in the treatment of germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Ifosfamide; Male; Salvage Therapy; Testicular Neoplasms | 1996 |
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasms; Treatment Outcome | 1996 |
[Salvage therapy for refractory testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Male; Salvage Therapy; Testicular Neoplasms | 1996 |
[Chemotherapy for recurrent or advanced persistent epithelial ovarian cancer].
Topics: Altretamine; Antineoplastic Agents; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Recurrence; Tamoxifen | 1996 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine | 1996 |
Factors that influence prognosis of intermediate-grade lymphomas at relapse.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Outcome Assessment, Health Care; Prognosis | 1996 |
Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cosyntropin; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Eye Neoplasms; Fatal Outcome; Humans; Hydrocortisone; Hyperkalemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Proteins; Oculomotor Muscles; Prednisone; Tomography, X-Ray Computed; Tuberculosis, Endocrine; Vincristine | 1997 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms | 1997 |
[Small cell carcinoma of the urinary bladder: a case report and review of the Japanese literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Pregnancy; Remission Induction; Trophoblastic Neoplasms | 1997 |
Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Platinum Compounds | 1998 |
Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms | 1998 |
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Clinical Trials as Topic; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Mitoxantrone; Neoplasm Staging; Paclitaxel; Taxoids; Thiotepa | 1998 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Component Removal; Busulfan; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fusion Proteins, bcr-abl; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Ifosfamide; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 1998 |
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Registries; Remission Induction; Risk Factors; Sarcoma; Scandinavian and Nordic Countries; Soft Tissue Neoplasms; Treatment Outcome | 1999 |
Malignant triton tumor of the head and neck: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Lung Neoplasms; Magnetic Resonance Imaging; Mesna; Neoplasm Recurrence, Local; Neurilemmoma; Radiotherapy Dosage; Vincristine | 1999 |
Ifosfamide in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel | 1999 |
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Deoxycytidine; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Topoisomerase I Inhibitors; Vinblastine; Vinorelbine | 1999 |
[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesothelioma; Middle Aged; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Recurrence | 2000 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation | 2001 |
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chromosome Aberrations; Cisplatin; Diseases in Twins; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Scapula; Shoulder Joint; Time Factors | 2001 |
Adult Gaucher disease in association with primary malignant bone tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Male; Prednisone; Radiography; Vincristine | 2001 |
Salvage chemotherapy in relapsed germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Testicular Neoplasms; Vinblastine | 2001 |
[Treatment of metastatic testicular carcinoma according to prognosis; new development].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Europe; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Testicular Neoplasms; United States | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Salvage Therapy; Testicular Neoplasms | 2001 |
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone | 2001 |
[A case of adult Wilms' tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nephrectomy; Treatment Outcome; Wilms Tumor | 2001 |
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Paclitaxel; Taxoids; Topoisomerase I Inhibitors; Topotecan; Vinblastine; Vinorelbine | 2001 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Mesna; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Uterine Neoplasms; Vincristine | 2001 |
[Chemotherapy and radiotherapy for urological cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2002 |
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Middle Aged; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Vincristine | 2002 |
Epithelial ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Practice Guidelines as Topic; Tamoxifen; Taxoids; Topotecan; Vinblastine; Vinorelbine | 2002 |
Phyllodes tumors of the breast.
Topics: Antineoplastic Agents; Breast Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mastectomy; Mastectomy, Segmental; Phyllodes Tumor; Practice Guidelines as Topic; Prognosis | 2001 |
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Case Management; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Retroperitoneal Space; Retrospective Studies; Risk Factors; Salvage Therapy; Seminoma; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2002 |
Successful chemotherapy for melanotic neuroectodermal tumor of infancy in a baby.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Maxillary Neoplasms; Neuroectodermal Tumor, Melanotic; Treatment Outcome; Vinca Alkaloids | 2003 |
Challenges in the management of Burkitt's lymphoma.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Etoposide; HIV Infections; Humans; Ifosfamide; Leucovorin; Methotrexate; Time Factors; Treatment Outcome; Urate Oxidase; Vincristine | 2002 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 2003 |
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Secondary Prevention; Stem Cell Transplantation | 2003 |
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Italy; Lymphoma, Non-Hodgkin | 2003 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine | 2003 |
Ifosfamide in advanced/disseminated breast cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Etoposide; Female; Humans; Ifosfamide; Neoplasm Staging; Paclitaxel; Treatment Outcome; Vinblastine; Vinorelbine | 2003 |
[Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Male; Orchiectomy; Pneumonectomy; Rhabdomyosarcoma; Seminoma; Testicular Neoplasms; Vincristine | 2003 |
Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Corpus Callosum; Etoposide; Germinoma; Humans; Ifosfamide; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Testicular Neoplasms | 2004 |
Improving second-line therapy in aggressive non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2004 |
Chemotherapy of small cell lung cancer: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Quality of Life; Survival Rate; Treatment Outcome | 2004 |
[The result of VIP chemotherapy as an induction therapy in 6 patients with non-seminomatous extragonadal germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies | 2004 |
Depression: a case of neuronal life and death?
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Division; Depression; Etoposide; Humans; Ifosfamide; Limbic System; Methotrexate; Models, Neurological; Models, Psychological; Mood Disorders; Neurons; Stress, Physiological | 2004 |
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids | 2004 |
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma, Small Cell; Cell Proliferation; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Nude; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Topotecan; Transplantation, Heterologous | 2005 |
[The second-line chemotherapy for urological cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Male; Methotrexate; Paclitaxel; Survival Rate; Testicular Neoplasms; Treatment Outcome; Urologic Neoplasms; Vinblastine | 2005 |
Malignant ectomesenchymoma in the wrist of a child: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Mesenchymoma; Soft Tissue Neoplasms; Vincristine; Wrist | 2005 |
Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Carmustine; Cisplatin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2005 |
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2005 |
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Anaplastic large cell lymphoma of bone--is it a bad tumor?
Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Remission Induction; Scapula; Treatment Outcome; United Kingdom | 2007 |
HIV-related lymphoma treated with maintenance thalidomide.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Axilla; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphatic Irradiation; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Thalidomide; Vincristine | 2005 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy | 2005 |
High dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Patient Selection; Prognosis; Risk Factors; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
Trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine | 2007 |
Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Ifosfamide; Irinotecan; Lymphatic Metastasis; Male; Rhabdomyosarcoma; Survival Analysis; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Treatment Outcome | 2006 |
[Testis germ cell tumours: which chemotherapy, for which patients?].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Seminoma; Testicular Neoplasms; Testis; Vinblastine | 2007 |
[ALK-negative primary gastric anaplastic large cell lymphoma].
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Remission Induction; Salvage Therapy; Stomach Neoplasms; Transplantation, Autologous | 2007 |
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lumbar Vertebrae; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Remission Induction; Retroperitoneal Neoplasms; Sarcoma, Synovial; Spinal Stenosis; Translocation, Genetic; Vincristine | 2008 |
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Glyoxal; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Peripheral Blood Stem Cell Transplantation; Prednimustine; Prednisolone; Prognosis; Radiotherapy; Vincristine | 2008 |
Chemotherapy for patients with poor prognosis germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vinblastine | 2009 |
Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.
Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Celecoxib; Child; Child, Preschool; Choristoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Diagnostic Errors; Doxorubicin; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Pyrazoles; Radiography; Sulfonamides; Teratoma; Thalidomide; Thymus Gland; Thyroid Neoplasms; Thyroidectomy | 2009 |
Embryonal rhabdomyosarcoma of the uterine cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Ovariectomy; Particle Accelerators; Photons; Polyps; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Remission Induction; Rhabdomyosarcoma, Embryonal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Young Adult | 2009 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2009 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine | 2009 |
Management of good risk germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors; Testicular Neoplasms | 2009 |
High-dose chemotherapy in nonseminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome; Vindesine | 2009 |
[Management of diffuse large B-cell lymphoma in the rituximab era].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2009 |
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy, Conformal; Surgical Procedures, Operative; Survival Rate; Vincristine; Young Adult | 2010 |
[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Japan; Killer Cells, Natural; Korea; Lymphoma, T-Cell; Male; Nose Neoplasms; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
Desmoplastic small round cell tumour successfully treated with caffeine-assisted chemotherapy: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Caffeine; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Male; Radiotherapy; Sarcoma, Small Cell | 2010 |
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Treatment Outcome | 2010 |
Double high-dose chemotherapy and stem cell transplantation in adult Wilms' tumor.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Paclitaxel; Radiography; Salvage Therapy; Topotecan; Transplantation, Autologous; Wilms Tumor; Young Adult | 2010 |
The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Octreotide; Radiography; Thymoma; Thymus Neoplasms; Treatment Outcome | 2011 |
Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epidural Neoplasms; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Molecular Diagnostic Techniques; Neoplasm Recurrence, Local; Sarcoma, Ewing; Thoracic Vertebrae; Vincristine | 2011 |
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Rituximab; Vincristine | 2011 |
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Therapeutic Equipoise | 2012 |
Spontaneous gastrosplenic fistula secondary to primary splenic lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cooperative Behavior; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fistula; Gastric Fistula; Humans; Ifosfamide; Image Interpretation, Computer-Assisted; Interdisciplinary Communication; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Multidetector Computed Tomography; Patient Care Team; Radiographic Image Enhancement; Rituximab; Spleen; Splenic Diseases; Splenic Neoplasms; Vincristine | 2010 |
Advanced therapeutic strategy for radiation-induced osteosarcoma in the skull base: a case report and review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Radiation-Induced; Osteosarcoma; Prognosis; Skull Base Neoplasms | 2012 |
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Retrospective Studies; Salvage Therapy; Soft Tissue Neoplasms; Young Adult | 2013 |
[PEB treatment of testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Contraindications; Drug Substitution; Etoposide; Humans; Ifosfamide; Male; Neoplasm Invasiveness; Prognosis; Testicular Neoplasms | 2012 |
High-dose etoposide in allogeneic stem cell transplantation.
Topics: Adenine Nucleotides; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Busulfan; Carboplatin; Carmustine; Clinical Trials as Topic; Clofarabine; Cyclophosphamide; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia; Leukemia, Myeloid, Acute; Lomustine; Mucositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2012 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinical Trials as Topic; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Nose Neoplasms | 2012 |
Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Disease Progression; Down Syndrome; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Paresis; Treatment Outcome | 2013 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Chemoradiotherapy, Adjuvant; Dendritic Cells; Dexamethasone; Etoposide; Humans; Ifosfamide; Immunohistochemistry; Male; Neoplasm Staging; Positron-Emission Tomography; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome; Whole Body Imaging | 2013 |
The role of high-dose chemotherapy in the management of germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy | 2014 |
Clinical study on carboplatin for treating pediatric patients with Wilms tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Treatment Outcome; Wilms Tumor | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids | 2014 |
Metaplastic carcinoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemoradiotherapy; Etoposide; Female; Humans; Ifosfamide; Metaplasia; Prognosis | 2015 |
[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2015 |
An update on chemotherapy for osteosarcoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic | 2015 |
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2017 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Transplantation, Autologous | 2017 |
Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Sarcoma, Ewing; Survival Rate | 2018 |
Placental Site Trophoblastic Tumor in Nonseminomatous Mixed Germ Cell Tumors of the Testis: a Case Report and Review of the Literature.
Topics: Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Pregnancy; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Trophoblastic Tumor, Placental Site | 2018 |
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine | 2018 |
Current medical management of patients with poor-risk metastatic germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Taxoids; Testicular Neoplasms | 2018 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Durable Response in Relapsed Adolescent Peripheral T-cell Lymphoma: A Case Report and Review of the Literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Recurrence; Stem Cell Transplantation | 2022 |
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2022 |
Professionals' adaptive expertise and adaptive performance in educational and workplace settings: an overview of reviews.
Topics: Clinical Competence; Educational Status; Etoposide; Humans; Ifosfamide; Workplace | 2022 |
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Progression-Free Survival; Sarcoma, Ewing; Skin Neoplasms; Vincristine | 2023 |
Trials
552 trial(s) available for etoposide and ifosfamide
Article | Year |
---|---|
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Thymosin; Thymus Hormones; Vincristine | 1979 |
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission, Spontaneous; Vincristine | 1979 |
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1992 |
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Random Allocation; Time Factors; Vincristine | 1992 |
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mesna; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Testicular Neoplasms; Vinblastine | 1992 |
Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms | 1992 |
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1992 |
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Survival Rate | 1992 |
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1992 |
Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1992 |
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vincristine | 1992 |
Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Eruptions; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Neoplasms, Germ Cell and Embryonal; Skin; Transplantation, Autologous | 1992 |
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Time Factors; Vincristine | 1992 |
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Vincristine | 1992 |
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Mesothelioma; Middle Aged; Palliative Care; Pleural Neoplasms; Remission Induction; Survival Rate | 1992 |
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasms; Survival Analysis; Transplantation, Autologous | 1992 |
Effect of chemotherapy combined with caffeine for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Calcaneus; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Infusions, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Salvage Therapy; Tibia | 1992 |
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Humans; Ifosfamide; Interleukin-3; Male; Middle Aged; Neoplasms; Neutrophils; Recombinant Proteins | 1992 |
High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
[Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Japan; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1991 |
Sequential chemotherapy in good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vincristine; Vindesine | 1991 |
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Quality of Life; Survival Rate; Vincristine | 1991 |
High dose chemotherapy with carboplatin, VP 16 +/- ifosfamide in germ cell tumors: the Italian experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Italy; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Reoperation | 1991 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine | 1991 |
[Comparison of the antiemetic effectiveness of granisetron and alizapride plus dexamethasone in cytostatic therapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Ifosfamide; Indazoles; Male; Middle Aged; Neoplasms; Pyrrolidines; Serotonin Antagonists; Single-Blind Method | 1991 |
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1991 |
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1991 |
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Survival Rate; Vinblastine | 1991 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine | 1991 |
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Mitoguazone; Prognosis | 1991 |
[Phase III study: cisplatin combination therapy vs. carboplatin monotherapy in metastasizing seminoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dysgerminoma; Etoposide; Genital Neoplasms, Male; Humans; Ifosfamide; Male | 1991 |
Chemotherapy for invasive thymoma. A 13-year experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Thymoma; Thymus Neoplasms; Vincristine | 1991 |
Ifosfamide in soft tissue sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms | 1990 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Prospective Studies; Spinal Cord Neoplasms | 1990 |
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine | 1990 |
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Vincristine; Vindesine | 1990 |
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Nimustine; Nitrosourea Compounds; Peplomycin; Prognosis; Random Allocation; Vincristine; Vindesine | 1987 |
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1988 |
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Prednisone; Procarbazine; Vincristine | 1988 |
Potential advances in combination chemotherapy for advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Podophyllotoxin; Testicular Neoplasms; Vinblastine; Vincristine | 1988 |
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1989 |
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Vincristine | 1989 |
Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany, West; Humans; Ifosfamide; Lung Neoplasms; Male; Multicenter Studies as Topic; Neoplasm Staging; Random Allocation; Remission Induction; Vincristine | 1989 |
Treatment of small cell lung cancer with induction chemotherapy followed by late intensification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Remission Induction; Survival Rate; Vincristine | 1989 |
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Recurrence; Remission Induction; T-Lymphocytes; Vinblastine; Vindesine | 1989 |
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Random Allocation; Vincristine | 1987 |
[Results of 2 multicenter therapy studies in inoperable non-small cell bronchial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Prognosis; Vincristine; Vindesine | 1987 |
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Bronchogenic; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Transplantation, Autologous; Vincristine | 1986 |
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Female; Humans; Hydroxyurea; Ifosfamide; Lymphoma; Male; Middle Aged; Recurrence | 1985 |
Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Vaccines; Brain; Carcinoma, Small Cell; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Propionibacterium acnes; Vincristine | 1981 |
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition; Procarbazine; Random Allocation; Vincristine | 1981 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neutropenia; Parenteral Nutrition; Procarbazine; Vincristine | 1981 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carcinoma, Small Cell; Cyclophosphamide; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Medical Records; Methotrexate; Middle Aged; Nausea; Palliative Care; Patient Compliance; Quality of Life; Self-Assessment; Vincristine; Vomiting | 1993 |
[CAMBO-VIP for advanced diffuse large cell lymphoma (LSG classification)--a long-term follow-up study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Vincristine | 1994 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine | 1994 |
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Length of Stay; Male; Middle Aged; Neoplasms; Transplantation, Autologous; Treatment Outcome | 1994 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1994 |
Chemotherapy for endocrine-therapy-refractory prostate cancer.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Estrogens; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Vincristine | 1994 |
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carboplatin; Carcinoma, Small Cell; Cause of Death; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Platelet Transfusion | 1995 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Survival Analysis | 1995 |
Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Alpha-Globulins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Carboplatin; Cisplatin; Etoposide; Fructose-Bisphosphatase; Humans; Ifosfamide; Immunoglobulin G; Kidney Tubules, Proximal; Male; Middle Aged; Testicular Neoplasms | 1994 |
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Neutrophils; Prognosis; Recombinant Proteins; Survival Rate; Vincristine | 1995 |
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
Topics: Actuarial Analysis; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Karnofsky Performance Status; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Treatment Failure; Vincristine | 1995 |
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1995 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Drug Tolerance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Thrombocytopenia | 1995 |
Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Salvage Therapy; Transplantation, Autologous | 1995 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Radiography; Regression Analysis; Survival Rate | 1995 |
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Remission Induction; Risk Factors; Sarcoma, Ewing; Survival Rate; Vincristine | 1995 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cognition; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Memory; Psychomotor Performance; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digestive System; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Nervous System; Ovarian Neoplasms; Sarcoma; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1995 |
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate | 1995 |
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colony-Forming Units Assay; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoietin; Etoposide; Female; Granulocytes; Hemoglobin A; Humans; Ifosfamide; Iron; Leukocyte Count; Lung Neoplasms; Macrophages; Male; Mesna; Middle Aged; Platelet Count; Platelet Transfusion; Recombinant Proteins; Vincristine | 1995 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1995 |
Salvage chemotherapy for recurrent Ewing's sarcomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Salvage Therapy; Sarcoma, Ewing; Treatment Outcome | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1995 |
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms; Recurrence | 1995 |
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Vindesine | 1995 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis | 1995 |
Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity.
Topics: Adolescent; Adult; Bone Marrow; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney; Male; Neoplasms; Treatment Outcome | 1995 |
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Recombinant Proteins; Vinblastine | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Female; Germinoma; Humans; Ifosfamide; Kidney; Male; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Pregnancy; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Tolerance; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Sarcoma; Testicular Neoplasms; Transplantation, Autologous | 1995 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Survival Analysis; Vincristine | 1995 |
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy | 1994 |
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Nervous System Diseases; Remission Induction; Survival Rate; Treatment Outcome | 1993 |
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1994 |
Results of a salvage regimen in refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Survivors; Time Factors; Treatment Failure | 1994 |
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Sarcoma; Survival Analysis | 1994 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Survival Analysis | 1994 |
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Forecasting; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasms; Transplantation, Autologous; Treatment Outcome | 1994 |
Phase I study of high-dose cisplatin, ifosfamide, and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome | 1994 |
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Radiotherapy | 1993 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Metastasis; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoiesis; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Treatment Outcome | 1994 |
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms; Treatment Outcome | 1994 |
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine; Vindesine | 1994 |
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia | 1994 |
Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1994 |
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Stem Cell Transplantation; Survival Analysis; Thiotepa | 1993 |
Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps; Infusions, Intravenous; Male; Mesna; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms | 1993 |
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1993 |
Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome | 1993 |
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Wor
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cause of Death; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Regression Analysis; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 1993 |
[Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Orchiectomy; Peplomycin; Prognosis; Prostatic Neoplasms; Survival Rate | 1993 |
Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Drug Resistance; Etoposide; Genetic Therapy; Genetic Vectors; Humans; Ifosfamide; Neomycin; Pilot Projects; Retroviridae; Stem Cell Transplantation; Transduction, Genetic; Transplantation, Autologous | 1993 |
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Testicular Neoplasms; Treatment Outcome | 1993 |
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Child; Drug Tolerance; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid; Mesna; Neoplasm Recurrence, Local; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Urinary Tract | 1993 |
Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy | 1993 |
EPIC: an effective low toxicity regimen for relapsing lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone | 1993 |
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Prognosis; Vincristine | 1993 |
Interleukin-3 enhances the endogenous leukotriene production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Humans; Ifosfamide; Interleukin-3; Leukocyte Count; Leukotriene B4; Leukotrienes; Lymphoma; Recombinant Proteins | 1993 |
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusion Pumps; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Quality of Life | 1993 |
The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days. The Granisetron Study Group.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Ifosfamide; Indazoles; Male; Metoclopramide; Middle Aged; Vomiting | 1993 |
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Pancytopenia; Prognosis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1993 |
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Least-Squares Analysis; Male; Neoplasms; Neutropenia; Thrombocytopenia; Treatment Outcome | 1993 |
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local | 1993 |
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Mesna; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome | 1993 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Mitoguazone; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Salvage Therapy; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine | 1995 |
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure | 1995 |
DICE (dexamethasone, ifosfamide, cisplatin, etoposide) as salvage therapy in non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Salvage Therapy | 1995 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Foot Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Pain; Peripheral Nervous System Diseases; Vincristine | 1996 |
Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prospective Studies; Survival Analysis; Vincristine | 1996 |
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1996 |
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Germinoma; Humans; Ifosfamide; Male; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1996 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prognosis; Survival Rate; Transplantation, Autologous; Vincristine | 1996 |
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Cisplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunologic Factors; Interferon-alpha; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neoplasm, Residual; Neoplastic Cells, Circulating; Philadelphia Chromosome; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Epidural Space; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Neutropenia; Ondansetron; Retrospective Studies; Salvage Therapy; Spinal Cord Neoplasms; Treatment Outcome; Vincristine | 1996 |
Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Retrospective Studies; Survival Rate; Transplantation, Autologous | 1996 |
Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Neoplasms | 1996 |
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Europe; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Remission Induction; Survival Rate; Vindesine | 1996 |
Intensified VICE regimen may improve SCLC survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1996 |
Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Misoprostol; Mouth Mucosa; Neoplasms; Stomatitis | 1996 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1996 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasms; Transplantation, Autologous | 1995 |
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Heart Failure; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1996 |
A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged | 1996 |
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Neutropenia; Prospective Studies | 1996 |
r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins | 1996 |
A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Prognosis; Survival Rate; Vinblastine | 1996 |
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Recombinant Proteins; Survival Rate | 1996 |
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Vinblastine | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1996 |
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1996 |
Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Remission Induction; Testicular Neoplasms | 1996 |
Early utilization of high-dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Protocols; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Testicular Neoplasms | 1996 |
High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Transplantation, Autologous | 1996 |
The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pregnancy; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
Combination chemotherapy for advanced bilharzial bladder carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Schistosomiasis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine | 1996 |
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Multivariate Analysis; Survival Analysis; Vincristine | 1996 |
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Drug Eruptions; Etoposide; Female; Humans; Ifosfamide; Interleukin-1; Male; Middle Aged; Premedication; Prospective Studies | 1996 |
Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged | 1996 |
Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neutropenia; Ovarian Neoplasms; Thrombocytopenia | 1996 |
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Salvage Therapy; Survivors; Testicular Neoplasms | 1997 |
[Clinical study of testicular cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Vinblastine | 1996 |
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Glioma; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Survival Rate; Tomography, X-Ray Computed | 1996 |
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma | 1996 |
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Individuality; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Survival Rate | 1997 |
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma; Survival Rate; Treatment Outcome | 1997 |
Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Granulocytes; Humans; Ifosfamide; Infant; Injections, Subcutaneous; Interleukin-1; Male; Neoplasms; Recombinant Proteins | 1997 |
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma | 1997 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Survival Analysis | 1997 |
Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cell Separation; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Transplantation, Autologous | 1997 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Prognosis; Vincristine | 1997 |
Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cross-Sectional Studies; Etoposide; Follicle Stimulating Hormone; Germ Cells; Germinoma; Humans; Ifosfamide; Longitudinal Studies; Luteinizing Hormone; Male; Middle Aged; Testicular Neoplasms; Testosterone; Vinblastine | 1997 |
[Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dimethoate; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1997 |
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis | 1997 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 1997 |
Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Salvage Therapy; Treatment Outcome | 1997 |
Combination salvage chemotherapy with MIZE (ifosfamide-mesna, idarubicin and etoposide) for relapsing or refractory lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Recurrence; Salvage Therapy | 1997 |
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome | 1997 |
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine | 1997 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Multiple Organ Failure; Renal Dialysis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 1997 |
High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Salvage Therapy; Transplantation, Autologous | 1997 |
Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation.
Topics: Adult; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cholinergic Antagonists; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Propantheline; Stomatitis; Transplantation Conditioning; Transplantation, Autologous | 1997 |
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Humans; Ifosfamide; Infant; Interleukin-3; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Recombinant Fusion Proteins | 1998 |
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulocytes; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1998 |
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1998 |
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Double-Blind Method; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate; Vincristine | 1998 |
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Survival Rate; Vincristine | 1998 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine | 1998 |
Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fusion Proteins, bcr-abl; Gene Rearrangement; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Ifosfamide; Immunophenotyping; Interferon-alpha; Interleukin-3; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Philadelphia Chromosome; Polymerase Chain Reaction; Recombinant Proteins | 1998 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1998 |
[Long-term follow up of aggressive lymphoma patients treated with CAMBO-VIP--clinical significance of a residual mass after otherwise successful chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Time Factors; Vincristine | 1998 |
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Survival Analysis | 1998 |
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Vincristine | 1998 |
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Thoracotomy | 1998 |
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Hypoxia; Disease-Free Survival; Dose-Response Relationship, Drug; Etanidazole; Etoposide; Expectorants; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Neoplasms; Recurrence; Survival Rate | 1998 |
Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma | 1998 |
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Recurrence; Salvage Therapy | 1998 |
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine | 1998 |
[Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hem
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Analysis; Time Factors; Vincristine | 1998 |
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carmustine; Cell Separation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Macrophages; Male; Melphalan; Neoplasms; Prednisolone; Vincristine | 1998 |
Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Prospective Studies; Treatment Outcome | 1998 |
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukemia; Male; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Prospective Studies; Risk Factors; Vincristine | 1998 |
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Ifosfamide; Male; Testicular Neoplasms | 1998 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer G
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carboplatin; Child; Child, Preschool; Cytokines; Drug Tolerance; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Interleukin-3; Length of Stay; Neoplasm Recurrence, Local; Neoplasms; Recombinant Fusion Proteins | 1998 |
[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Transplantation Conditioning | 1998 |
Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Patient Compliance; Prognosis; Quality of Life | 1998 |
Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Methotrexate; Middle Aged; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Predictive Value of Tests; Prognosis; Tomography, X-Ray Computed | 1998 |
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Survival Analysis | 1998 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Survival Analysis; Treatment Outcome | 1998 |
Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Salvage Therapy; Survival Rate; Time Factors | 1998 |
High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Mediastinal Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiation-Sensitizing Agents; Survival Rate | 1999 |
Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma.
Topics: Adolescent; Antineoplastic Agents; Carboplatin; Child; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Osteosarcoma; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1998 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 1999 |
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Paclitaxel; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 1998 |
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Megestrol Acetate; Mesna; Middle Aged; Protective Agents; Recombinant Proteins; Survival Analysis; Treatment Outcome | 1998 |
Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Salvage Therapy | 1999 |
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Survival Rate | 1999 |
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Epirubicin; Erythropoietin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous | 1999 |
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitoguazone; Outcome Assessment, Health Care; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Vinblastine; Vincristine | 1999 |
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Rate | 1999 |
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
Modifying the ICE regimen for better prognosis small cell lung cancer--an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Pilot Projects; Prognosis; Survival Rate | 1999 |
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Europe; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Recombinant Proteins | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Outcome | 1999 |
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome | 1999 |
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Movement; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Stem Cells | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Safety; Salvage Therapy | 1999 |
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine | 2000 |
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Component Removal; Carboplatin; Cytogenetic Analysis; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Philadelphia Chromosome; Platelet Count; Time Factors; Transplantation, Autologous | 1999 |
[Results of chemotherapy and salvage surgery for advanced testicular cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms; Vinblastine | 1999 |
[High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1999 |
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Injections, Subcutaneous; Leukapheresis; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Recombinant Proteins; Transplantation, Autologous; Treatment Outcome | 2000 |
Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine | 2000 |
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Transplantation, Autologous | 1999 |
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 1999 |
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Male; Middle Aged; Paclitaxel; Prospective Studies; Salvage Therapy; Survival Analysis | 2000 |
[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesothelioma; Middle Aged; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Recurrence | 2000 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Finland; Humans; Ifosfamide; Injections, Subcutaneous; Interferon-alpha; Isotretinoin; Lung Neoplasms; Male; Middle Aged | 2000 |
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carcinoma; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Recombinant Proteins; Transplantation, Autologous | 2000 |
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cryopreservation; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Recombinant Proteins; Regression Analysis; Survival Rate; Transplantation, Autologous | 2000 |
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine | 2000 |
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 2000 |
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome | 2000 |
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2000 |
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Genital Neoplasms, Female; Genital Neoplasms, Male; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Treatment Outcome | 2000 |
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Salvage Therapy; Survival Analysis | 2000 |
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Treatment Outcome | 2000 |
Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Middle Aged; Risk Factors; Treatment Outcome | 2000 |
Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma | 2000 |
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Middle Aged | 2000 |
[Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2000 |
Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vindesine | 2000 |
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome | 2000 |
Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Salvage Therapy; Testicular Neoplasms | 2000 |
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Membrane Permeability; Cisplatin; Doxorubicin; Etoposide; Forced Expiratory Volume; Humans; Ifosfamide; Lung; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Mitomycin; Mucociliary Clearance; Respiratory Mucosa; Technetium Tc 99m Pentetate; Vital Capacity | 2000 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia | 2001 |
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Taxoids | 2000 |
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Platelet Count; Quality of Life | 2001 |
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphatic Irradiation; Male; Middle Aged; Models, Biological; Prognosis; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Racial Groups; Recombinant Proteins; Recurrence; Survival Rate; Time Factors; United States | 2001 |
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a h
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Infusions, Intravenous; Interleukin-6; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Recombinant Proteins | 2001 |
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thorax | 2000 |
[Use of etoposide, ifosfamide and cisplatin (EIP) for treatment of inoperable non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction | 2000 |
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome | 2001 |
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Retrospective Studies; Salvage Therapy; Vincristine | 2001 |
Combination chemotherapy for extensive small cell lung cancer -- experience from India.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; Drug Costs; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; India; Lung Neoplasms; Male; Mesna; Middle Aged; Patient Compliance; Poverty; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differentiation; Cisplatin; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interferon-alpha; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies | 2001 |
Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunomagnetic Separation; Middle Aged; Models, Biological; Ovarian Neoplasms; Paclitaxel; Stem Cells; Time Factors; Transplantation, Autologous; Treatment Outcome | 2001 |
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays | 2001 |
Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Homovanillic Acid; Humans; Ifosfamide; Iodine Radioisotopes; Life Tables; Melphalan; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vanilmandelic Acid; Vincristine; Vindesine | 2001 |
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Etoposide; Female; Glucuronates; Humans; Ifosfamide; Interferon-gamma; Interleukin-2; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Remission Induction | 2001 |
Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Mitoguazone; Premedication; Recurrence; Transplantation, Autologous | 2001 |
Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kinetics; Lymphoma; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Prognosis; Salvage Therapy; Treatment Outcome | 2001 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2001 |
DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Sex Factors | 2001 |
Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma, B-Cell; Male; Middle Aged; Mitoxantrone; Recombinant Proteins; Remission Induction; Rituximab; Transplantation, Autologous | 2001 |
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous | 2001 |
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Survival Analysis; Treatment Outcome | 2001 |
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.
Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure | 2001 |
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cross-Over Studies; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma; Middle Aged; Organophosphorus Compounds; Prodrugs; Therapeutic Equivalency | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antibodies, Anti-Idiotypic; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hemocyanins; Humans; Ifosfamide; Immunity, Cellular; Immunoglobulin Idiotypes; Lymphocyte Activation; Lymphoma, B-Cell; Male; Polysorbates; Receptors, Antigen, B-Cell; Safety; Squalene; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vaccination; Whole-Body Irradiation | 2001 |
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Endpoint Determination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vindesine | 2001 |
[Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Treatment Outcome; Uterine Neoplasms | 2000 |
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Treatment Outcome | 2002 |
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoguazone; Recurrence; Salvage Therapy; Transplantation, Autologous; Vinblastine; Vinorelbine | 2002 |
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2002 |
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study.
Topics: Adult; Aged; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Survival Rate | 2002 |
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Life Tables; Male; Melphalan; Neoplasm Metastasis; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma; Sepsis; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate; Time Factors | 2002 |
Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Hypothermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasms; Paclitaxel; Scalp; Severity of Illness Index; Treatment Outcome | 2002 |
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoxantrone; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Survival Analysis; Thiotepa; Vincristine | 2002 |
Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Wilms Tumor | 2002 |
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 2002 |
Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cisplatin; Creatine Kinase; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Immunotherapy; Middle Aged; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Survival Rate | 2000 |
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Palliative Care; Prognosis; Risk Factors; Treatment Outcome; Vincristine | 2002 |
Toxicity of high-dose carboplatin: ultrafiltered and not total plasma pharmacokinetics is of clinical relevance.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Thiotepa; Time Factors; Ultrafiltration | 2002 |
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiography; Retroperitoneal Neoplasms; Sarcoma; Survival Analysis; Treatment Outcome; Viscera | 2002 |
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United Kingdom; Vincristine | 2002 |
Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Male; Mesna; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2002 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 2002 |
Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Stem Cells; Time Factors | 2002 |
[Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome | 2002 |
Population pharmacokinetics of etoposide.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Models, Biological | 2002 |
Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Outpatients; Prognosis; Survival | 2002 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Sepsis; Treatment Outcome | 2003 |
Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome | 2003 |
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Mitoxantrone; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2003 |
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Sarcoma; Survival Analysis; Treatment Outcome | 2003 |
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis; Prospective Studies; Treatment Outcome | 2003 |
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Saudi Arabia; Survival Rate; Vincristine | 2003 |
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine | 2003 |
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer S
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Survival Rate; Testicular Neoplasms; Time Factors; Transplantation, Autologous; Treatment Outcome | 2003 |
Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Prospective Studies; Radiotherapy; Survival Rate | 2003 |
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Injections, Spinal; Lenograstim; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Prognosis; Recombinant Proteins; Salvage Therapy; Sepsis; Treatment Outcome; Vincristine | 2003 |
Two schedules of application for mesna and their influence on the thiol-metabolism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Mesna; Neoplasms; Protective Agents; Sulfhydryl Compounds | 2003 |
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2004 |
Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Child; Child, Preschool; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Survival Rate; Treatment Outcome | 2004 |
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine | 2004 |
[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Mesothelioma; Pleural Neoplasms; Survival; Survivors | 2004 |
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Etoposide; Humans; Ifosfamide; Interleukin-2; Lymphoma, Non-Hodgkin; Middle Aged; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Analysis | 2004 |
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Palliative Care; Temozolomide; Topotecan; Treatment Outcome | 2004 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Seminoma; Testicular Neoplasms; Treatment Outcome | 2004 |
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Scandinavian and Nordic Countries; Treatment Outcome | 2004 |
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome | 2004 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine | 2004 |
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Colony-Stimulating Factors; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Proportional Hazards Models; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Rate | 2005 |
Long-term results of dose density therapy in patients with aggressive lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine | 2005 |
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Interleukin-11; Lymphoma; Male; Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2005 |
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis | 2005 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Gro
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Megakaryocytes; Neoplasms; Recombinant Proteins; Thrombopoietin | 2005 |
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Incidence; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Recombinant Proteins; Severity of Illness Index; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2005 |
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2005 |
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome; Vinblastine | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2005 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous | 2005 |
A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma | 2006 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Diarrhea; Etoposide; Female; Humans; Ifosfamide; Kidney; Leukocyte Count; Lung Neoplasms; Male; Radiotherapy Dosage; Stem Cell Transplantation; Survival Analysis; Treatment Outcome | 2005 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prognosis; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2005 |
Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cytarabine; Developing Countries; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter ran
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Quality of Life; Statistics, Nonparametric; Survival Analysis; United Kingdom; Vincristine | 2005 |
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Neutropenia; Nuclear Proteins; Oncogene Proteins; Ploidies; Prognosis; Risk Factors; Treatment Outcome | 2005 |
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experie
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Vincristine | 2006 |
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Vincristine | 2006 |
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Irinotecan; Low-Level Light Therapy; Male; Methotrexate; Mouth Mucosa; Neoplasms; Nutritional Status; Oral Hygiene; Severity of Illness Index; Stomatitis; Treatment Outcome | 2007 |
Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Magnetic Resonance Imaging; Monitoring, Physiologic; Reproducibility of Results; Sarcoma; Thermography; Treatment Outcome | 2006 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Infusions, Intravenous; Male; Neoplasm Staging; Predictive Value of Tests; Prognosis; Rhabdomyosarcoma; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cystoscopy; Edema; Erythrocytes; Etoposide; Exocytosis; Female; Hemorrhage; Humans; Ifosfamide; Male; Mesna; Middle Aged; Urinary Bladder; Urinary Bladder Diseases; Urothelium | 2007 |
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lenograstim; Male; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Time Factors; Transplantation, Autologous; Vinblastine | 2006 |
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2006 |
Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Pilot Projects; Rhabdomyosarcoma; Survival Rate; Vincristine | 2008 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Stem Cell Transplantation; Treatment Outcome | 2007 |
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Time Factors | 2007 |
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Salvage Therapy | 2007 |
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Preoperative Care | 2007 |
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2007 |
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Transplantation, Autologous | 2006 |
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Erythrocyte Transfusion; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prognosis; Recombinant Proteins; Survival Rate | 2007 |
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 2007 |
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2008 |
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Risk Assessment; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Survival Analysis; Testicular Neoplasms | 2007 |
Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cognition; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Psychomotor Performance; Speech | 2008 |
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Transplantation, Autologous | 2008 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Leukemia, Lymphoid; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Middle Aged; Recurrence | 2008 |
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Incidence; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Prognosis; Research Design; Survival Analysis; Treatment Outcome | 2008 |
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesna; Metabolic Clearance Rate; Middle Aged; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma | 2008 |
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis | 2008 |
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunophenotyping; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2008 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine | 2008 |
EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells.
Topics: Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Erythropoietin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Leukocyte Count; Leukocytes; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prospective Studies; Recombinant Proteins | 2009 |
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2009 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Radiotherapy; Rhabdoid Tumor; Teratoma; Thiotepa; Tomography, X-Ray Computed | 2009 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2008 |
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult | 2009 |
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2009 |
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Young Adult | 2009 |
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Time Factors; Treatment Outcome; Tumor Burden; Vincristine | 2009 |
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2009 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2010 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Sarcoma; Soft Tissue Neoplasms; Thermography; Treatment Outcome | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Peripheral Nervous System Diseases; Prednisolone; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Treatment Outcome; Vincristine | 2010 |
Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate; Treatment Outcome | 2009 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Japan; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nose Neoplasms; Probability; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Risk Assessment; Sex Factors; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Republic of Korea; Risk Assessment; Time Factors; Treatment Outcome; Young Adult | 2009 |
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Survival Rate; Vincristine; Vomiting; Young Adult | 2009 |
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Remission Induction; Rituximab; Thalidomide; Treatment Outcome; Vincristine | 2010 |
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epidemiologic Methods; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Retreatment; Salvage Therapy | 2010 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult | 2010 |
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Doxorubicin; Etoposide; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoadjuvant Therapy; Patient Selection; Radionuclide Imaging; Risk; Sarcoma; Time Factors; Treatment Outcome | 2010 |
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retroperitoneal Neoplasms; Sarcoma; Survival Rate; Young Adult | 2010 |
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Thymoma; Thymus Neoplasms | 2010 |
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prognosis; Risk Factors; Sarcoma, Ewing; Vincristine | 2010 |
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Follow-Up Studies; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult | 2010 |
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Chemotherapy, Adjuvant; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Europe; Female; Humans; Ifosfamide; Israel; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; New York City; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Rituximab; Salvage Therapy; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2010 |
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vindesine; Young Adult | 2010 |
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granisetron; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Paclitaxel; Treatment Outcome; Vomiting; Young Adult | 2011 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Stem Cell Transplantation; Testicular Neoplasms; Young Adult | 2011 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Topics: Adolescent; Adult; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Child; Child, Preschool; Cisplatin; Collagen Type I; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Methotrexate; Osteocalcin; Osteosarcoma; Young Adult | 2010 |
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Research Design; Risk Factors; Taiwan; Treatment Outcome | 2011 |
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Recurrence; RNA-Binding Protein EWS; Sarcoma, Ewing; Survival Rate; Vincristine | 2011 |
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine | 2011 |
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Pyrazines; Recurrence; Treatment Outcome; Young Adult | 2011 |
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Pilot Projects; Procarbazine; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 2011 |
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2012 |
A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prospective Studies; Quality of Life; Rituximab; Survival Rate; Transplantation Conditioning; Vidarabine | 2011 |
A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Salvage Therapy; Young Adult | 2012 |
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Combined Modality Therapy; DNA Topoisomerases, Type I; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Metabolic Clearance Rate; Middle Aged; Mucositis; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Topotecan; Transplantation, Autologous; Treatment Outcome | 2011 |
Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neuroblastoma; Salvage Therapy; Treatment Outcome | 2011 |
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2011 |
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Proteasome Endopeptidase Complex; Pyrazines; Recurrence; Rituximab; Time Factors; Treatment Outcome | 2012 |
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Seminoma; Stem Cell Transplantation; Testicular Neoplasms | 2012 |
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Rituximab; Salvage Therapy; Transplantation, Autologous; Treatment Failure; Young Adult | 2012 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult | 2012 |
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Topics: Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2012 |
A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Pyrazoles; Radiotherapy; Sarcoma, Ewing; Sulfonamides; Vinblastine; Young Adult | 2013 |
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult | 2012 |
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Survival; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2013 |
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Etoposide; Female; Humans; Hydroxamic Acids; Ifosfamide; Lymphoma; Male; Middle Aged; Rituximab; Vorinostat | 2013 |
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Recurrence; Survival Analysis; Treatment Failure; Young Adult | 2013 |
Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2013 |
Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Recurrence; Treatment Outcome; Young Adult | 2013 |
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Male; Melphalan; Mesna; Neoplasm Staging; Prognosis; Prospective Studies; Sarcoma, Ewing; Sex Factors; Survival Rate; Vincristine; Young Adult | 2014 |
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Young Adult | 2013 |
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2013 |
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Rituximab; Salvage Therapy; Thalidomide; Treatment Outcome | 2014 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
A phase I study of panobinostat in combination with ICE (Ifosfamide, Carboplatin and Etoposide) in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxamic Acids; Ifosfamide; Indoles; Male; Middle Aged; Panobinostat; Radiography | 2014 |
FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Brentuximab Vedotin; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Middle Aged; Positron-Emission Tomography; Radiography; Recurrence; Stem Cell Transplantation; Survival Rate | 2014 |
Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Sarcoma; Soft Tissue Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2014 |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Thiotepa; Treatment Failure; Young Adult | 2014 |
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Maximum Tolerated Dose; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 2015 |
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult | 2014 |
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisolone; Republic of Korea; Treatment Outcome; Young Adult | 2014 |
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Injections, Spinal; Leukemia; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Rituximab; Young Adult | 2014 |
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Polyethylene Glycols; Quality of Life; Research Design; Young Adult | 2015 |
Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell; Male; Middle Aged; Topotecan; Treatment Outcome; Young Adult | 2015 |
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2014 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Middle Aged; Neoadjuvant Therapy; New York City; Positron-Emission Tomography; Recurrence; Salvage Therapy; Stem Cell Transplantation; Time Factors; Treatment Outcome; Young Adult | 2015 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2015 |
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; HIV Infections; HIV-1; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Sarcoma, Ewing; Survival Rate; Thiotepa; Vincristine; Young Adult | 2015 |
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Second-Look Surgery; Thiotepa; Treatment Outcome | 2015 |
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Retrospective Studies; Salpingectomy; Sex Cord-Gonadal Stromal Tumors; Testicular Neoplasms | 2015 |
Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Cell Activating Factor; Bone Marrow; Chemokine CXCL12; Drug Resistance, Neoplasm; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Humans; Ifosfamide; Interleukin-7; Male; Mesna; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Osteocalcin; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Niche; Tumor Microenvironment; Young Adult | 2015 |
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Irinotecan; Lymphatic Metastasis; Male; Middle Aged; Patient Selection; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; Vincristine | 2016 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous | 2016 |
[Clinical Efficacy Comparison of Different Second Line Salvage Chemotherapy Regimens for the Treatment of Elderly Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prognosis; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2016 |
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Conformal; Republic of Korea; Time Factors; Treatment Outcome | 2016 |
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Internationality; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prevalence; Risk Factors; Salvage Therapy; Survival Analysis | 2016 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Bleomycin; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Nausea; Olanzapine; Vomiting; Young Adult | 2018 |
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Panobinostat; Survival Rate; Thrombocytopenia; Treatment Outcome; Young Adult | 2018 |
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Imidazoles; Kaplan-Meier Estimate; Male; Methotrexate; Neutropenia; Osteosarcoma; Young Adult; Zoledronic Acid | 2018 |
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Topics: Adenine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Remission Induction; Rituximab | 2018 |
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Young Adult | 2018 |
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Recurrence; Retreatment; Treatment Outcome | 2018 |
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load | 2018 |
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Skin Neoplasms; Steroids | 2019 |
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Recurrence; Treatment Outcome; Vincristine; Vinorelbine; Young Adult | 2019 |
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; France; Humans; Ifosfamide; Infant; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Prospective Studies; Recurrence; Rituximab; Survival Rate | 2019 |
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; France; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Survival Rate; Young Adult; Zoledronic Acid | 2020 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Rhabdomyosarcoma; Survival Rate; Time Factors; Vincristine | 2020 |
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Monitoring; Etoposide; Female; Genotype; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Pharmacogenetics; Pharmacogenomic Testing; Young Adult | 2020 |
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Comorbidity; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Survival Rate | 2020 |
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles | 2021 |
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2021 |
R-MACLO-IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma - Long term follow up results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Progression-Free Survival; Prospective Studies; Remission Induction; Rituximab; Thalidomide; Vincristine; Young Adult | 2021 |
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult | 2021 |
OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Etoposide; Humans; Ifosfamide; Middle Aged; Osteosarcoma; Phenylurea Compounds; Protein Kinase Inhibitors; Quality of Life; Quinolines; Young Adult | 2021 |
Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Young Adult | 2022 |
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Lymphoma; Neoplasm Recurrence, Local; Treatment Outcome | 2022 |
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prospective Studies; Rituximab | 2023 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Topics: Adolescent; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Rituximab; Young Adult | 2023 |
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ifosfamide; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy | 2023 |
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prospective Studies; Proteasome Endopeptidase Complex; Rituximab | 2023 |
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
Other Studies
830 other study(ies) available for etoposide and ifosfamide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.
Topics: Antineoplastic Agents; Aryldialkylphosphatase; Electrophoresis, Polyacrylamide Gel; Humans | 2016 |
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Remission Induction; Time Factors | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine | 1992 |
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Protocols; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Survival Rate | 1992 |
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Survival Rate; Vomiting | 1992 |
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Mesna; Middle Aged; Phosphopyruvate Hydratase; Probability; Prospective Studies; Remission Induction; Survival Rate | 1992 |
[Chemotherapy with cisplatin, adriamycin, etoposide and ifosfamide in microcytic lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1992 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins | 1992 |
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine | 1992 |
[Treatment of recurrent ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Parenteral; Lymph Node Excision; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Paclitaxel | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Prednisolone | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate | 1992 |
Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
Topics: Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Erythrocytes; Erythroid Precursor Cells; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cells; Humans; Ifosfamide; Immunophenotyping; Interleukin-3; Male; Megakaryocytes; Middle Aged; Monocytes; Neoplasms | 1992 |
[Recent progress in the chemotherapy program and its theoretical background--malignant lymphoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Prednisolone; Survival Rate; Vincristine | 1992 |
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy; Texas; Vincristine | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine | 1992 |
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Treatment Outcome | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Leukopenia; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia | 1992 |
Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysgerminoma; Etoposide; Hematuria; Humans; Ifosfamide; Male; Mesna; Severity of Illness Index; Vinblastine | 1992 |
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphangitis; Male; Radiotherapy Dosage | 1992 |
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Vincristine; Whole-Body Irradiation | 1992 |
Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors.
Topics: Cisplatin; Drug Therapy, Combination; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Neoplasms | 1992 |
Combination chemotherapy with ifosfamide and etoposide is effective in the treatment of central nervous system metastasis of childhood neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Etoposide; Female; Humans; Ifosfamide; Infant; Neuroblastoma | 1992 |
Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Salvage Therapy | 1992 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vincristine | 1991 |
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy Dosage | 1991 |
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Survival Rate; Testicular Neoplasms | 1991 |
Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Genital Neoplasms, Female; Humans; Ifosfamide; Middle Aged; Mullerian Ducts; Remission Induction; Survival Rate | 1990 |
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Peptide Fragments; Teratoma; Testicular Neoplasms; Vinblastine | 1991 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate | 1991 |
Surgical restaging of advanced Hodgkin's disease after first line chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Liver; Lymph Nodes; Neoplasm Staging; Prednimustine; Procarbazine; Spleen; Vinblastine | 1991 |
[Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Prednimustine; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine | 1991 |
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iatrogenic Disease; Ifosfamide; Male; Mitomycin; Prognosis; Testicular Neoplasms; Vinblastine; Vincristine | 1991 |
[Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1991 |
Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1991 |
Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Stability; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Mesna; Middle Aged; Mitoxantrone; Neoplasms | 1991 |
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Remission Induction; Sarcoma | 1991 |
Ifosfamide and etoposide salvage treatment in advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Salvage Therapy | 1991 |
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1991 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Lengthening; Bone Neoplasms; Bone Transplantation; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Italy; Male; Methotrexate; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prognosis; Prostheses and Implants; Survival Rate | 1991 |
[Two cases of Ewing's sarcoma originating from the adult rib].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Ribs; Sarcoma, Ewing | 1991 |
Experience with salvage regimens at M.D. Anderson Hospital.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate | 1991 |
Massively bleeding gastrosplenic fistula following cytostatic chemotherapy of a malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Fistula; Gastric Fistula; Gastrointestinal Hemorrhage; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Splenic Diseases; Stomach Neoplasms | 1991 |
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Survival Rate | 1991 |
Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Humans; Ifosfamide; Mesna; Middle Aged | 1990 |
Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Sarcoma, Ewing | 1990 |
Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesna; Middle Aged; Regression Analysis; Sarcoma; Soft Tissue Neoplasms | 1990 |
Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Organoplatinum Compounds; Survival Rate | 1990 |
Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Risk Factors | 1990 |
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prognosis | 1990 |
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Mesna; Middle Aged; Nausea; Ovarian Neoplasms; Sarcoma, Ewing; Testicular Neoplasms; Vomiting | 1990 |
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis | 1990 |
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Remission Induction | 1990 |
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Pilot Projects; Thrombocytopenia | 1990 |
[Platinum-based combination chemotherapy for malignant mixed mesodermal tumor of the ovary: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction | 1990 |
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Serpins; Uterine Cervical Neoplasms | 1990 |
[Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Myocardial Infarction; Neoplasm Recurrence, Local | 1990 |
VIM-D salvage chemotherapy in Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Mitoxantrone | 1990 |
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms | 1990 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies | 1990 |
Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Vincristine | 1990 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Chemotherapy-radiation interactions in human cervix carcinoma xenografts.
Topics: Animals; Bleomycin; Brachytherapy; Cell Line; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Mice; Mice, Nude; Neoplasm Transplantation; Radiotherapy Dosage; Transplantation, Heterologous; Uterine Cervical Neoplasms | 1988 |
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Colony-Stimulating Factors; Doxorubicin; Drug Evaluation; Etoposide; Granulocyte Colony-Stimulating Factor; Hemoglobins; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Mesna; Neutrophils; Platelet Count; Recombinant Proteins | 1988 |
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Remission Induction; Vindesine | 1989 |
[Treatment of stage I-IIB nonseminomatous testicular tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Retrospective Studies; Testicular Neoplasms; Vinblastine | 1989 |
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Prednisolone; Procarbazine | 1989 |
Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1989 |
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Remission Induction; Sarcoma | 1989 |
European experience with ifosfamide in non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Europe; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Vindesine | 1989 |
Ifosfamide in testicular cancer: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1989 |
A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies | 1989 |
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1989 |
Third-line chemotherapy of resistant advanced testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Dysgerminoma; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Teratoma; Testicular Neoplasms | 1989 |
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Vincristine | 1989 |
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms | 1989 |
Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Drug Evaluation; Egypt; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Remission Induction; Time Factors; Vincristine | 1989 |
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Evaluation Studies as Topic; Female; Humans; Ifosfamide; Lorazepam; Lung Neoplasms; Male; Mesna; Metoclopramide; Middle Aged | 1987 |
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Middle Aged | 1987 |
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Vincristine | 1988 |
Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Kidney Diseases; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Remission Induction; Vinblastine | 1988 |
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
[Hepatotoxicity with etoposide-ifosfamide combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Etoposide; Female; Humans; Ifosfamide; Liver Function Tests; Lung Neoplasms; Male; Middle Aged | 1988 |
Extragenital malignant mixed Müllerian tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peritoneal Neoplasms | 1988 |
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1989 |
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hypersensitivity, Delayed; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition, Total; Procarbazine; Prognosis; Vincristine | 1987 |
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1986 |
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous | 1988 |
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Combined Modality Therapy; Cystitis; Drug Evaluation; Etoposide; Humans; Ifosfamide; Mesna; Neoplasm Recurrence, Local; Sarcoma | 1987 |
[A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Mitomycin; Mitomycins; Ovarian Neoplasms | 1987 |
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Evaluation Studies as Topic; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mesna; Mesonephroma; Nausea; Sepsis; Teratoma; Testicular Neoplasms | 1988 |
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin | 1988 |
Salvage chemotherapy for lymphoma with VP-16, ifosfamide, and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etoposide; Hematopoiesis; Humans; Ifosfamide; Lymphoma; Middle Aged; Risk Factors | 1988 |
[Sequential animal experimental determination of optimal dosages for combinations of cytostatics using a reduced number of experimental animals (vepeside/ifosfamide combination)].
Topics: Animals; Animals, Laboratory; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Ifosfamide; Leukemia P388; Mice; Research Design | 1988 |
Salvage treatment for Hodgkin's disease in relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Methotrexate; Mitoguazone; Prognosis | 1987 |
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hematologic Diseases; Hematuria; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Mitoguazone | 1987 |
Results of MIME salvage regimen for recurrent or refractory lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Mitoguazone; Prognosis; Remission Induction | 1987 |
Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Podophyllotoxin; Recurrence | 1986 |
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vinblastine; Vincristine; Vindesine | 1984 |
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine | 1983 |
Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Flow Cytometry; Humans; Ifosfamide; Leukocytes; Male; Ovarian Neoplasms; Testicular Neoplasms; Urinary Bladder; Urine; Vinblastine | 1983 |
[Prevention of recurrence of small-cell lung cancer by adjuvant polychemotherapy (author's transl)].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Vincristine | 1982 |
Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Podophyllotoxin; Vinblastine; Vincristine; Vindesine | 1982 |
Small cell lung cancer. Serial bronchofiberscopy and photographic documentation--the bridge sign.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Cicatrix; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Fiber Optic Technology; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Prospective Studies; Vincristine | 1983 |
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Environment, Controlled; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1984 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine | 1984 |
Pharmacokinetic studies in lung cancer patients.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Naphthacenes; Organoplatinum Compounds | 1984 |
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Lymphoma | 1983 |
Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Middle Aged | 1983 |
High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Male; Middle Aged; Neoplasms; Pilot Projects; Platelet Count; Time Factors; Transplantation, Autologous; Vincristine | 1980 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |
Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Podophyllotoxin | 1982 |
Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Topics: Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Male; Podophyllotoxin; Testicular Neoplasms | 1982 |
Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine | 1995 |
[Cerebral germ cell tumors in adults. A retrospective study of 19 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Teratoma; Vinblastine | 1995 |
[Initial chemotherapy followed by orchiectomy and retroperitoneal lymphadenectomy--a case of seminoma with a testicular tumor and enlarged regional lymph nodes].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Orchiectomy; Peplomycin; Retroperitoneal Space; Seminoma; Testicular Neoplasms; Vinblastine | 1994 |
[Increased blood cell destruction during vigorous regeneration of bone marrow after CAMBO-VIP chemotherapy for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Bone Marrow Cells; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Vincristine | 1994 |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1994 |
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Clinical Protocols; Drug Resistance; Etoposide; Genetic Vectors; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Informed Consent; Interleukin-3; Interleukin-6; Mesna; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pancytopenia; Recombinant Fusion Proteins; Recombinant Proteins; Retroviridae; Stem Cell Factor; Transplantation, Autologous; Vinblastine | 1994 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Interleukin-10; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Bone Marrow Cells; Carboplatin; Carmustine; Cell Adhesion Molecules; Cell Movement; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Fluorouracil; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; L-Selectin; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Podophyllotoxin; Receptors, Very Late Antigen; Thiotepa | 1995 |
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors | 1995 |
A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Occipital Lobe; Orchiectomy; Remission Induction; Teratocarcinoma; Testicular Neoplasms; Thoracotomy; Vincristine | 1995 |
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous | 1995 |
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Pneumothorax; Testicular Neoplasms; Vincristine | 1995 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Time Factors; Transplantation, Autologous | 1995 |
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Salvage Therapy; Vincristine | 1995 |
High-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Parenteral Nutrition, Total | 1995 |
Introduction to ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide | 1995 |
High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Kidney; Kidney Function Tests; Male; Middle Aged; Transplantation, Autologous | 1995 |
Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome | 1995 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine | 1993 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; HIV Seropositivity; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Vincristine | 1993 |
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
Topics: Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Blood Transfusion, Autologous; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Platelet Count | 1993 |
[Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma. Study of 51 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 1994 |
Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide, and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Remission Induction; Time Factors; Uterine Neoplasms | 1995 |
Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 1995 |
Successful liver treatment of a juvenile granulosa cell tumor in a 4-year-old child by regional deep hyperthermia, systemic chemotherapy, and irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulosa Cell Tumor; Humans; Hyperthermia, Induced; Ifosfamide; Liver Neoplasms; Ovarian Neoplasms; Ovariectomy; Ovary; Remission Induction; Temperature; Transaminases | 1995 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome | 1995 |
Reversible myocardial ischaemia following vincristine containing chemotherapy.
Topics: Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Myocardial Ischemia; Vincristine | 1994 |
Ifosfamide: should the honeymoon be over?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Drug Tolerance; Etoposide; Female; Humans; Ifosfamide; Kidney; Neuroblastoma; Time Factors | 1995 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Refining therapeutic strategies for patients with resistant Wilm's tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Medical Records; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Wilms Tumor | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate | 1994 |
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia | 1994 |
[Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy | 1994 |
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate | 1994 |
Teniposide for meningeal carcinomatosis of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunologic Factors; Injections, Spinal; Interferon-gamma; Lung Neoplasms; Meningeal Neoplasms; Middle Aged; Morphine; Teniposide; Vincristine | 1993 |
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melphalan; Multiple Myeloma; Neoplasm Metastasis; Retroviridae; Transfection; Transplantation, Autologous; Whole-Body Irradiation | 1993 |
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1994 |
Spinal ganglioneuroblastoma--complete response to chemotherapy alone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Ganglioneuroma; Humans; Ifosfamide; Male; Spinal Cord Neoplasms; Vincristine | 1993 |
Active chemotherapy for metastatic stromal cell tumor of the testis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Sex Cord-Gonadal Stromal Tumors; Testicular Neoplasms | 1993 |
Ifosfamide-induced hyperpigmentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Humans; Hyperpigmentation; Ifosfamide; Infant; Male; Sarcoma; Time Factors | 1994 |
High-dose carboplatin, etoposide and ifosfamide and autologous stem cell rescue in the treatment of non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Transplantation, Autologous | 1993 |
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1993 |
Chemotherapy in the management of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Karyotyping; Leg; Male; Remission Induction; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 1993 |
[Soft tissue tumors: indications and results of hyperthermia].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Soft Tissue Neoplasms; Survival Rate | 1993 |
Management of small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Paraneoplastic Syndromes; Survival Rate | 1993 |
Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous | 1993 |
An unusual case of haematuria.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hematuria; Humans; Ifosfamide; Male; Mesna; Quadriplegia; Urinary Bladder Neoplasms | 1993 |
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Neuroectodermal Tumors, Primitive, Peripheral; Neurofilament Proteins; Pancoast Syndrome; Vincristine | 1993 |
Ifosfamide combination regimens for soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases | 1993 |
Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases | 1993 |
Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma; Treatment Outcome | 1993 |
IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Pilot Projects; Recombinant Proteins | 1993 |
Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Extremities; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Prognosis | 1993 |
Intratesticular effects of cisplatin-based chemotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Etoposide; Germ Cells; Humans; Ifosfamide; Immunohistochemistry; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Sertoli Cells; Testicular Neoplasms | 1995 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Time Factors | 1996 |
Hematopoietic reconstitution with autologous stem cells.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide | 1996 |
Case report: pulmonary blastoma in children--response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Pulmonary Blastoma; Vincristine | 1996 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glucocorticoids; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prospective Studies; Vincristine; Virus Activation | 1996 |
Intense gallbladder uptake associated with chemotherapy. An unusual finding in pediatric skeletal scintigraphy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Child; Etoposide; Female; Gallbladder; Humans; Ifosfamide; Liver; Male; Osteosarcoma; Radionuclide Imaging; Sarcoma, Ewing; Technetium Tc 99m Medronate; Tissue Distribution | 1995 |
[Combination chemotherapy of ifosfamide and etoposide for advanced neuroblastoma].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Neuroblastoma; Retroperitoneal Neoplasms | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pregnancy; Prognosis; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration.
Topics: Acne Vulgaris; Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Recurrence; Testicular Neoplasms | 1996 |
Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms; Remission Induction | 1995 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Prospective Studies; Salvage Therapy; Sweden; Transplantation, Autologous; Treatment Outcome | 1996 |
Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Topics: Adolescent; Adult; Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Blood Cell Count; Bone Transplantation; Cisplatin; Combined Modality Therapy; Drug Resistance; Etoposide; Fetal Tissue Transplantation; Flow Cytometry; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Immunologic Factors; Immunomagnetic Separation; In Situ Hybridization, Fluorescence; Interferon-alpha; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Mice; Mice, SCID; Middle Aged; Neoplasm Transplantation; Neoplastic Cells, Circulating; Philadelphia Chromosome; Radiation Chimera; Specific Pathogen-Free Organisms; Transplantation, Heterologous | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Keratins; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; Retrospective Studies; Sensitivity and Specificity | 1996 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia | 1996 |
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1995 |
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Tritium; Tumor Cells, Cultured | 1996 |
Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Heart Neoplasms; Humans; Ifosfamide; Infant; Leiomyosarcoma; Mesna; Microscopy, Electron; Time Factors | 1996 |
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate | 1996 |
Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Costs and Cost Analysis; Deoxycytidine; Etoposide; Gemcitabine; Germany; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging | 1995 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.
Topics: Antigen Presentation; Antigens, CD; Antigens, CD34; Bone Marrow; Cell Differentiation; Cells, Cultured; Cisplatin; Cytoplasmic Granules; Dendritic Cells; Drug Synergism; Epirubicin; Epithelial Cells; Etoposide; Hematopoietic Stem Cells; HLA-DR Antigens; Humans; Ifosfamide; Immunophenotyping; Interleukin-3; Interleukin-4; Interleukin-6; Langerhans Cells; Lymph Nodes; Recombinant Proteins; Spleen; Stem Cell Factor; T-Lymphocyte Subsets; Tetanus Toxoid; Tumor Necrosis Factor-alpha | 1996 |
ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia (Ph1)-negative PBPC in chronic myelogenous leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1996 |
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mesna; Middle Aged; Ovarian Neoplasms; Pilot Projects; Retroperitoneal Neoplasms; Testicular Neoplasms | 1996 |
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Multicenter Studies as Topic; Multivariate Analysis; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 1996 |
High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Time Factors; Transplantation, Autologous | 1996 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms | 1996 |
Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; DNA, Complementary; DNA, Neoplasm; Epirubicin; ErbB Receptors; Etoposide; Evaluation Studies as Topic; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoenzyme Techniques; Immunomagnetic Separation; Keratins; Leukapheresis; Melphalan; Middle Aged; Neoplasm Proteins; Neoplastic Cells, Circulating; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transplantation Conditioning | 1997 |
Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 1997 |
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mutation; Prospective Studies; Survival Analysis | 1997 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Vinblastine | 1997 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lymphoma, Follicular; Male; Methotrexate; Neoplasms, Multiple Primary; Prednisone; Remission Induction; Vincristine | 1997 |
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Pregnancy; Remission Induction; Trophoblastic Neoplasms; Uterine Neoplasms | 1997 |
Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Forearm; Hemangiopericytoma; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoplasm Recurrence, Local; Salvage Therapy; Thoracic Neoplasms | 1997 |
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.
Topics: Adult; Aged; Cyclophosphamide; Drug Combinations; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multivariate Analysis; Transplantation Conditioning | 1997 |
The VIP regimen effective treatment to refractory choriocarcinoma: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Pregnancy; Uterine Neoplasms | 1997 |
Central neurocytoma: a clinical study of response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Neurocytoma | 1997 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoguazone; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Treatment Failure | 1997 |
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoxantrone; Prognosis; Salvage Therapy; Texas; Treatment Outcome | 1997 |
Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE).
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Middle Aged; Transplantation Conditioning | 1997 |
Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1997 |
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Carboplatin; Creatinine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Magnesium; Male; Middle Aged; Neoplasms; Potassium; Retrospective Studies | 1997 |
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leiomyosarcoma; Stomach Neoplasms | 1997 |
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Case-Control Studies; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Male; Mouth Diseases; Mouth Mucosa; Oral Ulcer; Pain; Retrospective Studies; Stomatitis; Surveys and Questionnaires; Testicular Neoplasms; Vincristine | 1997 |
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Remission Induction; Survival Rate; Treatment Outcome | 1997 |
Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Risk Factors; Treatment Outcome | 1998 |
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine | 1997 |
Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1997 |
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Salvage Therapy; Vincristine; Wilms Tumor | 1997 |
[High-dose chemotherapy and reinfusion of hematopoietic stem cells in advanced germ cells tumors with poor prognosis--the position in 1996].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Recurrence; Transplantation, Autologous | 1997 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia | 1998 |
[A case of primary endobronchial mucosa-associated lymphoid tissue lymphoma with middle lobe atelectasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Pulmonary Atelectasis; Remission Induction; Vincristine | 1997 |
Postsurgical etoposide-ifosfamide regimen in poor-risk nonmetastatic osteogenic sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma; Prospective Studies; Remission Induction; Salvage Therapy | 1998 |
Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Male; Neuroectodermal Tumors; Prospective Studies; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Treatment Outcome | 1998 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasms, Second Primary; Prospective Studies; Salvage Therapy; Survival Analysis | 1998 |
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Salvage Therapy; Time Factors | 1998 |
Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Erythropoietin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Retrospective Studies | 1997 |
[High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Testicular Neoplasms | 1998 |
[Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation(PBSCT)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasm Invasiveness; Radiotherapy Dosage; Thymoma; Thymus Neoplasms; Vincristine | 1998 |
p53 gene mutation in the bone-marrow of a patient with diffuse mixed cell type lymphoma at diagnosis predicting eventual progression to large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Genes, p53; Genetic Markers; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mutation; Sequence Analysis, DNA | 1998 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Mesna; Prospective Studies; Recombinant Proteins; Vincristine | 1998 |
Late pulmonary toxicity of bleomycin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Lung Diseases; Vincristine | 1998 |
[High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Survival Analysis | 1998 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1998 |
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Meningeal Neoplasms; Pilot Projects; Rhabdomyosarcoma; Risk Factors; Sarcoma; Urogenital Neoplasms; Vincristine | 1998 |
[A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neutropenia; Seminoma; Testicular Neoplasms | 1998 |
[Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
Topics: Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Transplantation, Autologous | 1998 |
[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Salvage Therapy; Testicular Neoplasms | 1998 |
High-dose chemotherapy in germ cell tumours: a large single centre experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Prospective Studies; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 1998 |
Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buffers; Calibration; Carboplatin; Electrophoresis, Capillary; Electrophoresis, Polyacrylamide Gel; Etoposide; Germinoma; Humans; Ifosfamide; Male; Proteinuria; Quality Control; Reproducibility of Results; Testicular Neoplasms; Transferrin | 1999 |
Treatment of soft-tissue sarcomas: high-dose ifosfamide or combination of ifosfamide and etoposide?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 1999 |
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Prognosis; Risk Factors; Severity of Illness Index; Survival Analysis; Vincristine | 1999 |
Extraskeletal Ewing's sarcoma.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine | 1999 |
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Health Care Costs; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged | 1999 |
Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Intelligence; Magnetic Resonance Imaging; Male; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 1999 |
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Recurrence; Retrospective Studies | 1999 |
Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma; Male; Middle Aged; Prognosis; Transplantation, Autologous | 1999 |
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome | 1999 |
[Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Genital Neoplasms, Male; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Orchiectomy; Seminoma; Spermatic Cord; Testicular Neoplasms | 1999 |
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Testicular Neoplasms; Vinblastine | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
Role of the combination of ifosfamide and etoposide in the treatment of soft tissue sarcomas.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Sarcoma | 1999 |
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Immunophenotyping; Leukapheresis; Leukocyte Count; Male; Neoplasms | 1999 |
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Purging; Bone Neoplasms; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 22; Combined Modality Therapy; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Mesna; Neoplasm Proteins; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Paired Box Transcription Factors; PAX3 Transcription Factor; Proto-Oncogene Protein c-fli-1; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma, Alveolar; RNA-Binding Protein EWS; Sarcoma, Ewing; Sensitivity and Specificity; Soft Tissue Neoplasms; Transcription Factors; Translocation, Genetic; Vincristine | 1999 |
Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Risk Factors; Vinblastine | 1999 |
Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
Topics: Adult; Antigens, CD34; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Stem Cell Transplantation; Stem Cells | 1999 |
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Germany; Germinoma; Humans; Ifosfamide; Male; Matched-Pair Analysis; Multivariate Analysis; Neoplasm Metastasis; Prognosis; Survival Rate; United States | 1999 |
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Immunization, Passive; Interleukin-2; Male; Melphalan; Middle Aged; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
[Treatment of advanced testicular cancer and toxicity of chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Infections; Male; Oligospermia; Prognosis; Pulmonary Fibrosis; Respiratory Distress Syndrome; Seminoma; Survival Rate; Testicular Neoplasms | 1999 |
[A successfully operated case of choriocarcinoma with recurrent intratumoral hemorrhage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Child; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Hydrocephalus; Ifosfamide; Male; Pineal Gland | 2000 |
High-dose ifosfamide and etoposide infusion plus methylprednisolone for refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Recurrence; Salvage Therapy | 2000 |
Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 2000 |
[Treatment results of VIP (etoposide, ifosfamide and cisplatin) chemotherapy as a first-line therapy in metastatic germ cell tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Retrospective Studies; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2000 |
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Pilot Projects; Prospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survival Analysis; Vincristine | 2000 |
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Topics: Adolescent; Adult; Aged; Albuminuria; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Creatinine; Etoposide; Female; Glomerular Filtration Rate; Glycoproteins; Humans; Hyperthermia, Induced; Ifosfamide; Immunoglobulin G; Kidney; Male; Membrane Glycoproteins; Middle Aged; Sarcoma; Trypsin Inhibitor, Kunitz Soybean | 2000 |
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine | 2000 |
A brief intensive chemotherapy in T-prolymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Pentostatin; Prognosis; T-Lymphocyte Subsets; Transplantation, Autologous; Vincristine | 2000 |
[Intra-abdominal desmoplastic small round-cell tumors. An entity among peritoneal carcinomatoses in young adults].
Topics: Abdominal Neoplasms; Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Middle Aged; Treatment Outcome | 2000 |
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Ifosfamide; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Time Factors; Transplantation, Heterologous; Treatment Outcome | 2000 |
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Epirubicin; Etoposide; Female; Gene Expression; GTP-Binding Protein alpha Subunits, Gq-G11; Hematopoiesis; Heterotrimeric GTP-Binding Proteins; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; RNA, Messenger; Time Factors | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Recombinant Proteins | 2000 |
Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Prognosis | 2000 |
High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin | 2000 |
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Radiotherapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2000 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine | 2000 |
Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Skin Neoplasms | 2000 |
Long-term survival following extra-neural metastasis from a pineoblastoma.
Topics: Acetabulum; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Ilium; Pineal Gland; Pinealoma; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Skin Neoplasms; Thigh; Vincristine | 2000 |
Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Etoposide; Fungemia; Humans; Ifosfamide; Immunocompromised Host; Infant; Leukemia, Myeloid; Neutropenia; Saccharomyces cerevisiae; Yeast, Dried | 2000 |
[Expanding mature pineal teratoma syndrome. Case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cerebrospinal Fluid Shunts; Chorionic Gonadotropin; Combined Modality Therapy; Diagnosis, Differential; Diplopia; Etoposide; Germinoma; Humans; Ifosfamide; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Proteins; Pinealoma; Radiotherapy, Adjuvant; Remission Induction; Teratoma; Thalamus | 2000 |
Should we always choose a nonparametric test when comparing two apparently nonnormal distributions?
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Data Interpretation, Statistical; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukocyte Count; Lymphoma, Non-Hodgkin; Methotrexate; Mitoguazone; Models, Statistical; Neutrophils; Numerical Analysis, Computer-Assisted; Sample Size; Software; Statistical Distributions; Statistics, Nonparametric; Stochastic Processes; Time Factors | 2001 |
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine | 2001 |
Malignant rhabdoid tumour of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Rhabdoid Tumor; Uterine Neoplasms | 2001 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Topics: Amino Acid Substitution; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Isoenzymes; Ki-67 Antigen; Life Tables; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Neoplasm Proteins; Paclitaxel; Point Mutation; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Teniposide; Topotecan; Treatment Outcome; Vault Ribonucleoprotein Particles | 2001 |
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Germany; Humans; Ifosfamide; Lomustine; Medulloblastoma; Mesna; Nervous System Diseases; Neutropenia; Postoperative Period; Prospective Studies; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 2001 |
[Subcutaneous inflammatory edema induced by MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillary Leak Syndrome; Creatine Kinase; Edema; Etoposide; Fat Necrosis; Female; Hodgkin Disease; Humans; Ifosfamide; Inflammation; Magnetic Resonance Imaging; Male; Mitoguazone; Pain; Recurrence; Vinblastine | 2001 |
Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Cisplatin; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Treatment Outcome | 2001 |
Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Hydroxyurea; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Treatment Outcome | 2001 |
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Prognosis; Retroperitoneal Neoplasms; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Tyrosine 3-Monooxygenase; Vincristine | 2001 |
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Therapeutic Equivalency | 2001 |
Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms | 2001 |
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Diagnosis, Differential; Disease-Free Survival; Etoposide; Germinoma; Humans; Ifosfamide; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm, Residual; Remission Induction; Retroperitoneal Neoplasms | 2001 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome | 2001 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2002 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2001 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Risk Factors; Transplantation, Isogeneic; Treatment Outcome | 2002 |
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine | 2002 |
Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Logistic Models; Longitudinal Studies; Male; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Retrospective Studies; Survival Analysis; Tumor Suppressor Protein p53; Vincristine | 2002 |
Cure in a case of primary hepatic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lymphoma; Male; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine | 2000 |
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prognosis; Randomized Controlled Trials as Topic; Risk; Treatment Outcome | 2002 |
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2002 |
High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Ewing; Survival Rate; Treatment Outcome | 2002 |
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies | 2002 |
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Mesna; Neoplasm Metastasis; Remission Induction; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2002 |
High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Salvage Therapy; Stem Cell Transplantation; Time Factors | 2002 |
Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Infections; Kidney Diseases; Male; Middle Aged; Prospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2002 |
Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Salvage Therapy; Survival Analysis | 2002 |
Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cellular Senescence; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Male; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Predictive Value of Tests; ROC Curve; Transplantation, Autologous | 2002 |
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Heart Neoplasms; Humans; Ifosfamide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Ultrasonography; Vincristine | 2002 |
Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Thymoma; Thymus Neoplasms; Vincristine | 2002 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous | 2002 |
[Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Cisplatin; Etoposide; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Serpins; Urinary Bladder Neoplasms; Urologic Neoplasms | 2002 |
Embryonal rhabdomyosarcoma presenting in an adult: a case report and discussion of immunohistochemical staining.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Immunohistochemistry; Male; Neoplasm Proteins; Radiotherapy, Adjuvant; Rhabdomyosarcoma, Embryonal; Soft Tissue Neoplasms; Vincristine | 2003 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Pneumonectomy; Postoperative Care; Preoperative Care; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Small Cell; Thoracic Neoplasms; Treatment Outcome; Vincristine | 2003 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gallium; Humans; Ifosfamide; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Organ-confined primitive neuroectodermal tumor arising from the kidney.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Nephrectomy; Neuroectodermal Tumors, Primitive; Remission Induction; Vincristine; Weight Loss | 2003 |
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant, Newborn; Italy; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Oligospermia; Osteosarcoma; Puberty; Semen Preservation; Sperm Count; Surveys and Questionnaires | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Stem Cell Transplantation; Survival Rate | 2003 |
Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Secondary Prevention; Stem Cell Transplantation | 2003 |
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Management; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Salvage Therapy; Survival Rate; United Kingdom | 2003 |
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome | 2003 |
Modified Ifosphamide/CarboPlatin/Etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Patient Selection; Prognosis; Randomized Controlled Trials as Topic | 2003 |
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Liver Neoplasms; Nephroma, Mesoblastic; Sarcoma; Vincristine | 2003 |
Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Drug Administration Schedule; Etoposide; Eye Enucleation; Humans; Ifosfamide; Infant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Ultrasonography; Vincristine | 2003 |
Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Mesna; Neoplasm Staging; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2003 |
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Peritoneum; Statistics, Nonparametric; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Retrospective Studies | 2003 |
Extraocular retinoblastoma: a 13-year experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Enucleation; Female; Humans; Ifosfamide; Male; Retinal Neoplasms; Retinoblastoma; Teniposide; Time Factors; Vincristine | 2003 |
[Maintenance chemotherapy for small-cell lung cancer. A new publication].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2003 |
Ileoileal intussusception caused by a Ewing sarcoma tumour. An unusual case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Digestive System Surgical Procedures; Doxorubicin; Etoposide; Humans; Ifosfamide; Ileal Diseases; Ileal Neoplasms; Intussusception; Male; Sarcoma, Ewing; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2003 |
Poor-risk testicular cancer and high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Prognosis; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2003 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Paclitaxel | 2004 |
Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interprofessional Relations; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Neoplasms, Multiple Primary; Patient Care Team; Polymerase Chain Reaction; Prednisolone; Prednisone; Treatment Outcome; Vincristine; Vindesine | 2003 |
Association of intestinal malignant lymphoma and ulcerative colitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Colonoscopy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma; Methotrexate; Peripheral Blood Stem Cell Transplantation; Sigmoid Neoplasms; Vincristine | 2003 |
Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Pulmonary Embolism; Transplantation, Autologous; Vincristine | 2003 |
Fertility after high-dose chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Estradiol; Etoposide; Fertility; Follicle Stimulating Hormone; Humans; Ifosfamide; Infertility, Male; Luteinizing Hormone; Male; Oligospermia; Peripheral Blood Stem Cell Transplantation; Prolactin; Sperm Count; Sperm Motility; Spermatogenesis; Testicular Neoplasms; Testosterone | 2004 |
[Report of two cases with germinoma treated by individual adjuvant chemotherapy based on the mRNA expression of drug-resistance gene].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression; Genes, MDR; Germinoma; Humans; Ifosfamide; Male; Pharmacogenetics; RNA, Messenger; Treatment Outcome | 2004 |
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 8; Combined Modality Therapy; Dexamethasone; DNA-Binding Proteins; Etoposide; Genes, bcl-2; Genes, myc; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Radiotherapy, Adjuvant; Remission Induction; Transcription Factors; Translocation, Genetic | 2004 |
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2004 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Peripheral Blood Stem Cell Transplantation; Pneumonectomy; Testicular Neoplasms | 2004 |
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Carboplatin; CD4 Lymphocyte Count; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunophenotyping; Lymphoma, AIDS-Related; Male; Middle Aged; Pleural Effusion, Malignant; Prednisone; Salvage Therapy; Sarcoma, Kaposi; Skin Neoplasms; Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure; Vincristine; Viral Load | 2004 |
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Safety of rituximab therapy during the first trimester of pregnancy: a case history.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Lymphoma, Follicular; Male; Methotrexate; Mitoguazone; Peripheral Blood Stem Cell Transplantation; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, First; Remission Induction; Rituximab; Safety; Transplantation, Autologous; Vincristine | 2004 |
[Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Peripheral Blood Stem Cell Transplantation; Prognosis; Salvage Therapy; Testicular Neoplasms; Thiotepa; Transplantation, Autologous; Vinblastine | 2004 |
[Cellular changes in non-small cell lung cancer after neoadjuvant therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lung Neoplasms | 2004 |
Primary omental synovial sarcoma: a case with cytogenetic confirmation.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Maternal Age; Mesna; Neoplasm Recurrence, Local; Omentum; Peritoneal Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, High-Risk; Sarcoma, Synovial | 2004 |
Successful surgical treatment of angiosarcoma of the spine: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Bone Screws; Bone Substitutes; Calcium Compounds; Ceramics; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Durapatite; Etoposide; Follow-Up Studies; Hemangiosarcoma; Humans; Hypesthesia; Ifosfamide; Internal Fixators; Male; Middle Aged; Osteolysis; Prostheses and Implants; Prosthesis Implantation; Remission Induction; Silicates; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae | 2004 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma | 2004 |
[A case of advanced rhabdomyosarcoma of the spermatic cord who occurred epilepsy-like symptoms, but was completely responded to chemotherapy].
Topics: Adult; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diazepam; Epilepsy; Etoposide; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Rhabdomyosarcoma; Spermatic Cord | 2004 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Necrosis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Testicular Neoplasms | 2004 |
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2004 |
[Neoadjuvant chemotherapy for osteosarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Drug Administration Schedule; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Osteosarcoma; Retrospective Studies | 2004 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Nose Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
Tumor excision and reconstruction of the upper cervical spine: a multidisciplinary approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axis, Cervical Vertebra; Bone Transplantation; Cervical Atlas; Chemotherapy, Adjuvant; Chondrosarcoma; Chordoma; Combined Modality Therapy; Cranial Fossa, Posterior; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Ifosfamide; Interdisciplinary Communication; Internal Fixators; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Palliative Care; Patient Care Team; Proton Therapy; Remission Induction; Skull Base Neoplasms; Spinal Fusion; Spinal Neoplasms; Surgical Flaps | 2004 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neuroblastoma; Paraplegia; Retroperitoneal Neoplasms; Skull Neoplasms; Vincristine | 2004 |
[Tumour markers--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Orchiectomy; Prognosis; Remission Induction; Seminoma; Testicular Neoplasms; Testis; Time Factors; Treatment Outcome | 2004 |
VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Salvage Therapy; Sarcoma, Ewing; Survival Analysis | 2004 |
Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed | 2005 |
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Topics: Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cystectomy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Palliative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Organoplatinum Compounds; Thymus Neoplasms; Tomography, X-Ray Computed | 2005 |
[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thrombocytopenia; Transplantation, Autologous | 2005 |
Rhabdomyosarcoma in an adult presenting with nodal metastasis: a pitfall in fine-needle aspiration cytology of lymph nodes.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymph Nodes; Lymphatic Metastasis; Paranasal Sinus Neoplasms; Radiotherapy; Rhabdomyosarcoma, Alveolar; Tomography, X-Ray Computed | 2005 |
Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Immunohistochemistry; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Skin Neoplasms | 2005 |
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infections; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2005 |
Medulloblastoma in two successive pregnancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Medulloblastoma; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vincristine | 2005 |
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Candidiasis; Chlorides; Cytarabine; Etoposide; Fatal Outcome; Fever; Humans; Ifosfamide; Kidney Tubular Necrosis, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Neutropenia; Polycystic Kidney, Autosomal Dominant; Pyrrolidonecarboxylic Acid; Salvage Therapy; Systemic Inflammatory Response Syndrome | 2005 |
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Dermatomyositis; Etoposide; Humans; Ifosfamide; Male; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2005 |
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Leukemia; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2005 |
Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous | 2005 |
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
[Cardiac effects of cytokines produced after rituximab infusion].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Drug Monitoring; Etoposide; Fatal Outcome; Humans; Ifosfamide; Immunoglobulin M; Male; Methotrexate; Middle Aged; Mitoguazone; Rituximab; Waldenstrom Macroglobulinemia | 2005 |
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome | 2006 |
Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Culicidae; Epstein-Barr Virus Infections; Etoposide; Glyoxal; Humans; Hypersensitivity; Ifosfamide; Insect Bites and Stings; Killer Cells, Natural; Lymph Nodes; Lymphocytes; Lymphoma; Male; Prednimustine; Skin | 2006 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Superior Vena Cava Syndrome | 2005 |
Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; General Surgery; Humans; Ifosfamide; Male; Nose Neoplasms; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Teratocarcinoma; Treatment Outcome | 2005 |
[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Vinblastine | 2005 |
Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Etoposide; Fatal Outcome; Female; Hemoglobins; Humans; Idarubicin; Ifosfamide; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Magnetic Resonance Imaging | 2005 |
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Testicular Neoplasms | 2005 |
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysi
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
[Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prostatic Neoplasms; Retrospective Studies; Survival Analysis | 2005 |
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Medulloblastoma; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiosurgery; Radiotherapy Dosage; Retrospective Studies | 2006 |
Bronchial infiltration with diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bronchial Neoplasms; Carboplatin; DNA Primers; Etoposide; Gene Rearrangement; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Lymphoma, B-Cell; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Statistics, Nonparametric; Vincristine | 2006 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Mediastinal Neoplasms; Positron-Emission Tomography; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2006 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
[IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence | 2006 |
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2006 |
The Drosophila phosphatidylinositol transfer protein encoded by vibrator is essential to maintain cleavage-furrow ingression in cytokinesis.
Topics: Actins; Alleles; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Membrane; Cells, Cultured; Cisplatin; Contractile Proteins; Cytokinesis; Dexamethasone; Drosophila; Drosophila Proteins; Etoposide; Ifosfamide; Male; Membrane Proteins; Mutation; Phospholipid Transfer Proteins; Spermatocytes; Spindle Apparatus; Time Factors | 2006 |
[A case of secondary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Middle Aged; Mitoxantrone; Prednisone; Urinary Bladder Neoplasms; Vincristine | 2006 |
[Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Retroperitoneal Neoplasms; Salvage Therapy; Taxoids; Testicular Neoplasms | 2006 |
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurosurgical Procedures; Radiotherapy; Seminoma; Vinblastine | 2006 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine | 2007 |
Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Remission Induction; Rhabdoid Tumor; Vincristine | 2006 |
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine | 2006 |
[A case of pineal pure germinoma metastasized to the lumbosacral extradural space 8 years after initial therapy. Case report and review of literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Epidural Space; Etoposide; Germinoma; Humans; Ifosfamide; Laminectomy; Lumbar Vertebrae; Lumbosacral Region; Magnetic Resonance Imaging; Male; Pinealoma; Spinal Neoplasms | 2006 |
Retinoblastoma in children older than 5 years of age.
Topics: Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Brazil; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Laser Coagulation; Male; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Retinoblastoma; Teniposide; Treatment Outcome; Vincristine | 2007 |
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine | 2006 |
Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infection Control; Male; Middle Aged; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Seminoma; Testicular Neoplasms | 2006 |
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Time Factors; Treatment Outcome | 2006 |
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, CD34; Antineoplastic Agents; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Immunologic Factors; Kinetics; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recombinant Proteins; Rituximab; Stem Cell Transplantation; Stem Cells | 2006 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2006 |
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug Administration Schedule; Etoposide; Hemorrhage; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Radiography, Abdominal; Seminoma; Taxoids; Testicular Neoplasms; Tomography, X-Ray Computed; Tumor Lysis Syndrome | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retroperitoneal Neoplasms | 2006 |
Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms | 2006 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Vinblastine; Vinorelbine | 2007 |
Treatment of Burkitt's lymphoma during pregnancy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Male; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Registries; Vincristine | 2006 |
Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Disease Progression; Etoposide; Fatal Outcome; Follow-Up Studies; Glioblastoma; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Remission Induction; Supratentorial Neoplasms; Time Factors; Treatment Outcome; Vincristine | 2006 |
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Follicular; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Immunoenzyme Techniques; Mediastinal Neoplasms; Methotrexate; Middle Aged; Sarcoma; Taxoids; Treatment Outcome | 2006 |
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2006 |
[Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2006 |
[Role of radiotherapy of lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
Juvenile Ewing sarcoma presenting as a pelvic mass.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Sarcoma, Ewing | 2007 |
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymph Nodes; Lymphoma, T-Cell; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion, Malignant; Prednisolone; Tuberculosis, Pleural; Vincristine | 2006 |
Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Male; Middle Aged; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome | 2007 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine | 2008 |
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Survival Analysis | 2007 |
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pelvic Bones; Peripheral Blood Stem Cell Transplantation; Remission Induction; Risk; Sarcoma, Ewing; Scapula; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
The effect of short-term intensive chemotherapy on reactivation of tuberculosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Mycobacterium tuberculosis; Prednisone; Retrospective Studies; Tuberculosis; Vincristine; Virus Activation | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Renal Insufficiency; Treatment Outcome; Vincristine; Wilms Tumor | 2008 |
Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Treatment Outcome | 2007 |
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2007 |
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine | 2007 |
Orbital melanotic neuroectodermal tumor of infancy successfully treated with chemotherapy and subtotal excision.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Diagnosis, Differential; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neuroectodermal Tumor, Melanotic; Ophthalmologic Surgical Procedures; Orbital Neoplasms; Tomography, X-Ray Computed; Vincristine | 2007 |
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2007 |
Multimodal treatment of thymic carcinoma: Report of nine cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Thymoma | 2008 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
[Nutritional pathway for autologous stem cell transplantation].
Topics: Antineoplastic Agents, Alkylating; Body Weight; Carboplatin; Critical Pathways; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Multiple Myeloma; Parenteral Nutrition, Total; Transplantation Conditioning; Transplantation, Autologous | 2007 |
[Inductive systemic therapy of urological tumors with curative intent].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Delivery Systems; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Seminoma; Survival Rate; Taxoids; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2007 |
The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Retinal Neoplasms; Retinoblastoma; Sex Distribution; Survival Rate; Teniposide | 2007 |
Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Rhabdoid Tumor; Salvage Therapy; Survivors; Thoracic Neoplasms; Vincristine | 2007 |
[Long-term follow-up of patients with suprasellar germinomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diabetes Insipidus; Disease Progression; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Hypopituitarism; Ifosfamide; Male; Neoplasm Recurrence, Local; Paraneoplastic Endocrine Syndromes; Pituitary Irradiation; Pituitary Neoplasms; Survival Rate | 2007 |
[Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Stem Cell Transplantation; Transplantation, Autologous | 2007 |
Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, X; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Sarcoma, Ewing; Translocation, Genetic | 2007 |
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Drug Synergism; Etoposide; Female; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Mice; Mice, Nude; Piperazines; Pyrimidines; Transplantation, Heterologous | 2007 |
Germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms | 2007 |
Prognostic factors for local and distant control in Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Incidence; Infant; Male; Medical Records; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Treatment Failure | 2008 |
[Clinical analysis of primary mediastinal germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retrospective Studies; Seminoma; Survival Rate; Taxoids; Young Adult | 2007 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Mitoguazone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2008 |
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Confusion; Cryoprotective Agents; Cytarabine; Dacarbazine; Dexamethasone; Dimethyl Sulfoxide; Doxorubicin; Etoposide; Hippocampus; Hodgkin Disease; Humans; Hyperventilation; Ifosfamide; Magnetic Resonance Imaging; Male; Melphalan; Paresthesia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Vinblastine; Vision Disorders | 2008 |
[High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma].
Topics: Adult; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Salvage Therapy | 2008 |
Cutaneous plasmablastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; HIV Infections; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Doxorubicin; Etoposide; Facial Paralysis; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neurologic Examination; Omentum; Paraneoplastic Polyneuropathy; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2008 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2008 |
Diseases desperate grown.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Randomized Controlled Trials as Topic; Research Design; Sample Size; Treatment Outcome | 2008 |
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Premedication; Retrospective Studies; Transplantation, Autologous | 2008 |
Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Young Adult | 2008 |
Dose enhancement effect of anticaner drugs associated with increased temperature in vitro.
Topics: Antineoplastic Agents; Carboplatin; Cell Proliferation; Cell Survival; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gemcitabine; HeLa Cells; Humans; Hyperthermia, Induced; Ifosfamide; Organoplatinum Compounds; Oxaliplatin; Taxoids; Temperature; Vinblastine; Vinorelbine | 2008 |
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Immunotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2008 |
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; CA-19-9 Antigen; Carboplatin; Core Binding Factors; Diagnosis, Differential; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Lipase; Magnetic Resonance Imaging; Pancreatic Neoplasms; Sarcoma, Myeloid | 2008 |
Primary hepatic Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cytarabine; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Magnetic Resonance Imaging; Male | 2008 |
Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Prostatectomy; Prostatic Neoplasms; Rituximab; Survival | 2008 |
Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Topics: Acute Kidney Injury; Adult; Carboplatin; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Kidney; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation | 2008 |
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Cutaneous; Middle Aged; Panniculitis; Prednisone; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; T-Lymphocytes; Vincristine | 2008 |
Recurrent melanotic neuroectodermal tumor of infancy: a proposal for treatment protocol with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 7; Comparative Genomic Hybridization; Etoposide; Humans; Ifosfamide; Infant; Loss of Heterozygosity; Male; Mandibular Neoplasms; Neoplasm Recurrence, Local; Neuroectodermal Tumor, Melanotic; Vincristine | 2008 |
Undifferentiated sarcoma of the maxillary sinus: report of a rare case in an adult.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Maxillary Sinus Neoplasms; Mesna; Middle Aged; Protective Agents; Sarcoma; Vincristine | 2009 |
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma.
Topics: Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Myeloablative Agonists; Neoplasm Metastasis; Prospective Studies; Risk; Risk Factors; Sarcoma, Ewing; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Paclitaxel; Survival Rate; Topotecan; Transplantation Conditioning; Treatment Outcome; Vincristine; Young Adult | 2008 |
Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Survival Rate; Urinary Bladder Neoplasms | 2008 |
Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Urachus | 2008 |
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Survival Analysis; Syndecan-1; Transplantation, Autologous; Young Adult | 2009 |
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2008 |
Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Sarcoma, Ewing; Treatment Outcome; Young Adult | 2009 |
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Infant; Kidney Neoplasms; Kidney Tubules; Linear Models; Male; Nephrectomy; Prospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Male; Morpholines; Nausea; Nerve Sheath Neoplasms; Neurotoxicity Syndromes | 2008 |
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Doxorubicin; Etoposide; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Palliative Care; Piperazines; Pyrimidines; Small Cell Lung Carcinoma; Stomach Neoplasms | 2009 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Small Cell Lung Carcinoma; Treatment Outcome | 2009 |
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neoplasms; Severity of Illness Index; Whole-Body Irradiation; Young Adult | 2009 |
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Neoplasms, Unknown Primary; Orchiectomy; Positron-Emission Tomography; Seminoma; Stomach Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Melphalan; Prognosis; Rhabdoid Tumor; Survival Rate; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Ifosfamide; Lung Neoplasms; Male; Occipital Lobe; Remission Induction; Retroperitoneal Neoplasms; Stomach Neoplasms; Supratentorial Neoplasms; Thoracic Surgery, Video-Assisted | 2009 |
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Muscle Neoplasms; Pain; Pamidronate; Sarcoma, Synovial; Vincristine | 2009 |
Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Survival Analysis; Treatment Failure | 2009 |
A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Central Nervous System Neoplasms; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Rituximab; Stem Cell Transplantation | 2009 |
Desmoplastic small round cell tumor in children: a new therapeutic approach.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 22; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Pelvic Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Small Cell; Splenic Neoplasms; Translocation, Genetic; Transplantation, Autologous; Vincristine | 2009 |
Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy | 2009 |
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Bone Marrow; Combined Modality Therapy; Cyclams; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Ifosfamide; Lenalidomide; Leukapheresis; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Retrospective Studies; Risk Factors; Thalidomide; Transplantation, Autologous; Treatment Failure; Vincristine | 2009 |
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in adolescents.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cisplatin; Cyclophosphamide; Double-Blind Method; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Incidence; Morpholines; Nausea; Neutropenia; Randomized Controlled Trials as Topic; Sample Size; Vomiting | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Population analysis of myelosuppression profiles using routine clinical data after the ICE (ifosfamide/carboplatin/etoposide) regimen for malignant gliomas.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Computer Simulation; Etoposide; Female; Glioma; Humans; Ifosfamide; Immunosuppressive Agents; Kinetics; Leukocyte Count; Male; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Platelet Count; Reticulocyte Count; Retrospective Studies | 2009 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone; Diagnosis, Differential; Disease Progression; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymph Nodes; Lymphatic Diseases; Lymphoma, Extranodal NK-T-Cell; Male; Radiography; Splenomegaly; Still's Disease, Adult-Onset; Treatment Outcome | 2009 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male | 2009 |
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Biomarkers, Tumor; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Immunohistochemistry; Membrane Proteins; Middle Aged; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Salvage Therapy; Transplantation, Autologous; Tumor Suppressor Protein p53; Young Adult | 2010 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Male; Mesna; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine; Vinorelbine | 2009 |
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasm Proteins; Oncogene Proteins, Fusion; Pleural Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Synovial; Tomography, X-Ray Computed; Vincristine | 2010 |
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression; Humans; Ifosfamide; Lung Neoplasms; Mice; Mice, Nude; Small Cell Lung Carcinoma; Topotecan; Treatment Outcome; Xenograft Model Antitumor Assays | 2010 |
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Mitoguazone; Periodicity; Prednisone; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure; Vinblastine; Young Adult | 2010 |
Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine.
Topics: Adult; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Doxorubicin; Endocrine Gland Neoplasms; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neuroblastoma; Tomography, X-Ray Computed; Vincristine | 2010 |
Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Drug Synergism; Etoposide; Flow Cytometry; Humans; Ifosfamide; Melatonin; Sarcoma, Ewing; Vincristine | 2010 |
Primary intra-osseous liposarcoma of the femur: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Doxorubicin; Etoposide; Femoral Neoplasms; Humans; Ifosfamide; Liposarcoma; Magnetic Resonance Imaging; Male; Methotrexate; Neoadjuvant Therapy; Radiography; Whole Body Imaging | 2009 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prospective Studies; Scotland; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2010 |
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Young Adult | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2010 |
Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Teratoma; Treatment Outcome; Vincristine; Young Adult | 2010 |
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemotherapy, Adjuvant; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2010 |
[Result of treatment for advanced germ cell tumor in the last decade].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Young Adult | 2010 |
[Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retroperitoneal Neoplasms; Treatment Outcome | 2010 |
Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Child, Preschool; Choroid Plexus Neoplasms; Cognition Disorders; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Postoperative Complications; Reoperation; Retrospective Studies | 2010 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune | 2010 |
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Salvage Therapy | 2011 |
SenseCam as a rehabilitation tool in a child with anterograde amnesia.
Topics: Adolescent; Amnesia, Anterograde; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cues; Environmental Monitoring; Etoposide; Feasibility Studies; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Image Processing, Computer-Assisted; Male; Memory, Long-Term; Memory, Short-Term; Meningeal Neoplasms; Mental Recall; Microcomputers; Neuropsychological Tests; Photography; Radiation Injuries; Recognition, Psychology; Self-Help Devices | 2011 |
Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Chest wall Ewing sarcoma family of tumors: long-term outcomes.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Radiotherapy Dosage; Sarcoma, Ewing; Thoracic Wall; Time Factors; Vincristine; Young Adult | 2011 |
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy; Salvage Therapy; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Injections, Spinal; Leukemia, Large Granular Lymphocytic; Leukemic Infiltration; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Prednisone; Radiography; Remission Induction; Subarachnoid Hemorrhage; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2010 |
Acute pancreatitis induced by ifosfamide therapy.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Ifosfamide; Pancreatitis; Recurrence; Wilms Tumor | 2010 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Liver; Liver Neoplasms; Male; Survival Analysis; Treatment Outcome | 2011 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Mesna; Neuroblastoma; Pilot Projects; Risk Factors; Thoracic Neoplasms; Topotecan; Treatment Outcome | 2011 |
A case of pathological complete remission of a brain metastasis from germ cell tumor of the testis after systemic chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Male; Remission Induction; Testicular Neoplasms; Tomography, X-Ray Computed | 2010 |
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2010 |
Vaginal adenosarcoma arising from refractory endometriosis: a case report.
Topics: Adenofibroma; Adenosarcoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Endometriosis; Epirubicin; Etoposide; Female; Gestrinone; Humans; Hysterectomy; Ifosfamide; Membrane Proteins; Ovariectomy; Salpingectomy; Treatment Outcome; Vaginal Neoplasms; Vincristine | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Malignant germ cell tumors associated with Swyer syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Dysgerminoma; Etoposide; Female; Gonadal Dysgenesis, 46,XY; Humans; Ifosfamide; Karyotyping; Phenotype; Prognosis | 2011 |
Neuroblastoma in an adult: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neuroblastoma; Spinal Cord Compression; Spinal Cord Neoplasms; Thoracic Vertebrae; Vincristine; Young Adult | 2010 |
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult | 2011 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Secondary Prevention; Vincristine | 2011 |
Metastatic osteosarcoma presenting as a single pulmonary microembolus.
Topics: Adolescent; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diagnosis, Differential; Diagnostic Errors; Enoxaparin; Etoposide; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Male; Neoplastic Cells, Circulating; Osteosarcoma; Pneumonectomy; Postoperative Complications; Pulmonary Artery; Pulmonary Embolism; Thromboembolism; Tomography, X-Ray Computed | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Databases, Factual; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Thiotepa; Vinblastine; Young Adult | 2011 |
[EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoproliferative Disorders; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2011 |
[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Edema; Etoposide; Female; Glossitis; Hodgkin Disease; Humans; Hyperalgesia; Ifosfamide; Mesna; Mitoxantrone; Mucositis; Panniculitis | 2011 |
Age differences in temporal discounting: the role of dispositional affect and anticipated emotions.
Topics: Adult; Affect; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Choice Behavior; Emotions; Etoposide; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neuropsychological Tests; Wechsler Scales; Young Adult | 2011 |
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Topics: 12E7 Antigen; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calmodulin-Binding Proteins; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease Management; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Reoperation; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Shoulder; Skin Neoplasms; Vincristine; Young Adult | 2011 |
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Rituximab; Transplantation, Autologous; Young Adult | 2011 |
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Retrospective Studies; Treatment Outcome | 2011 |
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Proportional Hazards Models; Radiotherapy, Conformal; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2011 |
[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].
Topics: Adult; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Treatment Outcome; Wilms Tumor | 2011 |
[Mobilization and collection of autologous peripheral blood stem cells by CIE or IEV protocol in children with malignant solid tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Rhabdomyosarcoma; Transplantation, Autologous | 2011 |
Ewing sarcoma/primitive neuroectodermal tumor arising from the adrenal gland in an adolescent.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Sarcoma, Ewing; Vincristine | 2011 |
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome | 2011 |
Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.
Topics: Antineoplastic Agents; Camptothecin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Gemcitabine; Ifosfamide; Irinotecan; Methotrexate; Organophosphorus Compounds; Surface Properties; Tandem Mass Spectrometry; Vincristine | 2012 |
The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Taxoids; Testicular Neoplasms; Wilms Tumor; Young Adult | 2011 |
Intracranial germ cell tumors: efficacy of neoadjuvant chemo-radiotherapy without surgical biopsy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2011 |
Unusual seminoma revealed by bone metastasis.
Topics: Bone Neoplasms; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Seminoma; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult | 2011 |
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure | 2011 |
Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Time Factors; Young Adult | 2013 |
Dyspnoea and a lung mass in a young female 2 weeks after Caesarean delivery.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cesarean Section; Cyclophosphamide; Doxorubicin; Dyspnea; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Paresis; Pulmonary Blastoma; Radiography, Thoracic; Smoking; Treatment Outcome; Vincristine | 2011 |
Durable complete response to chemotherapy in an infant with a clival chordoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Mapping; Chordoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Remission Induction; Skull Base Neoplasms; Vincristine | 2012 |
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2011 |
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Germinal Center; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Male; Microarray Analysis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Proteins; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Rituximab; Salvage Therapy | 2011 |
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult | 2012 |
Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Busulfan; Carboplatin; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Melphalan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Vidarabine; Vincristine | 2011 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2012 |
Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Carboplatin; Child; Chromosome Duplication; Chromosomes, Human, Pair 1; Etoposide; Humans; Ifosfamide; Male; Mesna; Neoplasm Recurrence, Local; Rituximab | 2012 |
Uterine cervical malignant granular cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cervix Uteri; Cisplatin; Etoposide; Female; Granular Cell Tumor; Humans; Ifosfamide; Incidental Findings; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2013 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Induction Chemotherapy; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Radiography; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2012 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Management of a large retroperitoneal primitive neuroectodermal tumour: 'a multimodal approach'.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Vincristine | 2012 |
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Melphalan; Myeloablative Agonists; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Stem Cell Transplantation; Vincristine; Young Adult | 2012 |
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Orthopedic Procedures; Osteosarcoma; Transplantation, Autologous; Treatment Outcome | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Sarcoma, Synovial; Treatment Outcome | 2012 |
[Biphasic pulmonary blastoma with germ cell differentiation: a challenge in diagnosis and treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Male; Taxoids; Tomography, X-Ray Computed | 2011 |
[Young man with severe back pain].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Low Back Pain; Male; Neoplasm Metastasis; Orchiectomy; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials, Phase II as Topic; Cohort Studies; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
Clinical results of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in children with advanced stage rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2012 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiovascular Diseases; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Quality of Life; Stem Cell Transplantation; Surveys and Questionnaires; Survivors; Treatment Outcome; Young Adult | 2013 |
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine | 2013 |
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopathy, Dilated; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mechlorethamine; Photons; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome; Tunisia; Vincristine | 2012 |
Favorable course of pericardial angiosarcoma under paclitaxel followed by pazopanib treatment documented by cardiovascular magnetic resonance imaging.
Topics: Adrenal Cortex Hormones; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Delayed Diagnosis; Diagnostic Errors; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Indazoles; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Myocardium; Paclitaxel; Pericardial Effusion; Pericardiocentesis; Pericarditis; Pericardium; Protein Kinase Inhibitors; Pulmonary Embolism; Pyrimidines; Remission Induction; Sulfonamides; Vincristine | 2012 |
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2013 |
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Vinblastine | 2012 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose Neoplasms; Orchiectomy; Remission Induction; Skin; Testicular Neoplasms; Testis | 2013 |
Bilateral retinoblastoma: clinical presentation, management and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Eye Enucleation; Female; Humans; Ifosfamide; Infant; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2013 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine | 2013 |
Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gastrectomy; Hematemesis; Humans; Ifosfamide; Male; Neoplasm Staging; Osteosarcoma; Prognosis; Stomach Neoplasms | 2013 |
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Denmark; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Rituximab; Sweden; Treatment Outcome; Vincristine; Young Adult | 2013 |
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for pat
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; International Agencies; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2013 |
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Mucositis; Peripheral Blood Stem Cell Transplantation; Preoperative Care; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thoracic Surgical Procedures; Time Factors; Treatment Outcome; Young Adult | 2014 |
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4-year-old girl.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Maxilla; Maxillary Sinus Neoplasms; Proton Therapy; Sarcoma, Ewing; Vincristine | 2013 |
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recurrence; Sarcoma, Ewing; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2013 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Neuroectodermal Tumors, Primitive, Peripheral; Pleural Neoplasms; Retroperitoneal Neoplasms; Retrospective Studies; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine; Young Adult | 2015 |
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; DNA, Viral; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis | 2014 |
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Salvage Therapy; Treatment Outcome | 2013 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Ofatumumab in diffuse large B cell lymphoma?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male | 2013 |
Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid; Dexamethasone; Etoposide; Female; Headache; Humans; Ifosfamide; Lumbar Vertebrae; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Pia Mater; Polyradiculopathy | 2013 |
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; France; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Risk Factors; Seminoma; Testicular Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2014 |
Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Management; Disease-Free Survival; Drug Administration Schedule; Etoposide; Feasibility Studies; Germinoma; Hospitals, University; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Retrospective Studies; Risk Factors; Seminoma; Testicular Neoplasms; Treatment Outcome | 2013 |
Myoepithelial carcinoma treatment in children: a report from the TREP project.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Myoepithelioma; Neoplasm Staging; Prognosis; Remission Induction | 2014 |
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
Extraskeletal Ewing's Sarcoma: insight into a ten years follow-up.
Topics: Abdominal Neoplasms; Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Intestines; Radiotherapy, Adjuvant; Rupture, Spontaneous; Sarcoma, Ewing; Survivors; Tomography, X-Ray Computed; Vincristine | 2013 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load | 2014 |
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2014 |
[Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Eruptions; Drug Substitution; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prednisolone; Testicular Neoplasms | 2014 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult | 2016 |
NUT midline carcinoma: an aggressive intrathoracic neoplasm.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Gene Rearrangement; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Male; Nuclear Proteins; Oncogene Proteins, Fusion; Prognosis; Thoracic Neoplasms; Translocation, Genetic | 2013 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Treatment Outcome | 2014 |
Successful treatment of metastatic βHCG-secreting germ cell tumor occurring 3 years after total resection of a pineal mature teratoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Pinealoma; Radiotherapy, Adjuvant; Teratoma; Treatment Outcome | 2014 |
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposide; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Neoplasm Recurrence, Local; Treatment Outcome | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Green urine secondary to methylene blue.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Male; Methylene Blue; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Urine | 2014 |
All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Mediastinal Neoplasms; Rhabdoid Tumor; Tomography, X-Ray Computed; Vincristine | 2015 |
Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Receptor Protein-Tyrosine Kinases; Remission Induction; Treatment Outcome; Vincristine | 2015 |
Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous; Young Adult | 2014 |
Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Etoposide; Humans; Hyperpigmentation; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasms, Radiation-Induced; Orbital Neoplasms; Osteosarcoma; Triamcinolone | 2014 |
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Topics: Adult; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Retrospective Studies; Survival Rate; Testicular Neoplasms | 2013 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Survival Rate; Vincristine; Young Adult | 2014 |
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studies; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Young Adult | 2015 |
A case of mediastinal embryonal carcinoma successfully treated by integrative therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Thoracic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Ifosfamide; Langerhans Cell Sarcoma; Male; Recurrence; Remission Induction; Skin Neoplasms; Young Adult | 2015 |
How I treat Burkitt lymphoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Translocation, Genetic; Vincristine | 2014 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisolone; Prognosis; Retrospective Studies; Young Adult | 2015 |
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Arachidonic Acids; Asbestos; Asbestosis; Attitude of Health Personnel; Carboplatin; Child; Child, Preschool; Curriculum; Databases, Factual; Education, Medical; Enzyme Inhibitors; Etoposide; Europe; Female; General Surgery; Germany; Hospitals, University; Humans; Ifosfamide; Lung Neoplasms; Male; Medical History Taking; Mesothelioma; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Neurons; Muscular Atrophy; Neoplasms; Neuroprotective Agents; Phospholipase A2 Inhibitors; Phospholipases A2, Cytosolic; Physical Examination; Quality Improvement; Spinal Cord Injuries; Topotecan; Universities; World Health Organization; Young Adult | 2014 |
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Seminoma; Testicular Neoplasms | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Adjustment; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Temporal analysis of prostaglandin F2α receptor, caspase 3, and cyclooxygenase 2 messenger RNA expression and prostaglandin F2α receptor and cyclooxygenase 2 protein expression in endometrial tissue from multiparous Nelore (Bos taurus indicus) cows treate
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Caspase 3; Cattle; Cloprostenol; Cyclooxygenase 2; Endometrium; Etoposide; Female; Gene Expression; Ifosfamide; Immunohistochemistry; Luteolytic Agents; Methotrexate; Postpartum Period; Receptors, Prostaglandin; RNA, Messenger | 2015 |
High-dose chemotherapy for recurrent ovarian germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome; Vinblastine | 2015 |
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Brain Ischemia; Disease Models, Animal; Etoposide; Exercise Test; Ifosfamide; Intracranial Thrombosis; Lasers; Locomotion; Male; Methotrexate; Mice; Mice, Inbred Strains; Movement Disorders; Rotarod Performance Test; Wakefulness | 2015 |
[Patient receiving peritoneal dialysis after treatment of ovarian cancer].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Tubules; Ovarian Neoplasms; Peritoneal Dialysis; Peritoneal Neoplasms; Renal Insufficiency, Chronic | 2014 |
Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chondrosarcoma; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasms, Connective and Soft Tissue; Soft Tissue Neoplasms; Thigh | 2014 |
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine | 2015 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 2015 |
Characterization of a unique cell population marked by transgene expression in the adult cochlea of nestin-CreER(T2)/tdTomato-reporter mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cochlea; Ear, Inner; Estrogen Antagonists; Etoposide; Female; Gene Expression Regulation; Ifosfamide; Ki-67 Antigen; Luminescent Proteins; Male; Membrane Proteins; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nestin; Neurons; Plant Lectins; Receptors, Estrogen; Tamoxifen | 2015 |
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2015 |
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2015 |
Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Child, Preschool; Choroid Plexus Neoplasms; Etoposide; Female; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Retrospective Studies; Survival Analysis | 2015 |
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Camptothecin; Cisplatin; Etoposide; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retreatment; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2016 |
Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Carbon Radioisotopes; Child; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Disease-Free Survival; Etoposide; False Positive Reactions; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lateral Ventricles; Male; Melphalan; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Tissue Distribution; Young Adult | 2015 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2015 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Young Adult | 2015 |
Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cisplatin; Databases, Factual; Denmark; Disease Progression; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Proportional Hazards Models; Radiotherapy Dosage; Retreatment; Risk Factors; Testicular Neoplasms; Time Factors; Treatment Failure | 2015 |
Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Salvage Therapy; Treatment Outcome | 2015 |
Identification of Discrete Prognostic Groups in Ewing Sarcoma.
Topics: Adolescent; Adult; Age Factors; Bone Neoplasms; Child; Child, Preschool; Databases, Factual; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Sarcoma, Ewing; SEER Program | 2016 |
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Substitution; Etoposide; Female; Follow-Up Studies; Hearing Loss; Humans; Ifosfamide; Kidney Diseases; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Stroke Volume; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2015 |
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Etoposide; Febrile Neutropenia; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Treatment Outcome | 2015 |
[Malignant lymphoma complicated with posterior reversible encephalopathy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Rituximab | 2015 |
Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2016 |
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction | 2016 |
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Dactinomycin; Doxorubicin; Drug Synergism; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Ifosfamide; Metabolic Networks and Pathways; Mitochondria; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma, Ewing; Temozolomide; Vincristine | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Dexamethasone; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome | 2015 |
Successful Treatment of Extra-Renal Noncerebral Rhabdoid Tumors with VIDE.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Rhabdoid Tumor; Vincristine | 2016 |
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Prognosis; Pulmonary Blastoma; Testicular Neoplasms | 2015 |
Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Frail Elderly; Geriatric Assessment; Glyoxal; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Neoplasm Grading; Prednimustine; Prednisone; Prospective Studies; Republic of Korea; Treatment Outcome; Vincristine | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Topotecan; Vincristine | 2016 |
Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response.
Topics: Adolescent; Anticoagulants; Cytochrome P-450 CYP2C9 Inhibitors; Drug Interactions; Etoposide; Humans; Ifosfamide; International Normalized Ratio; Male; Rhabdomyosarcoma; Warfarin | 2016 |
Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Carboplatin; Cerebrum; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Intracranial Hemorrhages; Male; Neurofibromatoses; Retrospective Studies; Sarcoma; Treatment Outcome | 2016 |
Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Interleukin-2; Isotretinoin; Leuprolide; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Triple Negative Breast Neoplasms | 2015 |
Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Comorbidity; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Retrospective Studies; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2016 |
Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2016 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; Half-Life; HIV Infections; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Tenofovir; Vincristine; Young Adult | 2016 |
Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cisplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; Dexamethasone; DNA Mutational Analysis; Etoposide; Female; Humans; Hydrocortisone; Hydroxamic Acids; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; MAP Kinase Kinase 1; Methotrexate; Mutation; Positive Regulatory Domain I-Binding Factor 1; Precision Medicine; Repressor Proteins; STAT3 Transcription Factor; Vorinostat | 2016 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Retroperitoneal Neoplasms; Risk Assessment; Survival Rate; Testicular Neoplasms; Vaginal Neoplasms; Vinblastine | 2016 |
Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Consolidation Chemotherapy; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Recurrence; Retrospective Studies; Rituximab; Stem Cell Transplantation; Treatment Outcome | 2016 |
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2016 |
Myoepithelial Carcinoma: The Role of Radiation Therapy. A Case Report and Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Myoepithelioma; Radiotherapy, Adjuvant; Retrospective Studies; SEER Program; Survival Rate; Vincristine | 2016 |
A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
Topics: Abdominal Neoplasms; Acute Lung Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Etoposide; Fluoroscopy; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Postoperative Complications; Prosthesis Implantation; Radiography, Thoracic; Radiotherapy; Respiratory Distress Syndrome; Transfusion Reaction; Vascular Access Devices | 2015 |
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prognosis; Transplantation, Homologous; Young Adult | 2016 |
Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Rhabdomyosarcoma | 2016 |
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome | 2016 |
Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients.
Topics: Antigens, CD34; Antineoplastic Agents; Epirubicin; Etoposide; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cells; Prospective Studies; Salvage Therapy | 2016 |
Neoadjuvant Intraarterial Chemotherapy for Treatment of Malignant Vaginal Tumors in Children: A Single-Center Experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child, Preschool; China; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ifosfamide; Iliac Artery; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Metastasectomy; Neoadjuvant Therapy; Pelvic Neoplasms; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vaginal Neoplasms; Vindesine | 2016 |
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Blood Transfusion; Carboplatin; Cyclams; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Young Adult | 2016 |
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calmodulin-Binding Proteins; Cell Differentiation; Chemotherapy, Adjuvant; Child; Doxorubicin; Etoposide; Femoral Neoplasms; Femur; Ganglioneuroblastoma; Gene Rearrangement; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Prognosis; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2016 |
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Humans; Ifosfamide; Indiana; Lung Neoplasms; Male; Mediastinal Neoplasms; Metastasectomy; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Pneumonectomy; Postoperative Complications; Retrospective Studies; Risk Factors; Testicular Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2016 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male; Neoadjuvant Therapy; Prognosis; Treatment Outcome | 2016 |
Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Salvage Therapy; Treatment Outcome; Young Adult | 2016 |
Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Cisplatin; Cranial Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neutropenia; Paresis; Remission Induction; Supratentorial Neoplasms | 2017 |
Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Methotrexate; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Osteosarcoma; Proto-Oncogene Protein c-fli-1; Remission Induction; RNA-Binding Protein EWS; Sarcoma, Ewing; Vincristine | 2017 |
Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Mesna; Methotrexate; Orbital Cellulitis; Paranasal Sinus Neoplasms; Prognosis; Treatment Outcome | 2016 |
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Radiotherapy; Receptors, Interleukin-2; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2017 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagnosis; Dexamethasone; Diagnostic Errors; Etoposide; Fistula; Humans; Ifosfamide; Leucovorin; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinusitis; Methotrexate; Mouth Diseases; Nose Diseases; Nose Neoplasms; Palatal Neoplasms; Radiotherapy | 2017 |
Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Indazoles; Infant; Male; Pyrimidines; Remission Induction; Sarcoma; Sulfonamides | 2017 |
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2017 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cisplatin; Compassionate Use Trials; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Nivolumab; Platinum Compounds; Programmed Cell Death 1 Receptor; Retrospective Studies; Seminoma; Stem Cell Transplantation; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome | 2017 |
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substitution; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Methylprednisolone; Mycophenolic Acid; Postoperative Complications; Remission Induction; Tacrolimus; Transplant Recipients | 2017 |
Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Craniospinal Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Salvage Therapy; Sciatic Nerve; Vincristine | 2017 |
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Rhabdomyolysis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2017 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Female; Humans; Ifosfamide; Length of Stay; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Prednisolone; Treatment Outcome | 2018 |
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Fertility; Humans; Ifosfamide; Neoplasm Staging; Pregnancy; Term Birth; Uterine Cervical Neoplasms | 2017 |
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Chemokines; Cytokines; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Tumor Burden; Young Adult | 2017 |
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Ifosfamide; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Nephrosis, Lipoid; Nephrotic Syndrome; Panniculitis; Paraneoplastic Syndromes; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 2017 |
Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cells; Sarcoma, Ewing; Vincristine; Young Adult | 2017 |
Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2017 |
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Extremities; Humans; Ifosfamide; Infant; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Retrospective Studies; Sarcoma, Ewing; Treatment Failure | 2017 |
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cohort Studies; Dacarbazine; Etoposide; Female; Glioma; Humans; Ifosfamide; Leukopenia; Male; Neoplasm Grading; Prospective Studies; Temozolomide; Treatment Outcome; Vincristine | 2018 |
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; International Agencies; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Survival Rate; Testicular Neoplasms; Young Adult | 2017 |
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis | 2018 |
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Kidney; Male; Middle Aged; Retrospective Studies; Young Adult | 2018 |
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2017 |
Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Endostatins; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Osteosarcoma; Pleural Effusion, Malignant; Recombinant Proteins | 2017 |
Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem C
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Energy Intake; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Nutritional Physiological Phenomena; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult | 2018 |
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cohort Studies; Dexamethasone; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Analysis; Young Adult | 2018 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Middle Aged | 2018 |
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate; Time Factors; Vincristine | 2018 |
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Sickle Cell Trait; Transplantation, Autologous | 2018 |
R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2018 |
Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Case-Control Studies; Cementation; Child; Child, Preschool; Combined Modality Therapy; Curettage; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Phenol; Recovery of Function; Retrospective Studies; Sarcoma, Ewing; Sclerosing Solutions; Sclerotherapy; Wound Healing | 2019 |
Au/Pd@rGO nanocomposite decorated with poly (L-Cysteine) as a probe for simultaneous sensitive electrochemical determination of anticancer drugs, Ifosfamide and Etoposide.
Topics: Antineoplastic Agents; Biosensing Techniques; Cysteine; Electrochemical Techniques; Electrodes; Etoposide; Graphite; Ifosfamide; Limit of Detection; Nanocomposites | 2018 |
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methylene Blue; Middle Aged; Rituximab; Thiamine | 2019 |
Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
Topics: Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brentuximab Vedotin; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Neoplasm Proteins; Prednisone; Remission Induction; Salvage Therapy; Tonsillar Neoplasms; Vincristine | 2019 |
Pure Seminoma and Concurrent Aggressive Lymphoma: Case Report of a Patient With Persistent Müllerian Duct Syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disorder of Sex Development, 46,XY; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Rituximab; Seminoma; Testicular Neoplasms; Treatment Outcome | 2019 |
Safety and Cost-effectiveness of Outpatient Administration of High-dose Chemotherapy in Children With Ewing Sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Outpatients; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2019 |
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Ifosfamide; Male; Prednisone; Skin Neoplasms; Vincristine | 2019 |
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Liposarcoma; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Pneumonectomy; Retroperitoneal Neoplasms; Surgical Procedures, Operative; Thoracoscopy; Time Factors; Treatment Outcome | 2018 |
Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Germ Cells; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Ifosfamide; Inguinal Canal; Male; Neuroblastoma; Nuclear Proteins; Octamer Transcription Factor-3; Transcription Factors; Vincristine | 2019 |
Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine; Young Adult | 2019 |
Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 19; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Immunoglobulin G4-Related Disease; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Rituximab; Salvage Therapy; Translocation, Genetic | 2019 |
Osteosarcoma journey over two decades in India: Small steps, big changes.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; India; Male; Middle Aged; Osteosarcoma; Survival Rate | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Irinotecan; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction | 2020 |
Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Incidence; Lymphoma; Male; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies; Thiamine | 2020 |
Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2020 |
Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy.
Topics: Aged; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Injections, Intraocular; Intraocular Lymphoma; Killer Cells, Natural; Methotrexate; Radiotherapy, Adjuvant; Remission Induction; Vitreous Body | 2019 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Transplantation, Autologous; Treatment Outcome | 2019 |
A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary.
Topics: Abdominal Neoplasms; Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biomarkers, Tumor; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Jordan; Ovarian Neoplasms; Vincristine; Young Adult | 2019 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemoradiotherapy; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose; Nose Neoplasms; Skin Neoplasms | 2020 |
Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2019 |
Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Middle Aged; Retrospective Studies; Sarcoma; Vincristine; Young Adult | 2020 |
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neurofibromatosis 1; Prognosis | 2020 |
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular; Etoposide; Female; Germany; Humans; Ifosfamide; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2020 |
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy | 2020 |
Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Japan; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Rhabdomyosarcoma, Alveolar | 2020 |
Successful treatment of stage 4 rhabdomyosarcoma in a female with Williams-Beuren syndrome.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Irinotecan; Neoplasm Staging; Proton Therapy; Rhabdomyosarcoma; Vincristine; Williams Syndrome | 2020 |
Challenges in the management of localized Ewing sarcoma in a developing country.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Patient Compliance; Prognosis; Retrospective Studies; Sarcoma, Ewing; Sepsis; Survival Rate; Vincristine | 2020 |
Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Treatment Outcome | 2021 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Vindesine; Young Adult | 2020 |
Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Prognosis; Splenic Neoplasms; Turner Syndrome | 2020 |
Splenic embolization to continue chemotherapy in a child with hypersplenism-related thrombocytopenia.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Embolization, Therapeutic; Etoposide; Female; Humans; Hypersplenism; Ifosfamide; Thrombocytopenia; Vincristine | 2021 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
Para-neoplastic optic neuritis presenting in a child with fusion positive localised para-testicular alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunoglobulins; Male; Optic Neuritis; Rhabdomyosarcoma; Steroids; Testicular Neoplasms; Vincristine | 2021 |
Nivolumab Treatment of Burkitt Lymphoma: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nivolumab; Vincristine | 2021 |
Mediastinal desmoplastic small round cell tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Desmoplastic Small Round Cell Tumor; Etoposide; Humans; Ifosfamide; Image-Guided Biopsy; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Salvage Therapy; Young Adult | 2020 |
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2021 |
Hyperthermic intraperitoneal chemotherapy (HIPEC) as another treatment modality for desmoplastic round cell tumour patients: first paediatric experience from UK.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Cytoreduction Surgical Procedures; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Humans; Hyperthermic Intraperitoneal Chemotherapy; Ifosfamide; Liver Neoplasms; Maintenance Chemotherapy; Neoadjuvant Therapy; Pelvic Neoplasms; Peritoneal Neoplasms; Radiotherapy; Remission Induction; United Kingdom; Vincristine; Vinorelbine | 2021 |
A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematuria; Humans; Ifosfamide; Infant; Sarcoma, Ewing; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2021 |
Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Remission Induction | 2020 |
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult | 2021 |
First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal | 2021 |
A primary mediastinal germ cell tumor of yolk sac type: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chest Pain; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Mediastinal Neoplasms; Platinum Compounds; Tomography, X-Ray Computed; Young Adult | 2021 |
Sequencing therapies in Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carboplatin; Dacarbazine; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Vinblastine | 2021 |
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cost Savings; COVID-19; Etoposide; Humans; Ifosfamide; Retrospective Studies; SARS-CoV-2 | 2022 |
Primary pharyngeal synovial sarcoma in a pediatric patient: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Deglutition Disorders; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Multimodal Imaging; Pharyngeal Neoplasms; Reoperation; Sarcoma, Synovial; Vincristine | 2021 |
High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Transplantation, Autologous | 2022 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Feasibility and safety of outpatient administration of ifosfamide and etoposide for pediatric patients with Ewing sarcoma in a resource-limited setting amid the COVID-19 pandemic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; COVID-19 Drug Treatment; Etoposide; Feasibility Studies; Humans; Ifosfamide; Outpatients; Pandemics; Retrospective Studies; Sarcoma, Ewing | 2022 |
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Depsipeptides; Etoposide; Humans; Ifosfamide; Ki-1 Antigen; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy | 2022 |
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, T-Cell; Retrospective Studies; Treatment Outcome | 2022 |
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Latin America; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Registries; Retrospective Studies; Rituximab; Vincristine | 2022 |
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma; Salvage Therapy | 2022 |
Outcomes of Pediatric Patients With Metastatic Ewing Sarcoma Treated With Interval Compression.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasms, Second Primary; Sarcoma, Ewing; Vincristine | 2023 |
Analysis of stem cell collections in adult patients with Ewing sarcoma.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Child; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Stem Cells; Vincristine; Young Adult | 2022 |
A report on second neo-plasms in seven children with solid tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Second Primary; Neuroblastoma; Retrospective Studies; Rhabdomyosarcoma; Vincristine | 2022 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Enzyme Therapy; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Child; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Prospective Studies; Retrospective Studies; Vincristine; Young Adult | 2023 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2022 |
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms | 2023 |
Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations.
Topics: Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Repressor Proteins; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2023 |
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver Disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cholestasis; Cholestasis, Intrahepatic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Hemorrhage; Humans; Ifosfamide; Neoplasms; Proton Therapy; Ulcer; Vincristine | 2023 |
Tolerability of ifosfamide-containing regimen in patients with high-risk renal and INI-1-deficient tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infant; Kidney; Neoplasms; Vincristine | 2023 |
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Retrospective Studies; Rituximab | 2023 |
Expression and Clinical Significance of circRNA Changes in Stored Erythrocytes During Platelet Transfusion in Acute Lymphoblastic Leukemia.
Topics: Clinical Relevance; Etoposide; Humans; Ifosfamide; MicroRNAs; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA; RNA, Circular; Splenomegaly | 2023 |
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 2024 |